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Abstract
We study known and potential numerical earmarks of schizophrenia through mathematical methods. One known numerical characteristic of schizophrenia is that of
prolonged encoding latencies in response to cognitive stimuli. Motivated by the need
to explain interaction patterns in 2 × 2 factorial data where one factor is encoding
load and the other is diagnostic status, we define a class of general serial mixture
models based on the number of encoding subprocesses executed and the speed at
which they are executed. Mathematical derivations performed on these models yield
closed form expressions for the mean encoding latency and average intertrial variance,
which in turn yield expressions for the mean interaction contrast and variance interaction contrast. Different interaction signatures correspond to different members of
the model class. A wealth of examples are provided linking various potential physical
and neurophysiological encoding mechanisms to members of the model class. We also
derive results for a specific subset of the general model class where only the number
of subprocesses is allowed to vary over factorial cells. Our development includes a
numerical test (verified by theory and simulation methods) to determine if the number of encoding subprocesses varies over trials. Theoretical results are then developed
for the case where the speed of encoding subprocesses is allowed to vary. Secondly,
by means of an exhaustive literature search and application of contingency tables,
we investigate whether a collection of numerical indices, called nonlinear indices or
complexity indices, can be utilized to support or refute a conjecture in the literature
which states that complexity in EEG recordings tends to be higher in schizophrenia
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patients than controls with this tendency being dampened (and even inverted) by
medication, increasing age, and decreasing symptomatology. Our analysis indicates
only weak effects due to age and medication, and suggests that symptomatology may
play a greater role. Moreover, we observe a strong “study effect” which suggests
that laboratory procedures may also play a role. Our systematic review of nonlinear
indices does, however, indicate that heart rate variability is reduced in schizophrenia
and bipolar disorder.
Keywords: schizophrenia, stimulus encoding, mixture models, mean interaction contrast, nonlinear dynamics, complexity, EEG, heart rate variability, bipolar
disorder
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Summary
Schizophrenia is a mental disorder which is usually described in behavioural terms.
A person with schizophrenia will often exhibit symptoms of delusions (strongly-held
false beliefs) or hallucinations (the experience of sensations or perceptions without
supporting stimulus events accessible to others). Other symptoms may include incoherent speech and disorganized thought. This thesis, however, focuses on characteristics of schizophrenia that can be quantified numerically. One such characteristic is
that of prolonged encoding times. Encoding is the process by which a person mentally transforms an observed event or object into a format which facilitates the task
at hand, e.g., transforms a word into a picture for comparison with another picture.
Experimental evidence has shown that schizophrenia patients require longer encoding
times than normal controls or even other psychiatric controls. This thesis develops
a family of mathematical models which can be used to describe and investigate the
possible physical and psychological mechanisms that underlie the encoding process.
These models are constrained to fit known experimental data in which encoding load
and diagnostic status are manipulated. Secondly, the thesis investigates whether a
collection of numerical indices, called nonlinear indices or complexity indices, can be
used to differentiate schizophrenia (and bipolar disorder) patients from normal controls in EEG and ECG studies. In particular, we examine the question of whether
there is a tendency toward greater complexity in the EEG of schizophrenia patients,
with this tendency dampened or even reversed with medication, increasing age, and
reduced symptomatology. This analysis was spurred by a large literature with contra-
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dictory findings. We found only weak effects due to age and medication, and noted
that symptomatology as well as laboratory procedures may play a greater role in
outcomes. On the other hand, nonlinear indices seem to consistently indicate lower
complexity in the heart rate of both schizophrenia and bipolar patients.
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Chapter 1
Introduction to the Thesis
In the study of clinical psychology, the earmarks of psychopathology are of particular interest – those identifying characteristics which may allow us to distinguish a
disordered state from that of a healthy one. In this thesis we bring rigorous mathematical methods to bear on a suite of numerically quantifiable potential earmarks,
seen, for specificity, primarily through the lens of schizophrenia, yet demonstrably applicable to certain other disorders (see, for example, the sections on bipolar disorder
in Chapter 3). The potential earmarks we consider can largely be subsumed under
the rubric of the cognitive neuroscience of schizophrenia, with the chiefly studied
numerical characteristics either taking the form of cognitive-processing latencies (in
particular, encoding times) or nonlinear functions of reactive electroencephalogram
(EEG) signals in response to cognitive stimuli. However, further potential earmarks
that are studied are nonlinear functions of heart rate variability (HRV), the latter
which is governed by neuro-signals through the autonomic nervous system (ANS)
and may be measured easily in a noninvasive fashion.
One broad goal of the thesis is to illustrate the value and utility of mathematics as a tool to describe, model, investigate, quantify, and validate (or invalidate)
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potential earmarks of psychopathology (in this case the pathology of schizophrenia).
This theme is omnipresent throughout the thesis. In Chapter 2, we focus specifically
on the earmark of prolonged encoding latencies which are observed in schizophrenia
(R. W. J. Neufeld and coauthors; for details see Chapter 2 and the references therein).
Encoding is the mental process by which a person transforms cognitive stimuli into
a task-facilitative format (for example, transforms a word into a picture for comparison with another picture). Neufeld and coauthors have determined experimentally
that the encoding process requires more time for schizophrenia patients than it does
for normal controls or other psychiatric controls (such as persons exhibiting major
depression), thus rendering its prolongation a verified earmark of the disorder. In
Sec 2.1.1 we review the literature on 2 × 2 factorial experimental paradigms (with
encoding load as one factor and diagnostic status as the other) which have given rise
to the above conclusions. These results are accompanied by the observation that the
mean interaction contrast (MIC) is always found to be zero whereas the variance interaction contrast (VIC) may be zero or nonzero depending on the experiment. In Sec
2.1.2 we review some early models for encoding latencies which satisfy the constraint
VIC = 0 if and only if MIC = 0 and are sufficient to explain certain experimental
paradigms. These early models act as a springboard to the definition of a general
class of serial mixture models in Sec 2.2, which is the first original contribution of
the thesis. (Material in Chapter 2 from Sec 2.2 onward is original work by the thesis
author.) This class of serial mixture models features two key components: K, the
number of encoding subprocesses being executed on a trial, and Θ, a vector which governs the speed at which each subprocess is encoded. Each serial mixture model also
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features a base distribution which can essentially be any continuous positive righttailed probability distribution. The broad generality in the definition of this class of
models allows it to be potentially applicable to a wide range of cognitive-processing
latencies (where encoding subprocesses are replaced by the relevant components of
the cognitive process under consideration). In Theorem 1 we further illustrate the
flexibility of this model class by demonstrating that each instantiation can also be
interpreted in parallel form as well as serial form; specifically, each instantiation has
a representation as a fixed capacity parallel model with reallocation. Mathematical
derivations performed on this model class then lead to Theorem 2 which provides
closed form formulae for mean encoding latencies E(T ) and average intertrial variances E(Var(T )) (calculations which heretofore had to be computed by integrals on
a case-by-case basis). These closed form expressions are a highlight of the thesis,
as they in turn yield expressions for MIC and VIC which can be developed for any
member of the model class. In Sec 2.3 we study a specific subset of the model class
which we call generalized Cutler-Neufeld (gen-CN) models as they are extensions
of the earlier models developed by Neufeld and Cutler and Neufeld reviewed in Sec
2.1.2. These models have the feature that only the number of subprocesses K can
vary over factorial cells whereas the distribution of Θ remains the same from cell to
cell. Thus these models correspond to encoding mechanisms where changes in E(T )
and E(Var(T )) over cells can be explained by changes in the number of subprocesses
executed. The structure of gen-CN models allows for simple elegant expressions for
MIC and VIC (Theorem 3) and for mathematical derivation of numerous examples
which feature various MIC-VIC signatures, some of which satisfy VIC = 0 if MIC =
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0 and some of which satisfy VIC 6= 0 if MIC = 0. The potential underlying physical
and/or neurophysiological encoding mechanisms corresponding to each of these examples is also discussed. It would seem that gen-CN models have the potential for
wide applicability, given the number of encoding mechanisms that can be put in this
format and given the fact that converging experimental evidence has indicated that
in many cases changes in encoding latencies can be explained by changes in the number of subprocesses executed (see Sec 2.1.2). In Sec 2.4 we consider the problem of
distinguishing gen-CN models with variation from gen-CN models without variation.
A gen-CN model has variation if K varies over trials for a participant in addition
to possibly varying over participants, whereas in a gen-CN model without variation
K can only vary over participants. Variation over trials can occur for a number of
reasons, but one specific cause of particular interest to experimenters is (unwanted)
variability of the stimulus input sequence of the experiment. We show that VIC 6= 0
implies variability over trials (Theorem 4) which in many cases will be a quick sufficient method to establish variation. However, it is possible for variation to occur
even in the presence of VIC = MIC = 0 so an alternative method to Theorem 4
required development. In Theorem 5 and Corollary 5.1 we develop a ratio statistic
(based on the sample variances and means of the cell encoding latencies) and show
that if this ratio differs over cells then variation over trials must be present. Extensive simulation studies are carried out to illustrate both the use and limitations of
this ratio statistic. Finally, in Sec 2.5, we turn our attention to the case where Θ,
rather than K, varies over cells. This amounts to explaining changes in E(T ) and
E(Var(T )) across cells by changes in the encoding speed of subprocesses rather than
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by changes in the number of subprocesses. Although there is less experimental evidence supporting this paradigm where encoding is involved, it is possible that it may
describe some encoding situations as well as being applicable to cognitive-processing
latencies other than encoding. Since the definition of Θ depends explicitly on the base
distribution, one must choose a particular base and derive results on a case-by-case
basis. Theorems 6-8 (along with attendant corollaries) develop MIC-VIC expressions
for different choices of base distribution and different choices of varying component in
the Θ vector. The section is rounded out with a number of examples illustrating various MIC-VIC signatures. The chapter closes with the section Discussion and Future
Directions.
Chapter 2 saw us focus attention on the goal of developing mathematical
models for a numerical characteristic (encoding latency) which has been verified experimentally as an earmark of schizophrenia. In Chapter 3 we turn our attention
to a different goal – specifically, that of attempting to ascertain whether a certain
collection of (or subset of) numerical characteristics can be utilized as earmarks of
schizophrenia. The numerical characteristics we consider are called nonlinear indices
and are often referred to as complexity indices, in spite of the fact that the term
“complexity”, although ubiquitous in the nonlinear science literature, is actually an
ill-defined concept. At least some authors regard a complex state as one falling somewhere between a completely ordered state and a completely random state, but this
intuitive idea is complicated by the fact that the various nonlinear indices do not
all measure the same quantity, and in fact some of these indices, such as entropy
indices, actually reach their maximum value in the case of completely random states.
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Chapter 3 has been published as the article Cutler and Neufeld (2019)1 but here we
provide a version of this article with slightly expanded introductory material (Secs
3.1-3.3) which gives concise but precise definitions of the various nonlinear indices
and the methods used to obtain them since these are typically not well-known quantities or methodologies outside of nonlinear science. In Sec 3.4 we proceed to examine
the potential utility of nonlinear indices in distinguishing the EEG of schizophrenia
patients from that of normal controls. A vast array of authors have attempted to utilize nonlinear indices in this way – specifically, to ascertain if a particular nonlinear
index (or group of indices) can indicate whether EEG recordings, in response to cognitive stimuli, are more complex or less complex in schizophrenia patients compared
to those of normal controls. The resulting literature has provided numerous contradictory findings in this regard. The centerpiece of this chapter and its chief unique
contribution (presented as Section 3.4.1), is an exhaustive quantitative analysis of the
existing literature on this topic. In particular, we attempt to determine whether a
certain hypothesis put forward in the literature by some authors (a hypothesis which
we call the L-F proposal) appears to have merit based on the totality of studies that
have been done. The L-F proposal, paraphrased, is the claim that “complexity tends
to be higher in the EEG of schizophrenia patients, especially first episode patients,
than that of controls, but this tendency is dampened or even inverted by antipsychotic medication, increasing age, and reduced symptomatology”. Obviously such
a proposal implies a delicate interplay between several factors, and can be used to
1

Cutler, C. D., & Neufeld, R. W. J. (2019). Nonlinear indices with applications to schizophrenia
and bipolar disorder. Nonlinear Dynamics, Psychology, and Life Sciences, 23, 17-56.
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explain the various contradictory and perplexing results found in the literature. We
utilize chi-square contingency tables in our quantitative analysis and find only weak
effects due to age and medication, and propose that symptomatology may be the most
important of the suggested L-F factors. However, it should be noted that the most
consistent and significant finding yielded by our analysis was that of a pronounced
“study effect”, i.e., the observation that, in most cases, each study showed similar
EEG outcomes in the patients over a range of cognitive stimuli. This is of course
not inconsistent with the suggestion that symptomatology of the patients is the most
important factor, but it also does not preclude the possibility that the different EEG
procedures and analyses used by different laboratories were contributing factors in
the outcomes. In Sec 3.5 we carry out a systematic review of nonlinear indices applied to heart rate variability in both schizophrenia and bipolar disorder; here we
find much more consistent results, with nonlinear indices suggesting lower complexity
(greater regularity) in heart rate in both these disorders. It is known that greater
regularity in heart rate creates a predisposition toward cardiac disease and sudden
cardiac events. Sec 3.6 reviews the limited literature applying nonlinear indices to
mood data in bipolar disorder, and the chapter closes out with Sec 3.7 Discussion
and Future Directions. Chapter 4 consists of Concluding Remarks which summarize
the key points of the thesis.
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Chapter 2
Encoding Latencies in
Schizophrenia and
Psychopathology
2.1

Introduction to Chapter 2

The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) of the American
Psychiatric Association (2013) provides categorical descriptions of mental disorders,
generally focusing on the observed behavioural symptoms of a disorder. For example,
schizophrenia is characterized by an individual displaying two or more of the following features: delusions, hallucinations, disorganized speech, grossly disorganized or
catatonic behviour, and negative symptoms (with at least one among the first three
features being present) (DSM-5, p. 99). In this chapter, however, we focus our attention on a quantitative characteristic of schizophrenia (specifically, prolonged encoding
latencies – see below) which may be modelled analytically, thereby rendering insight
into the nature of the underlying disease process. The general family of models we
develop (Sec 2.2 and onward), while explicated here in the context of encoding times
in schizophrenia, can be applied in principle to other cognitive-process latencies in
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both healthy individuals and those exhibiting various psychopathologies.
Cognitive deficits have long been recognized to play a significant role in the
presentation of schizophrenia (see, e.g., American Psychiatric Association, 2013; Andreasen, 1999; Bleuler, 1950; Friston, 1999). The cognitive deficit we focus on here
is that of the prolongation of encoding latencies or encoding times (the two terms
to be used interchangeably). Stimulus encoding (encoding, for short), is the mental
process by which an individual transforms a cognitive stimulus into a format which
facilitates carrying out the task at hand. As a concrete example, consider the classic
memory search Choice Reaction Time (CRT) task as described in Sternberg (1966,
1975). Here the participant is first presented with a set of alphanumeric items (memory set), then later presented with an item (probe item) which may or may not have
been a member of the memory set. The participant must determine, as quickly and
accurately as possible, whether the probe item was a member of the memory set,
indicating a decision by pressing a button with a “yes” or “no” response. In order
to achieve this, the participant must first encode the probe item, that is, extract its
salient physical features, such as lines, curves, and intersections, to facilitate subsequent comparison with the members of the memory set. The total response latency
or reaction time (to be denoted RT ) is the time measured from onset of presentation
of the probe item to completion of the “yes” or “no” response. This may be expressed
mathematically (e.g., Townsend & Ashby, 1983) as
RT = Tencoding + Y + W

(2.1.1)

where Tencoding represents the time spent encoding the probe item, Y represents the ad-

10
ditional time required to complete the mental task, such as making comparisons with
members of the memory set to render a decision, and W represents the additional time
required for the physical yes-no response. Although in some experimental paradigms
it is possible that these three steps are carried out sequentially in a nonoverlapping
manner, (2.1.1) allows them to overlap, permitting behaviour such as the cascade
model of McClelland (1979) in which encoding and comparisons operate simultaneously. The results of Neufeld (1978), combined with those of Neufeld (1977), in a more
complex sentence-verification CRT task, provide evidence that in some experiments,
at least for patients with schizophrenia, the ability to continuously access the probe
item (what we call, somewhat imprecisely, as “ongoing encoding”) improves performance in making comparisons. Highgate-Maynard and Neufeld (1986) deliberately
kept the probe item in view throughout their entire experiment to permit ongoing
encoding.
In a variety of CRT tasks, the memorial comparison times, as exemplified by Y
in (2.1.1), have been shown to be equivalent between normal controls and schizophrenia patients (Boksman, 2006; Checkosky, cited in Sternberg, 1975; Highgate-Maynard
& Neufeld, 1986; Marusarz & Koh, 1980; Neufeld, 1977; Wishner, Stein, & Paestrel,
1978). This is seen by examining the plot of the RT vs. the size of the memory set
(typically 1-4 items) or vs. the complexity of the comparison task quantified in some
suitable way (see Neufeld (1977, 1978) for an example of a sentence-verification CRT
task of varying complexity). The slope of the RT vs. memory set size (or complexity) is the same for both normal controls and schizophrenia patients, indicating that
they are making comparisons at equivalent rates. However, the RT s differ in their
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intercept values, with those of the schizophrenia patients being elevated above those
of the controls. The intercept value accounts for the encoding time plus the physical
response time, as exemplified by T + W in (2.1.1). These elevated intercepts cause
the RT s of schizophrenia patients to be elongated as compared to those of controls.
Converging evidence has indicated that both Y and the physical response time
W are spared in schizophrenia, and the elevation in RT intercepts is due solely to a
prolonged encoding time T . Neufeld (1978) designed an experiment where encoding
was arranged to take place first, then the probe item was removed, followed by the
commencement of timing. Under these circumstances the differences in intercepts
disappeared. Moreover, Carter and Neufeld (1999, 2007) found that estimates of the
time engaged in memory search, decision-making, and physical response did not differ
between schizophrenia patients and controls. Intercept inequalities also remained
after accounting for memorial comparisons and physical response time in Neufeld,
Vollick, and Highgate (1993). These results point to the conclusion that encoding is
the process chiefly affected in schizophrenia.
It is worthy of note that the elongation of RT s is also more pronounced among
schizophrenia patients compared to other psychiatric control groups (such as patients
with major depression) and that schizophrenia patients with paranoid symptoms
(delusions and hallucinations) generally exhibit the most prolonged RT s of all (George
& Neufeld, 1987; Highgate-Maynard & Neufeld, 1986; Neufeld, 2007a; Neufeld &
Williamson, 1996).
The potential consequences of protracted encoding times are numerous. We
provide a summary of some of these here, and refer the reader to Neufeld (2021) for

12
an excellent and thorough review. A direct link has been posited between elongated
encoding times and thought-content disorder (thematic delusions) in schizophrenia
(Neufeld, 2007a; Neufeld, 2021; Neufeld, Boksman, Vollick, George, & Carter, 2010).
Given a fixed small window of time available to encode a situation (e.g., a passing
conversation) it is possible that a person who requires considerably more time for
satisfactory encoding may fail to properly transform several of the less salient but
nonetheless important contextual features of the situation, thus coming away with
a false impression of what transpired. A natural need to contextualize the situation
may lead the person to attribute persecutory or grandiose elements to the circumstances, considering that such attribution may have a self-protective element to it.
Prolonged encoding times can also be used to explain the compromised coherence
of judgments that depend on execution of multiple stimulus dimensions (Carter &
Neufeld, 1999). Moreover, schizophrenia patients, particularly those with paranoid
features, exhibit increased numbers of rapid eye-movement saccades when visually
tracking a slow moving target. The increased number of saccades are believed to
be due to inefficient encoding of the spatial stimulus properties required for smooth
tracking (Adams, Huys, & Rosier, 2016; Collewijn & Tamminga, 1982; Neufeld &
Williamson, 1996). Finally, protracted encoding impacts negatively on the successful
navigation of environmental stressors (Morrison, Neufeld, & Lefebvre, 1988; Neufeld
& Grant, 2018; Shanahan & Neufeld, 2010).
In this chapter we will be looking at mathematical models applied to encoding times and designed to explain patterns in mean interaction contrast (MIC) and
average intertrial variance contrast (VIC) (see below) arising in certain 2 × 2 factorial
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CRT experimental paradigms. We describe these paradigms, with specific examples,
in the subsection below.

2.1.1

2 × 2 Factorial Paradigms

Here we will consider 2 × 2 factorial experiments where one factor to be manipulated
is encoding load (designated to be low (L) or high (H)) and the second factor to be
manipulated is diagnostic status (designated to be normal health (N) or schizophrenia
(S)). The format is that of a 2 × 2 mixed model ANOVA where the between-subjects
factor is diagnostic status and the within-subjects factor is encoding load. We perform
a CRT task and obtain the RT s for all participants in the four factorial cells (LN,
LS, HN, and HS). The experiments we consider all have the feature that memorial
comparisons Y and physical response times W behave the same way for both controls and schizophrenia patients (as discussed in the Introduction to Chapter 2) but
encoding times T depend on both encoding load and diagnostic status. Specifically,
T tends to increase as the encoding load moves from low to high (which is intuitively
credible) and, as we have discussed earlier, T also tends to increase as diagnostic
status changes from normal to schizophrenia. Thus we can replace the general RT
model (2.1.1) here by the specific factorial RT model
RTload, diagnosis = Tload, diagnosis + Y + W

(2.1.2)

We now describe some specific examples of such experiments. Highgate-Maynard and
Neufeld (1986) asked participants to decide, “yes” or “no”, whether a probe item (an
object or animal) was similar in real-life size to any member of a memory set of objects
(e.g., an airplane and a coffee pot are not similar in real-life size). Encoding load was
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manipulated by either presenting both probe item and memory set in pictures (low
encoding load; see Paivio (1975, 1979)) or presenting both probe item and memory
set in words (high encoding load, as this requires transformation to visual imagery;
again see Paivio (1975, 1979)). For the sake of the factorial design, only trials on
which there were no matches were considered. George and Neufeld (1987) conducted
a CRT task where participants were briefly shown a four-letter word in the central
visual field (memory set), followed by a probe item. The probe item consisted of two
words, one presented in the right visual field and one presented in the left visual field.
Participants were asked to indicate, “yes” or “no”, whether either one of the two words
matched the memory set. For the sake of the factorial design, only the case of matched
trials was considered. The encoding load was appraised to be low if the matching
word was presented in the right visual field (left hemispheric superiority for processing
of verbal stimuli) and high if the matching word was presented in the left visual field.
Boksman (2006) considered a CRT task where participants were asked to determine
if a probe item (a consonant) belonged to a previously memorized set of consonants.
Encoding load was manipulated by presenting the probe item either in the same font
as the memory set (low encoding load) or in a different font (high encoding load).
Kieffaber et al.˜(2006) provided participants with a pre-trial auditory cue (“shape”
or “size”), then asked them to decide, “yes” or “no”, whether a presented pair of
items were the same in terms of the cue. Trials were divided as either “stay” trials
(where the cue was the same as on the previous trial) or “switch” trials (where the cue
changed from the previous trial). Stay trials can be designated as low encoding load
and switch trials as high encoding load (see Schneider & Logan (2005)) and indeed
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results showed a marked increase in the length of correct-response RT s for switch
trials compared to stay trials. Finally, Taylor, Théberge, Williamson, Densmore, and
Neufeld (2016, 2017) considered the Stroop cognitive task where the congruent case
(colour of name matching the name of colour) comprised the low encoding load, and
the incongruent case (colour of name not matching name of colour) comprised the
high encoding load.
We now define the mean interaction contrast (MIC) as
MIC = (E(RT )HS − E(RT )HN ) − (E(RT )LS − E(RT )LN )

(2.1.3)

= (E(T )HS − E(T )HN ) − (E(T )LS − E(T )LN )
where equality between the two lines of (2.1.3) comes about because the expectations
E(Y ) and E(W ) are the same over the four factorial combinations (see (2.1.2)).
Thus we may express MIC in terms of the second-order differences of either the raw
RT s or the implicit encoding times T . We will utilize the encoding times because
those are the particular cognitive processes we wish to model; however, in practice
it is the RT s which are readily available from data. Rough estimates of encoding
times can be determined by employing the method of subtraction (Donders, 1969) as
illustrated in Neufeld et al. (2010) after estimating E(Y ) and replacing E(W ) by an
estimated experimental quantity (Woodworth & Schlossberg, 1954, p. 36). However,
these estimates of encoding times can be too crude to be useful in some cases (Cutler
& Neufeld, 2017) although Neufeld et al. (2010) was able to exploit them profitably.
However, due to the equality of the two lines in (2.1.3), we can continue to express
MIC in terms of second order differences of mean encoding times while in practice
computing it by second order differences of estimated mean RT s.
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The case MIC = 0 of course corresponds to the case where there is no interaction between the two factors encoding load and diagnostic status. Perhaps surprisingly, this feature was observed in all five of the experiments described in this subsection; mean reaction times in schizophrenia patients and normal controls increased
by the same amount as the encoding load moved from low to high (factorial additivity of means). Although some caution must be applied in accepting this conclusion
(since testing for interactions favours the null hypothesis) the replication of this result over a variety of experimental paradigms suggests it is a genuine phenomenon. It
appears that schizophrenia and encoding load operate separately and independently
to alter encoding times. Thus any models we utilize for encoding times should easily
accommodate this phenomenon; see the discussion in Neufeld (2021) and Neufeld et
al. (2010) and Sec 2.2 onward of this chapter.
Another quantity which can be used to augment our ability to model is the
average intertrial variance contrast VIC. In order to define VIC, first note that, under
the assumption that T , Y , and W act independently of one another, from (2.1.2) we
have, for any random trial on any participant in a particular cell
Var(RT )load, diagnosis = Var(T )load, diagnosis + Var(Y ) + Var(W )

(2.1.4)

and hence, taking expectations over all participants in each cell:
VIC = (E(Var(RT ))HS − E(Var(RT ))HN ) − (E(Var(RT ))LS − E(Var(RT ))LN )
= (E(Var(T ))HS − E(Var(T ))HN ) − (E(Var(T ))LS − E(Var(T ))LN )

(2.1.5)

where the two lines in (2.1.5) are equal because E(Var(Y )) and E(Var(W )) are the
same over each of the four cells. Thus, as in the case of MIC, VIC can be de-
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fined in terms of either second order differences of average intertrial variances of
RT s or of second order differences of average intertrial variances of encoding times.
E(Var(RT ))load, diagnosis can be estimated from the data in a cell by computing the
sample variance of the RT s of each cell participant, then averaging these sample variances over all participants in the cell. The case VIC = 0 indicates factorial additivity
in the variances.
George and Neufeld (1987) (see Neufeld et al. (2007) and Neufeld et al. (2010)
for discussion) as well as Taylor et al. (2016, 2017) found results compatible with
MIC = VIC = 0. However, factorial additivity of variances is not as universal as
factorial additivity of means; the Highgate-Maynard and Neufeld (1986) data, as cited
in Neufeld and Williamson (1993), found factorial superadditivity in the variances,
i.e., VIC > 0 in company with MIC = 0.
This chapter is devoted to developing a class of models that spawn various
examples which, when MIC = 0, provide different outcomes for VIC; more specifically, for these different examples we are able to compute the exact form of VIC for
MIC = 0. The physical mechanisms underlying these examples are also discussed.
This provides a collection of templates against which an experimenter can compare
theoretical mechanisms and factorial data to choose or eliminate certain models.
Earlier models considered by Neufeld (2021), Neufeld et al. (2010), and Cutler
and Neufeld (2017) provide a springboard to the general class of models we develop
in Sec 2.2 and onward. We review these earlier models in the next subsection.
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2.1.2

The Neufeld and Cutler-Neufeld Models

The encoding process overall can be viewed as the execution of a collection of component subprocesses; e.g., in a basic Sternberg memory search CRT task (Sternberg,
1975), the alphanumeric probe item is encoded as a collection of lines, curves, and intersections (subprocesses) for comparison against the memory set. In a more complex
CRT language-verification task (Neufeld, 1977, 1978), sentences needed to be encoded
as an abstract set of negative vs. affirmative components for comparison against a
visual display. It has been shown (Townsend & Nozawa, 1995; Townsend & Wenger,
2004) that MIC = 0 (factorial additivity of means as discussed in the previous subsection) is a signature of constituent subprocesses being carried out in serial. To this
end, Neufeld et al. (2007), Neufeld et al. (2010), and Neufeld (2021) used the simple
standard serial model as a starting point to model encoding times T . This model
has the exponential distribution as its base. The time to complete each individual
component encoding subprocess `j is assumed to follow an exponential distribution
with the same rate parameter v and probability density function (pdf)
φ(`) = ve−v`

for ` > 0

(2.1.6)

We can then express T as the sum of its k individual subprocess encoding times
T = `1 + · · · + `k

(2.1.7)

which, under the assumption the `j s also act independently of one another (independent intercompletion times) leads to T following an Erlang distribution with param-
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eters k and v with pdf given by
v k tk−1 −vt
e
f(t) =
(k−1)!

for t > 0

(2.1.8)

The Erlang is a special case of the gamma distribution (see Appendix B). Here the
parameter k is interpreted as the number of encoding subprocesses and v is interpreted
as the rate at which each subprocess can be completed (elemental workload capacity).
The serial model as described above in (2.1.7) is intuitively appealing but it should
be noted that it can be mimicked by a fixed capacity parallel model with reallocation
(FCPR model); see Townsend and Ashby (1983, p. 138) for a discussion focusing
on the exponential case, as well as Sec 2.2 of this chapter for details and a general
equivalence between such models even in the non-exponential case. In fact Neufeld
et al. (2010) presented the Erlang model as an FCPR model. It can be seen that
the Erlang (whether interpreted in its serial or parallel form) easily accommodates
the signature VIC = 0 if MIC = 0, and that MIC = 0 is achieved by appropriately
varying the number of subprocesses k across cells while holding v fixed; see Sec 2.2
and onward where more general models are considered. Taylor et al. (2016, 2017)
were able to utilize the Erlang model profitably in fitting their Stroop factorial data.
It should be noted that Neufeld et al. (2010) and Neufeld (2021) considered
two other models for T which can easily accommodate the signature MIC = 0; one
is the independent parallel model with moderately limited capacity, and the other is
a first stage unlimited capacity model. In both these cases the distribution of T is
seen to have a general gamma distribution (McGill & Gibbon, 1965) in which the
pdf of T is a weighted combination of exponential distributions with different rates.
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In particular, the intercompletion times are not identically-distributed. We will not
expand on these two models because in this chapter we focus on developing a class of
models where the intercompletion times are independent and identically-distributed
(i.i.d.) on any given trial, thus extending the Erlang model.
In some cases the Erlang model can explain factorial data well (e.g., Taylor et
al. (2016, 2017)). However, other data may display extra variation or “over dispersion” which degrades the model fit. A novel approach to account for over dispersion
in encoding latencies, given by Neufeld, Vollick, Carter, Boksman, and Jetté (2002),
Neufeld et al. (2007), and Neufeld et al. (2010), was to expand the Erlang model to
a Bayesian mixture model (Batchelder & Riefer, 2007; Berger, 1985; Neufeld, 2016).
In a mixture model extension of the Erlang model1, each participant i is assigned
their own values ki and vi representing, respectively, the number of subprocesses
they require to encode the stimulus and the rate at which they encode them. This
extension is quite natural as we would not generally expect two individuals to behave in identical fashion in the course of an experiment. The differences between the
ki s and the vis, ranging over participants, can account for the variation previously
dismissed as exogenous “noise”. Moreover, this variation, now captured within the
model itself as a meaningful and elucidated feature, can itself be modelled in terms of
distributions (called Bayesian priors or Bayesian mixing distributions) over the four
cells. In the specific mixture model we call the Neufeld model, specific choices for
prior distributions were made on the number of subprocesses k and the rate v. The
number of subprocesses k, distributed across participants in cell *, was assumed to
1

in this case the Erlang may be considered as the “skeleton” of the mixture model
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D

follow a Poisson distribution with mean m∗ (abbreviated k ∼ Pois(m∗)), whereas v
was assumed distributed across participants in each cell according to a gamma distribution with constant shape parameter u and constant rate parameter r (abbreviated
D

v ∼ Gam(u, r)) (see Appendices A and B for distributions). In this context, m∗, u, r
are called hyperparameters. These hyperparameters can take on specific psychological
meanings within an experiment (Neufeld, 2007b). The hyperparameter m∗ of course
represents the average number of subprocesses required for encoding by participants
in cell *. The hyperparameter u is a competence-based parameter, where higher
values of u reflect greater participant competence (owing, for example, to practice
effects), and r is a stress-related hyperparameter, where larger r detracts from the
performance of the participants.
The reason in the Neufeld model for allowing m∗ to vary with the cell * while
keeping u and r fixed over the cells was to easily satisfy the signature VIC = MIC = 0;
this was profitably utilized in fitting the George and Neufeld (1987) factorial data
(Neufeld et al., 2007; Neufeld et al., 2010). Note that allowing m∗ to vary over cells
while keeping the distribution of v fixed over cells proclaims that the increase in mean
encoding latencies seen in moving diagnostic status from normal health to schizophrenia, or from low encoding load to high encoding load, is due to an increase in the
number of subprocesses being executed rather than any change in the rate at which
they are being executed. Thus this model posits a hypothesis about the neurophysiological mechanism behind prolonged encoding times in schizophrenia patients. It
is intuitively credible that the number of required subprocesses would increase when
shifting from a low encoding load to a high encoding load, but it is less obvious why the
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schizophrenia disease process should produce additional encoding operations above
those of a control. Nonetheless, converging evidence suggests that the mechanism
posited by the Neufeld model is indeed accurate for a class of factorial experimental paradigms. Russell and Knight (1977) noted that elevated preparatory activity
(described as “process system priming”) appeared to take place in schizophrenia patients at the inception of a cognitive task. A wealth of results from neuroimaging
studies and related paradigms support the notion of an atypical resting state defaultmode network of neurocircuitry in schizophrenia patients (Bluhm et al., 2007; Hare
et al., 2019; Lee, Doucet, Leibu, & Frangou, 2018; Murphy, Birn, Handwerker, &
Bandettini, 2000; Orliac et al., 2013; Penner et al., 2018; Williamson & Allman,
2012). Braver and Barch (2006) note that atypical default-system connectivity in
schizophrenia may negatively impact the efficient implementation of encoding steps
once encoding is initiated. Failure to implement may arise from a variety of sources,
e.g., failing to successfully navigate an encoding step and therefore being required to
repeat it, or failing to tag a step as completed and thus unnecessarily repeating it
(Hemsley, 1993, 1994; Steffy & Galbraith, 1980; Steffy & Waldman, 1993). There
may also be failure to aggregate redundant elements of a subprocess into a single
Gestalt (Treisman, 1996).
As successful as the Neufeld model has been in modelling some factorial experiments, it has also exhibited one particular flaw. Specifically, estimates of the average
number mLN of subprocesses required to be executed by participants in the LN (LowNormal) cell were considerably below one; in Neufeld et al. (2010) it was observed
that mLN = .0971 and in Highgate-Maynard and Neufeld (1986) it was observed that
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mLN = .00001. Assuming these estimates are all based on valid encoding trials (i.e.,
the participants did not disengage from the task or respond based on some other cue)
this implies that some participants were encoding instantaneously. In other words,
they were encoding without executing any subprocesses, which is unsatisfactory both
conceptually and mathematically. Cutler and Neufeld (2017) managed this situation
by introducing a task parameter α > 0 (smaller α implies the task is easier) and
replacing the exponential base (2.1.6) with the following gamma base
φ(`) =

v α`α−1 −v`
e
Γ(α)

(2.1.9)

Once again a random encoding time T can be represented in serial form by the
sum of the `j s as in (2.1.7), only now T follows a Gam(kα, v) distribution rather
than an Erlang distribution. We further cast it in the form of a mixture model by
allowing ki and vi to vary with the participant i as in the Neufeld model. However,
we further stipulate that the distribution of k over participants in each cell must
follow a distribution which takes mass only on positive integers, thereby disallowing
the Poisson distribution as a mixing distribution. Thus, the Cutler-Neufeld model
differs from the Neufeld model only in two fundamental ways; one in the choice of
base distribution on the subprocesses (gamma rather than exponential) and second
in a restriction on the legitimate mixing distributions for subprocesses. Both models
accommodate VIC = MIC = 0 but the Cutler-Neufeld model allows for arbitrarily
small (but nonzero) estimates of mLN , recast now as being estimates of the product
αmLN (Cutler & Neufeld, 2017) rather than that of the mean itself. This provides
one motivation and justification for considering base distributions other than the
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exponential, as we do in Sec 2.2. Allowing a wide range of base distributions not
only permits a flexible range of modelling for encoding times, it allows extension of
modelling to other cognitive-processing latencies which may suit a particular base
distribution. In Sec 2.2 we also relax our restriction on requiring mixing distributions
on k to be restricted to positive integers, instead interpreting cases where k = 0 as
“faulty trials” where the participant has disengaged or responded based on some other
cue. This provides a convenient mathematical and conceptual bookend to possible
outcomes. (In practice the experimenter would likely identify and remove faulty trials
from consideration before analysis.)
In this chapter we will be focusing on the development and analysis of models
(nested within a large class of mixture models) yielding examples with specific values
of VIC given the constraint MIC = 0 and thereby extending the work of Neufeld
and Williamson (1996) and Neufeld (2021). Having said that, it is worth noting that
mixture models have an enormous range of applicability beyond the scope in which
we consider them here. Examples range from obtaining accurate personal parameter
estimates (e.g., ki , vi) based on a relatively small samples of encoding latencies from
a participant to estimating the probabilities of illness severity (group membership)
again based on a relatively small sample of encoding latencies compared against a
population (Neufeld, 2021; Neufeld et al., 2010).
Other sources on applications of modelling include Ahn and Busemeyer (2016),
Chechile (2020), Neufeld (2007b, 2015, 2016, 2021), Neufeld and Cutler (2019),
Neufeld and Shanahan (2021), and Townsend, Fifić, and Neufeld (2007).
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2.2

A Class of General Serial Mixture Models

The Cutler-Neufeld model can be considered as an extension of the Neufeld model
in the sense that the former allows for a general gamma base (2.1.9) of which the
exponential base (2.1.6) is the special case α = 1. Neufeld and Williamson (1996),
Neufeld et al. (2010), and especially Neufeld (2021), have considered extensions of
the Neufeld model which retain the exponential base but deviate from the Neufeld
model in other ways; for example, by allowing the number of subprocesses k or the
rate v to vary over encoding trials (rather than, or in addition to, varying over participants) according to a Poisson or gamma distribution respectively. We will see
that these Neufeld extensions are specific examples of the class of models we develop
now. This class is a general extension of the standard serial model (2.1.7). We allow any continuous positive infinite-tailed distribution to act as the base distribution
for an encoding latency, subject to the mild constraint that it have finite first and
second moments. The parameters that govern the base distribution are allowed to
vary over both trials and participants (and cells), and the number of subprocesses is
also allowed to vary over both trials and participants (and cells). Note that the form
of the base distribution (i.e., its probability distribution, with the exception of the
values of its parameters) is kept the same for all participants in all four cells. This
is a simplifying assumption in keeping with the observation of Neufeld et al. (2010)
and Neufeld (2021) that seldom is a change in overall model architecture required for
different participants within a given experimental paradigm; any necessary changes
can generally be accommodated by tweaking distributional parameters.
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Definition 1: the general serial mixture model: Let Ti denote a random encoding trial for participant i. We may express this in serial form as
(
0
if Ki = 0
Ti =
`i1 (Θi ) + · · · + `iKi (Θi ) if Ki ≥ 1

(2.2.1)

where the number of subprocesses Ki is a nonnegative integer-valued random variable
(that is, its values may vary over trials within a participant, and it may also vary
across participants) and the `i1 (Θi ), . . . , `iKi (Θi ) are independently and identicallydistributed (i.i.d.) continuous positive infinite-tailed random variables with the simplifying assumption that, for each participant, the distributional form of `ij (Θi ) is
the same except possibly for the values of the governing parameters Θi . The Θi are
random vectors which may vary over trials within a participant as well as across
participants. In other words, for all participants, the individual subprocess encoding
times `ij (Θi ) share a common base distribution but the parameters of that distribution on a particular trial for participant i depend on the value Θi = θi for that trial.
We further define the first and second-order moment functions
µ(θ) = E(`(Θ) | Θ = θ) and

σ 2(θ) = Var(`(Θ) | Θ = θ)

(2.2.2)

and make the assumption that µ(θ) and σ 2 (θ) are finite for all possible values of θ.
The mappings i → Ki and i → Θi can be considered as measure-valued random
processes (Kallenberg, 2017) over the individuals in each cell * with respective distributions P∗ (K) and Q∗ (Θ). It is assumed that the processes P∗ (K) and Q∗ (Θ) act
independently.
Notes Attendant to Definition 1: The capital letter notation Ki is used to indicate
the possibility that the number of subprocesses varies over trials for the ith participant;
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the capital Θi is used for similar reasons. The lower case letters ki and θi will be
reserved for two situations, the first being the case where there may be variation
across participants but none across trials (in which case Ki = ki and Θi = θi are
constants for participant i) or, secondly, when we are conditioning on the observed
outcome of a given trial, yielding Ki = ki and Θi = θi for that trial. The case Ki = 0
represents the situation where, on the specified trial, participant i does not encode at
all but either disengages from the task or responds based on some other cue (“faulty
trial”). Variability in Ki across trials can have a number of sources, such as variability
in the experimental input sequence from trial to trial, variability in the participant’s
attention from trial to trial, and instances of “partial encoding” (needing or choosing
to encode only parts of the stimulus before executing a response). Variability in
Ki across participants is of course due to differences between participants. Note
that changes in the vector parameter Θi (whether it be over trials or participants)
represent changes in the encoding speed of the subprocesses (thus Θ may be seen as
a generalization of the rate V associated with the exponential distribution) and we
may well envisage situations in which the nature of the input sequence or state of
mind of the participant may affect encoding speed of individual components.
Below we delineate a small number of potential base distributions. We refer the reader to Appendix B for details, properties, and abbreviations concerning
these distributions. The reader can find information about these distributions in
Hogg, McKean, and Craig (2005), Johnson, Kotz, and Balakrishnan (1994), and Van
Zandt (2000). Note that, in practice, any continuous positive right-tailed distribution
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would be a valid candidate provided it satisfied the finite moment constraints on µ(θ)
and σ 2(θ).
examples of base distributions:
D

1. exponential base: Here Θi = Vi and `ij ∼ expo(Vi ). It follows that µ(Θi ) =
1/Vi and σ 2(Θi ) = 1/Vi2 . For observed Ki = ki and Vi = vi on a trial, we obtain
D

Ti = `i1 (vi ) + · · · + `iki (vi ) ∼ Gam(ki , vi ) which is the Erlang distribution.
D

2. gamma base: Here Θi = (Ai , Vi ) and `ij ∼ Gam(Ai, Vi ). It follows that
µ(Θi ) = Ai /Vi and σ 2 (Θi ) = Ai /Vi2 . For observed Ki = ki , Ai = ai, and Vi = vi
D

on a trial, we obtain Ti = `i1 (ai, vi ) + · · · + `iki (ai , vi) ∼ Gam(ki ai , vi )
D

3. inverse Gaussian base: Here Θi = (Mi , Λi ) and `ij ∼ IG(Mi , Λi ). It follows
that µ(Θi ) = Mi and σ 2 (Θi ) = Mi3 /Λi . For observed Ki = ki , Mi = µi , and
D

Λi = λi , we obtain Ti = `i1 (µi , λi ) + · · · + `iki (µi , λi ) ∼ IG(ki µi , ki2 λi ).
D

4. Weibull base: Here Θi = (Ai , Bi ) and `ij ∼ Wei(Ai , Bi ). It follows that
µ(Θi ) = Bi Γ(1+1/Ai ) and σ 2 (Θi ) = Bi2 {Γ(1+2/Ai )−(Γ(1+1/Ai ))2 }. For given
values Ki = ki , Ai = ai and Bi = bi we obtain Ti = `i1 (ai , bi) + · · · + `iki (ai , bi).
In the case of the Weibull, a closed form expression for the distribution of Ti is
not known.
D

5. lognormal base: Here Θi = (Mi , Σ2i ) and `ij ∼ LN(Mi , Σ2i ). It follows that
2

2

2

µ(Θi ) = eMi +Σi /2 and σ 2(Θi ) = e2Mi+Σi (eΣi − 1).For given values Ki = ki ,
Mi = µi and Σ2i = σi2 we obtain Ti = `i1 (µi , σi2 ) + · · · + `iki (µi , σi2). In the
case of the log normal, a closed form expression for the distribution of Ti is not
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known.
We now show that the general serial mixture model can be mimicked distributionally by a fixed capacity parallel model with reallocation (FCPR model) as first
discussed in Sec 2.1.2. In an FCPR model, all subprocesses begin executing simultaneously at time t = 0; as soon as one subprocess finishes executing, its workload
capacity is reallocated over the remaining ki − 1 subprocesses and these remaining
subprocesses are “restarted” simultaneously with this new capacity. This procedure
is repeated until all subprocesses have finished executing. We make this precise
in the following (see also Atkinson, Holmgren, and Juola (1969), Townsend (1972,
1990), Townsend and Ashby (1983), and more recently Houpt, Townsend, and Jefferson (2018) and Townsend, Wenger, and Houpt (2018)).
Theorem 1: Suppose the encoding latency Ti can be represented by the general
serial mixture model in Definition 1. Then Ti has an equivalent (up to a random
ordering of the subprocesses) representation as an FCPR model.
proof: Condition on the outcome Ki = ki and Θi = θi for a given trial. In the cases
ki = 0 or ki = 1 there is nothing to prove as the parallel process is the same as the
serial process. Therefore assume ki ≥ 2. Let Si (t) denote the survivor function of
`ij (θi ), i.e., Si (t) = P (`ij (θi ) > t). At time t = 0 simultaneously start ki parallel
(1)

(1)

(1)

i.i.d. processes `1 , . . . , `ki where each `j has survivor function S (1)(t) = (Si (t))1/ki .
That is, S (1)(t) is the kith root of Si (t). Note that S (1)(t) is itself a survivor function
because S (1)(t) is decreasing, S (1)(0) = 1, and S (1)(∞) = 0. Let m1 be the time of
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(1)

(1)

finishing of the fastest process, i.e., m1 = min(`1 , . . . , `ki ). Then
(1)

(1)

(1)

(1)

P (m1 > t) = P (min(`1 , . . . , `ki ) > t) = P (`1 > t) · · · P (`ki > t)
= (S (1)(t))ki
= Si (t))1/ki

ki

(2.2.3)

= Si (t)
= P (`i1 > t)
D

Thus m1 has the same distribution as `i1 , i.e., m1 ∼ `i1 . Now at time m1 simultaneously speed up and independently restart the remaining ki − 1 processes
(2)

(2)

to produce new parallel i.i.d. processes `1 , . . . , `ki −1 which have survivor function
S (2)(t) = (Si (t))1/(ki−1) . (This amounts to redistributing capacity over the remaining
(2)

(2)

ki − 1 processes and restarting them from time m1.) Let m2 = min(`1 , . . . , `ki −1 )
which is the fastest finishing time of the restarted processes. Note that m2 represents
the intercompletion time between the first finishing time m1 and the second overall
finishing time m1 + m2. Moreover
(2)

(2)

(2)

(2)

P (m2 > t) = P (min(`1 , . . . , `ki −1 ) > t) = P (`1 > t) · · · P (`ki −1 > t)
= (S (2)(t))ki −1
= Si (t))1/(ki−1)

ki −1

(2.2.4)

= Si (t)
= P (`i2 > t)
D

and, from independence of the restarting process, m1 + m2 ∼ `i1 + `i2 . If ki ≥ 3
we can continue on in this manner, independently restarting and speeding up the
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(3)

(3)

remaining ki − 2 processes to produce new parallel i.i.d. processes `1 , . . . , `ki −2 which
D

have survivor function S (3)(t) = (Si (t))1/(ki −2) and intercompletion time m3 ∼ `i3 .
Carrying on in this way we have an overall parallel process with ki subprocesses and
D

independent intercompletion times m1, . . . , mki where mj ∼ `ij and
D

m1 + · · · + mki ∼ `i1 + · · · + `iki

(2.2.5)

The parallel and serial models are equivalent up to an ordering of the execution of
the subprocesses. The serial model may (or may not) specify a specific ordering of
execution of the subprocesses whereas the order of completion of the subprocesses
in this FCPR model is uniformly at random. However, they are distributionally
equivalent in the sense that they lead to the same distribution of the overall encoding
time Ti for given values Ki = ki and Θi = θi. 4
Thus the ability to consider the distribution of Ti as the result of a serial or
parallel process provides flexibility to the model architecture.
We now wish to derive general closed-form expressions for the mean encoding
latency E(T )∗ and average intertrial variance E(Var(T ))∗ in cell * for the general serial
mixture model. Although we will continue to use the convenient notation E(T )∗ and
E(Var(T ))∗ to denote these quantities, we will be more careful with the notation in
the computational formulas, since they will require computing moments over both
trials and participants. Before we take this step, we will summarize some standard
known formulas for calculating moments.
Lemma 1: standard calculation formulas: Suppose X and Y are two random
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variables. Then
E(X) = EY [E(X | Y )]

(2.2.6)

Var(X) = VarY [E(X | Y )] + EY [Var(X | Y )]

(2.2.7)

and if X and Y are independent, then
Var(XY ) = Var(X)Var(Y ) + E(X)2 Var(Y ) + E(Y )2 Var(X)

(2.2.8)

proof: see Ross (2007) for (2.2.6) and (2.2.7). The expression (2.2.8) follows from
elementary properties of the variance and independence. 4
We now derive closed form expressions for E(T )∗ and E(Var(T ))∗. We note
that this notation is somewhat careless, in that we should precisely express these
quantities as
E(T )∗ = E∗i [E(Ti)] and

E(Var(T ))∗ = E∗i [Var(Ti )]

(2.2.9)

where E(Ti ) and Var(Ti) denote the mean and variance, respectively, of the encoding
latencies of the ith participant over trials, and E∗i denotes the subsequent averaging
of those quantities over all participants in cell *. For convenience we will continue to
employ the casual notation E(T )∗ and E(Var(T ))∗ with the understanding that they
represent (2.2.9), but in the following computational formulas we will be very precise
with notation in order to avoid any confusion.
Theorem 2: general formulas for cell means and cell variances: Suppose we
have a general serial mixture model where, for the ith participant, Ti has associated
subprocess number Ki and random vector Θi . Let µ(Θi ) and σ 2(Θi ) be the moment
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functions defined in (2.2.2). Then
E(T )∗ = E∗i [E(Ki )]E∗i [E(µ(Θi ))]

(2.2.10)

and

E(Var(T ))∗ = E∗i [Var(Ki )]E∗i [Var(µ(Θi ))] + E∗i [E(Ki )2]E∗i [Var(µ(Θi ))]

(2.2.11)

+ E∗i [E(µ(Θi ))2 ]E∗i [Var(Ki )] + E∗i [E(Ki )]E∗i [E(σ 2(Θi ))]
proof: We first precisely define the notation on the right hand side of both (2.2.10)
and (2.2.11) and ask the reader to compare with (2.2.9). The outer expectations E∗i
refer to expectations being taken across all participants in cell *. The inner moments
(either expectations E or variances Var) are taken across trials within a participant
within a cell. These inner moments are computed first. Conditioning on Ki = ki and
Θi = θi for participant i we obtain
(Ti | Ki = ki , Θi = θi ) = `i1 (θi) + · · · + `iki (θi ) i.i.d. sum
so
E(Ti | Ki = ki , Θi = θi) = E(`i1 (θi )) + · · · + E(`iki (θi ))

(2.2.12)

= ki µ(θi )
and similarly
Var(Ti | Ki = ki , Θi = θi ) = Var(`i1 (θi)) + · · · + Var(`iki (θi))

(2.2.13)

2

= ki σ (θi )
Expressed in functional form these become
E(Ti | Ki , Θi ) = Ki µ(Θi ) and Var(Ti | Ki , Θi ) = Ki σ 2(Θi )

(2.2.14)
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Applying the standard calculation formulas in Lemma 1 and the independence of Ki
and Θi we obtain
E(Ti ) = E(Ki )E(µ(Θi ))

(2.2.15)

and
Var(Ti) = Var(E(Ti | Ki , Θi)) + E(Var(Ti | Ki , Θi ))
= Var(Ki µ(Θi )) + E(Ki σ 2 (Θi ))
(2.2.16)

= Var(Ki )Var(µ(Θi )) + E(Ki )2 Var(µ(Θi )) + E(µ(Θi ))2 Var(Ki )
+ E(Ki )E(σ 2(Θi ))
Now averaging over all participants in cell * (that is, applying E∗i ) and using (2.2.9)
and the fact that the random measures K and Θ are independent of one another, we
obtain (2.2.10) and (2.2.11). 4
Note: When applying expectations in (2.2.10) and (2.2.11), care must be taken
to apply expectations in the correct manner over the correct quantities. As noted
at the beginning of the proof of Theorem 2, inner moments, such as E(Ki )2 and
Var(µ(Θi )), are computed across trials for the ith participant. Thus, if Ki = ki and
Θi = θi are constant over trials for the ith participant, we obtain E(Ki )2 = ki2 and
Var(µ(Θi )) = Var(µ(θi )) = 0. On the other hand, the outer expectations E∗i are taken
across all participants in cell *.
Theorem 2 yields general closed form solutions to E(T )∗ and E(Var(T ))∗ for
any base distribution with any admissible choice of distributions P∗ (K) and Q∗ (Θ).
In the following we apply Theorem 2 to the exponential base.
Corollary 2.1: exponential base: Suppose we have a general serial mixture model
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with an exponential base and distributions P∗ (K) and Q∗(V ). (Recall Θ = V , the
exponential rate, in the case of an exponential base.) Then
E(T )∗ = E∗i [E(Ki )]E∗i [E(1/Vi )]

(2.2.17)

and

E(Var(T ))∗ = E∗i [Var(Ki )]E∗i [Var(1/Vi )] + E∗i [E(Ki )2]E∗i [Var(1/Vi )]

(2.2.18)

+ E∗i [E(1/Vi )2 ]E∗i [Var(Ki )] + E∗i [E(Ki )]E∗i [E(1/Vi2 )]
D

proof: Here `ij ∼ expo(Vi ) and hence µ(Vi ) = 1/Vi and σ 2 (Vi ) = 1/Vi2 (see Appendix B). Plugging these values into (2.2.10) and (2.2.11) yields the desired results.
4
We now apply Corollary 2.1 to a collection of examples considered by Neufeld (2021).
The examples fall under the umbrella of Corollary 2.1, each exhibiting an exponential base, accompanied by a Poisson distribution over K (either over participants or
trials) and a gamma distribution over V (either over participants or trials). Thus
these examples represent extensions of the Neufeld model. The purpose of examining
these examples is to show how easily E(T )∗ and E(Var(T ))∗ can be calculated by
utilizing known related distributional moments (see Appendix A and Appendix B for
moments and notation) and plugging into (2.2.17) and (2.2.18). This contrasts with
Neufeld (2021) where it was necessary to calculate integrals on a case-by-case basis.
Example 1: This is the Neufeld model, and corresponds to example 5 of Neufeld (2021).
D

Here k ∼ Pois(m∗) across participants in cell * and v ∼ Gam(u, r) across participants
in each cell where u > 2. There is no variation over trials, and so all three terms
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within the braces of (2.2.18) vanish. This yields
E(T )∗ =

E∗i [ki ]E∗i [1/vi ]

= m∗




m∗ r
r
=
u−1
u−1

and
E(Var(T ))∗ =

E∗i [ki ]E∗i [1/vi2 ]

= m∗




r2
m∗ r 2
=
(u − 1)(u − 2)
(u − 1)(u − 2)
D

Example 2: This corresponds to example 6 of Neufeld (2021). Here Ki ∼ Pois(m∗)
D

across trials for each participant in cell * whereas v ∼ Gam(u, r) across participants
in each cell where u > 2. Applying (2.2.17) yields
E(T )∗ = E∗i [E(Ki )]E∗i [1/vi ] = E∗i [m∗]E∗i [1/vi ] = m∗E∗i [1/vi ] =

m∗ r
u−1

Now because Ki is a random variable over trials whereas vi is constant over trials, we
see from (2.2.18) that the first two terms inside the braces vanish whereas the last
term inside the braces does not, and we obtain
E(Var(T ))∗ = E∗i [1/vi2 ]E∗i [Var(Ki )] + E∗i [E(Ki )]E∗i [1/vi2]
= E∗i [1/vi2 ] E∗i [Var(Ki )] + E∗i [E(Ki )]
=

E∗i [1/vi2 ] 2m∗



(2.2.19)

since Var(Ki ) = E(Ki ) = m∗

2m∗r2
=
(u − 1)(u − 2)
D

Example 3: This corresponds to example 7 of Neufeld (2021). Here Ki ∼ Pois(mi )
D

over trials for participant i, and then m ∼ Gam(w∗ , z∗) across participants in cell *.
(Thus Ki varies over both trials and participants.) As in the previous two examples,
D

v ∼ Gam(u, r) over participants in each cell where u > 2. Applying (2.2.17) yields
E(T )∗ =

E∗i [E(Ki )]E∗i [1/vi ]

=

E∗i [mi]E∗i [1/vi ]



w∗
=
z∗




r
rw∗
=
u−1
z∗(u − 1)
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As in Example 2, the first two terms inside the braces of (2.2.18) vanish whereas the
third does not, yielding
E(Var(T ))∗ =

E∗i [1/vi2 ]E∗i [mi]

+

E∗i [mi]E∗i [1/vi2 ]



w∗
=2
z∗



r2
(u−1)(u−2)



2r2 w∗
=
z∗(u−1)(u−2)

(2.2.20)

D

Example 4: This corresponds to example 9 of Neufeld (2021). Here Ki ∼ Pois(m∗)
D

over trials for each participant in cell * and also Vi ∼ Gam(u∗, r∗ ) over trials for each
participant in cell * where u∗ > 2. Applying 2.2.17 yields
E(T )∗ = E∗i [m∗]E∗i [r∗ /(u∗ − 1)] =

m ∗ r∗
u∗ − 1

Now since both Ki and Vi are random variables over trials here, all terms within
the braces of (2.2.18) are nonzero. Noting that E(Ki ) = Var(Ki ) = m∗ and that
E(1/Vi ) = r∗ /(u∗ − 1), E(1/Vi2 ) = r∗2 /[(u∗ − 1)(u∗ − 2)] and Var(1/Vi ) = r∗2 /[(u∗ −
1)2 (u∗ − 2)] (see Appendices A and B), we can plug into (2.2.18) to obtain


m∗r∗2
m2∗r∗2
r∗2 m∗
r∗2 m∗
E(Var(T ))∗ =
+
+
+
(u∗ −1)2 (u∗ −2) (u∗ −1)2 (u∗ −2) (u∗ −1)2
(u∗ −1)(u∗ −2)
=

m∗ r∗2 [m∗ + 2(u∗ −1)]
(u∗ −1)2 (u∗ −2)

(2.2.21)
D

Example 5: This corresponds to example 10 of Neufeld (2021). Vi ∼ Gam(u∗, r∗ )
across trials for each participant in cell * where u∗ > 2 (as in previous example)
D

D

but here Ki ∼ Pois(mi) across trials for participant i where m ∼ Gam(w∗ , z∗) across
participants in cell *. Applying (2.2.17) gives
E(T )∗ =

E∗i [mi ]E∗i [r∗/(u∗



w∗
− 1)] =
z∗




r∗
r∗ w ∗
=
u∗ − 1
z∗(u∗ − 1)

38
Again all terms inside the braces of (2.2.18) are nonzero. Since E(Ki ) = Var(Ki ) = mi
we obtain E∗i [E(Ki )2] = E∗i [m2i ] = [(w∗ +1)w∗ ]/z∗2 and E∗i [Var(Ki )] = E∗i [mi] = w∗ /z∗.
Plugging into (2.2.18) yields
 


 
r∗2
w∗(w∗ + 1)
r∗2
w∗
+
E(Var(T ))∗ =
z∗
(u∗ − 1)2 (u∗ − 2)
z∗2
(u∗ − 1)2 (u∗ − 2)

   

r∗2
w∗
w∗
r∗2
+
+
(u∗ − 1)2
z∗
z∗
(u∗ − 1)(u∗ − 2)


r2 w∗ 2z∗ (u∗ − 1) + w∗ + 1
= ∗2
z∗
(u∗ − 1)2 (u∗ − 2)
(2.2.22)
Below we apply Theorem 2 to a gamma base distribution.
Corollary 2.2: gamma base: Suppose we have a general serial mixture model with
a gamma base and distributions P∗ (K) and Q∗(Θ). Recall Θ = (A, V ), the shape and
rate parameters, respectively, in the case of a gamma base. Further assume that the
distributions of A and V act independently over both trials and participants. Then
E(T )∗ = E∗i [E(Ki )]E∗i [E(Ai)]E∗i [E(1/Vi )]

(2.2.23)

and

E(Var(T ))∗ = E∗i [E(Ki2)] E∗i [Var(Ai)]E∗i [Var(1/Vi )] + E∗i [E(Ai)2 ]E∗i [Var(1/Vi )]
+ E∗i [E(1/Vi )2]E∗i [Var(Ai )] + E∗i [E(Ai)2 ]E∗i [E(1/Vi )2 ]E∗i [Var(Ki )]
+ E∗i [E(Ki )]Ei∗[E(Ai)]E∗i [E(1/Vi2 )]
(2.2.24)
proof: For the gamma base µ(Θi ) = Ai /Vi and σ 2 (Θi ) = Ai /Vi2 . Plugging into
(2.2.10) and using the assumed independence of A and V yields (2.2.23). Now as
direct application of (2.2.11) will produce a very lengthy algebraic expression, we
shorten it first by noting that Var(Ki ) + E(Ki )2 = E(Ki2 ) and thus (2.2.11) can
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equivalently be written in the more compact asymmetric form

E(Var(T ))∗ = E∗i [E(Ki2 )]E∗i [Var(µ(Θi ))] + E∗i [E(µ(Θi ))2 ]E∗i [Var(Ki )]

(2.2.25)

+ E∗i [E(Ki )]E∗i [E(σ 2(Θi ))]
Now expanding Var(µ(Θi )) = Var(Ai /Vi ) according to (2.2.8) and plugging into
(2.2.25) and using independence yields (2.2.24). 4
Corollary 2.3: the Cutler-Neufeld base: This is a special case of the gamma
base where the shape parameter Ai = α is a constant; hence Var(Ai ) = 0. Plugging
into (2.2.23) and replacing E(Ki2 ) with Var(Ki ) + E(Ki )2 in (2.2.24) yields
E(T )∗ = αEi∗ [E(Ki )]Ei∗[E(1/Vi )]

(2.2.26)

and

E(Var(T ))∗ = α2 E∗i [Var(Ki )]E∗i [Var(1/Vi )] + E∗i [E(Ki )2 ]E∗i [Var(1/Vi )]

(2.2.27)

+ E∗i [E(1/Vi )2]E∗i [Var(Ki )] + αE∗i [E(Ki )]E∗i [E(1/Vi2)]
Corollary 2.4: inverse Gaussian base: Suppose we have a general serial mixture
model with an inverse Gaussian base and distributions P∗ (K) and Q∗ (Θ). Recall
Θ = (M, Λ), the mean and shape parameters, respectively, in the case of an inverse
Gaussian base. Further assume that the distributions of M and Λ act independently
over both trials and participants. Then
E(T )∗ = E∗i [E(Ki )]E∗i [E(Mi )]

(2.2.28)

and

E∗i [Var(Ti )] = E∗i [Var(Ki )]E∗i [Var(Mi )] + E∗i [E(Ki )2 ]E∗i [Var(Mi )]
+ E∗i [E(Mi )2]E∗i [Var(Ki )] + E∗i [E(Ki )]E∗i [E(Mi3)]E∗i [E(1/Λi )]
(2.2.29)
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proof: This follows directly by plugging µ(Θi ) = Mi and σ 2(Θi ) = Mi3 /Λi into
(2.2.10) and (2.2.11) and utilizing independence. 4
Note: In Corollary 2.2 and 2.4 we assumed that the components of the vector Θ
acted independently of one another; i.e., A and V were independent in the case of
the gamma, and M and Λ in the case of the inverse Gaussian. This assumption
was made simply in order to allow us to calculate the cell means and variances in
terms of the moments of the individual components of Θ. If the components of Θ
are not independent, this in no way invalidates (2.2.10) and (2.2.11); however, these
expressions must then be calculated using the joint distribution of Θ.
D

Example 6: Here we consider an inverse Gaussian base where the mean m ∼
D

Gam(u, r) across participants in each cell and the shape parameter λ ∼ Gam(w, z)
across participants in each cell with w > 1 (there is no variation over trials for either
m or λ). Assume m and λ act independently over participants. In addition, assume
Ki varies over trials according to a geometric distribution with parameter pi (i.e.,
D

Ki ∼ geom(pi ); see Appendix A) and p follows a beta distribution across participants
in cell * with pdf f(p) = β∗ pβ∗ −1 for 0 < p < 1 and some β∗ > 2. Then
E(T )∗ = E∗i [E(Ki )]E∗i [E(Mi )] = E∗i [1/pi ]E∗i [mi]

(2.2.30)

and the first two terms inside the braces of (2.2.29) vanish, yielding
E∗i [Var(Ti )] = E∗i [m2i ]E∗i [(1 − pi )/p2i ] + E∗i [1/pi ]E∗i [m3i ]E∗i [1/λi ]

(2.2.31)

Applying the gamma distributions Gam(u, r) and Gam(w, z) yields
E∗i [mi] =

u
,
r

E∗i [m2i ] =

u(u + 1)
,
r2

E∗i [m3i ] =

u(u + 1)(u + 2)
,
r3

E∗i [1/λi ] =

z
w−1
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and applying the beta distribution yields
E∗i [E(Ki )]

=

E∗i [1/pi ]

=

Z

0

1

β∗
1
β∗ pβ∗ −1 dp =
p
β∗ − 1

and
E∗i [Var(Ki )]

=

E∗i [(1

−

pi )/p2i ]

=

Z

1
0




1−p
β∗
β∗ pβ∗ −1 dp =
2
p
(β∗ − 1)(β∗ − 2)

Plugging in to (2.2.30) and (2.2.31) produces


h i
β∗
u
β∗ u
=
E(T )∗ =
β∗ − 1 r
r(β∗ − 1)

(2.2.32)

and




u(u + 1)
β∗
E(Var(T ))∗ =
r2
(β∗ − 1)(β∗ − 2)




β∗
u(u + 1)(u + 2)
z
+
β∗ − 1
r3
w−1

(2.2.33)

Thus we have seen by numerous examples that Theorem 2 allows us to compute E(T )∗
and E(Var(T ))∗ for various continuous positive infinite-tailed base distributions with
different choices for P∗ (K) and Q∗(Θ). This in turn will allow us to compute MIC
and VIC by plugging into (2.1.3) and (2.1.5). However, in taking our first steps
toward calculating MIC and VIC, we first consider a particular subset of the class
of general serial mixture models, a subset we call generalized Cutler-Neufeld models.
These models have the feature that MIC and VIC take particularly simple forms.

2.3

Generalized Cutler-Neufeld Models

Definition 2: Generalized Cutler-Neufeld Model: This is a specific subset of
the class of general serial mixture models in Definition 1 with unspecified base and
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having the properties that (a) Θi = θi for each participant i (i.e., Θi = θi does not
vary over trials although it may vary across participants) and (b) the distribution of
θ over participants is the same in each cell. Note that (a) and (b) can be summarized
by stating that there exists a distribution Q(θ) such that Q∗ (Θ) = Q(θ) in each
cell *. On the other hand, Ki may vary over both trials and participants, and its
distribution P∗ (K) depends on the cell *. In the case Ki varies over trials for some
participants, we say it is a generalized Cutler-Neufeld model with variation. In the
case Ki = ki is constant for each participant i, we say it is a generalized Cutler-Neufeld
model without variation, in which case the notation P∗ (K) can be replaced by the
notation P∗ (k) describing the distribution of k across participants in cell *. Both
the Neufeld and Cutler-Neufeld models are examples of generalized Cutler-Neufeld
models without variation. For convenience, we use the abbreviation gen-CN model
to denote generalized Cutler-Neufeld models.
There are three motivations behind defining gen-CN models. First, they describe a large flexible subset of the class of general serial mixture models that includes
the Neufeld model, the Cutler-Neufeld model, as well as Examples 1, 2, 3, and 6 given
above. Second, specific cases of such models have proven useful in modelling factorial experiment encoding latencies (see Neufeld et al. (2002), Neufeld, Vollick, et
al. (2007), Neufeld et al. (2010), Taylor et al. (2016, 2017)) in which the changes in
E(T )∗ and E(Var(T ))∗ over cells have been satisfactorily explained by shifting the
distribution of the number of subprocesses K over cells while keeping the distribution of all other parameters constant. Third, the gen-CN models permit particularly
succinct and aesthetic expressions for MIC and VIC.
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Theorem 3: MIC and VIC for gen-CN models: Suppose we have a genCN model with moment functions µ(θ) and σ 2(θ). Since the distribution of θ over
participants in a cell is the same for each cell, we can reflect this by writing E∗i [µ(θi )] =
E i [µ(θi )] and E∗i [σ 2(θi )] = E i [σ 2(θi )]. Define
i
i
i
i
KMIC = (EHS
[E(Ki )] − EHN
[E(Ki )]) − (ELS
[E(Ki )] − ELN
[E(Ki )])

(2.3.1)

and
i
i
i
i
[Var(Ki )]) − (ELS
[Var(Ki )] − ELN
[Var(Ki )]) (2.3.2)
[Var(Ki )] − EHN
KVIC = (EHS

Then
MIC = E i [µ(θi)]KMIC

(2.3.3)

VIC = E i [µ(θi )2]KVIC + E i [σ 2(θi )]KMIC

(2.3.4)

and

proof: It follows from the assumptions of the theorem and (2.2.10) that
E(T )∗ = E∗i [E(Ki )]E i [µ(θi)]

(2.3.5)

and since Var(µ(θi )) = 0, leading to a vanishing of the first two terms in (2.2.11), we
obtain
E(Var(T ))∗ = E i [µ(θi)2 ]E∗i [Var(Ki )] + E∗i [E(Ki )]E i [σ 2(θi )]

(2.3.6)

Thus applying (2.1.3) and the above, we obtain
 i
i
i
i
MIC = E i [µ(θi )] (EHS
[E(Ki )] − EHN
[E(Ki )]) − (ELS
[E(Ki )] − ELN
[E(Ki )])
= E i [µ(θi )]KMIC
(2.3.7)
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whereas applying (2.1.5) and the above yields

i
i
VIC = (E i [µ(θi )2 ]EHS
[Var(Ki )] + EHS
[E(Ki )]E i [σ 2(θi )])
i
i
− (E i [µ(θi )2]EHN
[Var(Ki )] + EHN
[E(Ki )]E i [σ 2(θi)])


i
i
− (E i [µ(θi)2 ]ELS
[Var(Ki )] + ELS
[E(Ki )]E i [σ 2(θi)])
i
i
− (E i [µ(θi )2]ELN
[Var(Ki )] + ELN
[E(Ki )]E i [σ 2(θi)])

 i
i
i
i
= E i [µ(θi )2 ] (EHS
[Var(Ki )]−EHN
[Var(Ki )])−(ELS
[Var(Ki )]−ELN
[Var(Ki )])
 i
i
i
i
[E(Ki )])
[E(Ki )] − ELN
+ E i [σ 2(θi)] (EHS
[E(Ki )] − EHN
[E(Ki )]) − (ELS
= E i [µ(θi )2 ]KVIC + E i [σ 2(θi)]KMIC
(2.3.8)
as claimed. 4
Note: We see that the base distribution itself plays no role in the form of (2.3.3) and
(2.3.4) except for the specific values that E i [µ(θi)], E i [µ(θi )2], and E i [σ 2(θi )] attain.
Moreover, we see that MIC = 0 if and only if (iff) KMIC = 0. Thus these models
will exhibit factorial additivity over means iff KMIC = 0.
We now note that the situation becomes even simpler in the case of gen-CN
models without variation.
Corollary 3.1: MIC and VIC in gen-CN models without variation: Assume
the gen-CN model is without variation, i.e., Ki does not vary over trials for any
participant. Then
MIC = E i [µ(θi)]KMIC

(2.3.9)

VIC = E i [σ 2(θi)]KMIC

(2.3.10)

and
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Thus VIC = 0 iff MIC = 0 which in turn occurs iff KMIC = 0.
proof: Since there is no variation over trials, Ki = ki and Var(ki ) = 0 for all i and
hence KVIC = 0. The result then follows from (2.3.4) and (2.3.3). 4
Corollary 3.2: alternate expression of Corollary 3.1: In the case of a gen-CN
model without variation, we have Ki = ki and can express
i
i
i
i
ELN
[ki ] = m, EHN
[ki ] = m + h, ELS
[ki ] = m + g, EHS
[ki ] = m + f

(2.3.11)

Thus KMIC = f − (h + g) and it follows from Corollary 3.1 that
MIC = E i [µ(θi )][f − (h + g)]

(2.3.12)

VIC = E i [σ 2(θi )][f − (h + g)]

(2.3.13)

and

Thus VIC = 0 iff MIC = 0 which in turn occurs iff f = h + g. 4
Note: In the experimental paradigms we are considering, E(T )∗ is shortest in the
LN cell, increasing as we shift into any of the other three cells. This combined with
(2.3.5) implies that, for all practical purposes, h > 0, g > 0, and f > 0. Although this
positivity constraint is not necessary for most mathematical expressions to be valid,
it will simplify things going forward (especially when evaluating the sign of VIC) to
assume related definitions of such quantities are positive. We will call attention to
this as the situation arises.
Note: The value of Corollary 3.2 is as follows. For a given outcome of a specific experiment, we may observe the equality f = h+g as the result of serendipity. However,
if repeated manipulations of the encoding load (perhaps over a series of increasing
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loads) and repeated manipulations of diagnostic status (perhaps by considering patients of increasing levels of illness) always result in f = h + g, this suggests that the
observed additivity is a real phenomenon. In this case the additional subprocesses
due to increases in encoding load (represented by h) and the additional subprocesses
due to schizophrenia diagnostic status (represented by g) act independently of one
another, producing f = h + g and the result VIC = MIC = 0.
In the case of gen-CN models with variation, we may or may not obtain the
signature VIC = 0 iff MIC = 0. Below we present an assortment of gen-CN models
that permit a variety of different explicit MIC-VIC signatures.
Example 7: Poisson over trials: Consider a gen-CN model where, for participant
i in cell *, Ki follows a Poisson distribution over trials with mean mi which in turn
may vary over participants in the cell according to some positive distribution P∗ (m).
Since mi = E(Ki ) = Var(Ki ) for the Poisson, then setting E∗i [mi] = λ∗ yields
i
i
i
i
KMIC = KVIC = (EHS
[mi] − EHN
[mi]) − (ELS
[mi] − ELN
[mi])

(2.3.14)

= (λHS − λHN ) − (λLS − λLN )
where the boundary conditions 0 < λLN < λHN , λLS < λHS hold in order to satidy
(2.3.5) and the factorial outcomes of E(T )∗ in Sec 2.1.1. Hence VIC = 0 iff MIC = 0
and there is a wide range of admissible choices of λ∗ which will permit this outcome .
Thus this is an example of a gen-CN model with variation that satisfies the signature
VIC = 0 iff MIC = 0. Note that Example 7 also embraces the special subcase where
there is no variation in mi across participants in the cell, in which case P∗ (m) is just
a point mass at λ∗ and Ki only varies over trials.
Example 8: a simple negative binomial model: Consider a gen-CN model where
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we assume that, for each participant i, Ki has a negative binomial distribution across
trials with parameters r∗ and p∗ in cell * (see Appendix A). There is no variation
across participants. We interpret r∗ as the number of steps that must be encoded in
cell * in order for successful encoding of the entire stimulus to occur, and p∗ represents
the probability of successful encoding of a step on any one try. Thus Ki represents
the total number of tries (subprocesses) required to successfully encode the stimulus
on a trial. It follows that E(Ki ) = r∗/p∗ and Var(Ki ) = r∗ (1 − p∗ )/p2∗ in cell *.
Assume further that the required number of steps r∗ is the same in cells LN and LS
and can be denoted by rL . Similarly assume that the required number of steps r∗
is the same in cells HN and HS and can be denoted by rH . (Note this assumption
is very reasonable as it implies the same set of stimuli are presented to both normal
controls and schizophrenia patients, but that there is a difference in number of steps
between the low and high encoding loads.) Assume that the probability of successful
encoding of a step on any try is pN for a normal control and pS for a schizophrenia
patient (and this does not vary with encoding load, which also is reasonable). Make
the assumption that the experiment satisfies rL < rH and pS < pN in order to be
consistent with observed outcomes E(T )∗ in the factorial experiments described in
Sec 2.1.1. Then
 

rH
rL
rL
rH
−
−
−
KMIC =
pS
pN
pS
pN


1
1
= (rH − rL )
−
pS pN


>0

(2.3.15)
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and
KVIC =



rH (1 − pS ) rH (1 − pN )
−
p2S
p2N



−



rL (1 − pS ) rL (1 − pN )
−
p2S
p2N



(2.3.16)
= (rH − rL )



1 − pS
(1 − pN )
−
2
pS
p2N



>0
It follows that both MIC > 0 and VIC > 0 always in this simple negative binomial
model. Thus this model, while appealing in its explanatory physical mechanism, is
not a candidate for modelling the experimental paradigms considered in Sec 2.1.1
because those experiments always produced MIC = 0.
Example 9: an alternative negative binomial model: In Example 8 above a
specific negative binomial model was considered where the number of successful steps
required to encode under the low encoding condition was rL whereas the number of
successful steps required to encode under the high encoding condition was rH . These
steps may be considered to be determined by the physical complexity of the input
stimulus sequence (e.g., consider encoding a 3-letter word as opposed to a 6-letter
word). An alternative model which may be more appropriate in some cases is when the
complexity of the input sequence physically stays the same (e.g., always present a 6letter word) but some quality in the presentation results in a differential encoding load
(e.g., present the word in bold face vs. faded) which leads to a differential probability
of successfully encoding a step on any try. The diagnostic status of the participant
also affects this probability. In this case the number of required encoding steps r
remains the same from cell to cell but the probability p∗ of successfully encoding a
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step on any one try depends on the cell. The number of subprocesses Ki required to
encode follows a negative binomial distribution over trials with parameters r and p∗ .
Hence E(Ki ) = r/p∗ and Var(Ki ) = r(1 − p∗ )/p2∗ . In order to be consistent with the
factorial outcomes of Sec 2.1.1 we have the boundary conditions
0 < pHS < pHN , pLS < pLN < 1
These boundary conditions imply that there exists p > 0, h > 0, g > 0, and f > 0
such that
1
pLN

1
1
1
1
1
1
1
= ,
= + h,
= + g,
= +f
p pHN
p
pLS
p
pHS
p

It follows that


r

r 

r

r 



−
−
−
pHS pHN
pLS pLN



  1
1
1
1
=r
+f −
+ h − ( + g) −
p
p
p
p

KMIC =

(2.3.17)

= r[f − (h + g)]
so here MIC = 0 iff f = h + g, which is a possible scenario. We will show that
MIC = 0 always implies VIC > 0 for this model. First note that
p∗ =

p
1 + px∗

where x∗ = 0, h, g or f depending on the cell *

and furthermore
1 − p∗ =

1 + px∗ − p
1 + px∗
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Then it follows that






1 − pHN
1 − pLS
1 − pLN
1 − pHS
KVIC = r
−
−r
−
p2HS
p2HN
p2LS
p2LN
"
2 
 
2 
#
1 + pf
1 + pf − p
1 + ph
1 + ph − p
=r
−
p
1 + pf
p
1 + ph
"
#
2 

1 + pg
1 + pg − p
(1 − p)
−r
−
p
1 + pg
p2
=

(2.3.18)

r
(1 + pf)(1 + pf − p) − (1 + ph)(1 + ph − p)
p2
− [(1 + pg)(1 + pg − p) − (1 − p)]

=

r 
2p[f − (h + g)] − p2 [f − (h + g)] + p2 [f 2 − (h2 + g 2 )]
p2

Substituting in the restriction f = h + g corresponding to MIC = 0 yields
KVIC = r[(h + g)2 − (h2 + g 2 )] = 2rhg > 0

(2.3.19)

VIC = 2rE i [µ(θi )2]hg > 0

(2.3.20)

so MIC = 0 yields

Thus this alternative negative binomial model is a candidate for modelling experiments that yield factorial additivity of means and factorial superadditivity of variances.
Example 10: a binomial model: Suppose we have a gen-CN model and assume
that there exists n ≥ 1 such that for each individual there is a set of n underlying
subprocesses which could be activated on any encoding trial and, in cell *, p∗ is the
probability that any one of these subprocesses is activated. We let Ki = number of
activated subprocesses for participant i, and assume that this does not depend on
i but only the cell probabilities p∗ . If the subprocesses are activated independently
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of one another then Ki follows a binomial distribution over trials with parameters n
and p∗ with E(Ki ) = np∗ and Var(Ki ) = np∗ (1 − p∗ ). In order to accommodate the
factorial data outcomes E(T )∗ we have the boundary conditions
0 < pLN < pHN , pLS < pHS < 1
We obtain
KMIC = n[(pHS − pHN ) − (pLS − pLN )]

(2.3.21)

and
KVIC = n[(pHS (1 − pHS ) − pHN (1 − pHN )) − (pLS (1 − pLS ) − pLN (1 − pLN ))] (2.3.22)
There are many admissible solutions rendering KMIC = 0 and hence MIC = 0; for
example, select any 0 < x < 1/4 and set pLN = x, pHN = 2x, pLS = 3x, and
pHS = 4x. Then KMIC = 0 and KVIC = −4nx2 < 0 so VIC < 0. In fact we can
show that in this model, MIC = 0 always implies VIC < 0. Note that if KMIC = 0
then there must exist x, y, and d such that pLN = x, pLS = x + d, pHN = y, and
pHS = y + d. Under the usual factorial data outcomes we will have x < y and d > 0.
Now
KVIC = n [(y + d)(1 − (y + d)) − y(1 − y) − {(x + d)(1 − (x + d)) − x(1 − x)}]


= n (y + d) − (y + d)2 − y(1 − y) − {(x + d) − (x + d)2 − x(1 − x)}


= n y + d − y 2 − 2dy − d2 − y + y 2 − {x + d − x2 − 2dx − d2 − x + x2}


= n d − 2dy − d2 − {d − 2dx − d2 }
= −n [2d(y − x)] < 0

(2.3.23)
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Thus here we always have MIC = 0 implying VIC < 0. Therefore the binomial model
is a candidate for modelling those factorial experiments exhibiting factorial additivity
of means but factorial subadditivity of variances.
The next model can exhibit VIC < 0 or VIC > 0 depending on the situation
when MIC = 0.
Example 11: the truncated Poisson: Assume we have a gen-CN model where, in
cell *, Ki follows a truncated Poisson distribution over trials (see Appendix A) with
parameter m∗ > 0. The truncated Poisson can be described as a Poisson distribution
conditional on having at least one observation (i.e., at least one subprocess occurs),
so the range of K is k = 1, 2, 3, . . . . It follows that
m∗
E(Ki ) =
1 − e−m∗

m∗
and Var(Ki ) =
−
1 − e−m∗



m∗
1 − e−m∗

2

e−m∗

(2.3.24)

Note that E(Ki ) and Var(Ki ) converge rapidly to m∗ as m∗ increases, and that since
the function f(v) = v/(1 − e−v ) is a 1-1 increasing function over (0, ∞) we have the
boundary conditions
0 < mLN < mHN , mLS < mHS
We obtain
i
i
i
i
KMIC = (EHS
[E(Ki )] − EHN
[E(Ki )]) − (ELS
[E(Ki )] − ELN
[E(Ki )])
=



mHS
mHN
−
−m
HS
1−e
1 − e−mHN



−

so KMIC = 0 is equivalent to the constraint



mLS
mLN
−
−m
LS
1−e
1 − e−mLN

mHS
mHN
mLS
mLN
=
+
−
−m
−m
−m
1 − e HS
1 − e HN
1 − e LS
1 − e−mLN



(2.3.25)

(2.3.26)

which for notational convenience we will rewrite as
z
w
y
x
=
+
−
−z
−w
−y
1−e
1−e
1−e
1 − e−x

(2.3.27)
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Note that the above constraint is invariant under an interchange of w and y. Note
that since f(v) = v/(1 − e−v ) is increasing over (0, ∞) then, given 0 < x < w, y,
there is a unique solution z > w, y to (2.3.27) which can be computed by numerical
iteration, thereby rendering MIC = KMIC = 0. Note also that as, v → ∞, f(v) is
asymptotic to v, and this asymptotic behaviour is achieved rapidly. Thus, once x is
modestly large, the exact constraint (2.3.27) can be approximated well by the easily
computable linear constraint
z = w + y − x where w, y > x

(2.3.28)

which corresponds to the solution to MIC = 0 for the original (non-truncated) Poisson
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distribution. Now
i
i
i
i
KVIC = (EHS
[Var(Ki )] − EHN
[Var(Ki )]) − (ELS
[Var(Ki )] − ELN
[Var(Ki )])
"
!

2
mHS
mHS
=
−
e−mHS
−m
−m
HS
HS
1−e
1−e
!#

2
mHN
mHN
−
−
e−mHN
1 − e−mHN
1 − e−mHN
"
!

2
mLS
mLS
−
−
e−mLS
1 − e−mLS
1 − e−mLS
!#

2
mLN
mLN
−mLN
−
e
−
1 − e−mLN
1 − e−mLN
#
"
2

2
m
mHN
HS
e−mHN −
e−mHS
= KMIC +
1 − e−mHN
1 − e−mHS
"
#
2

2
mLN
m
LS
−
e−mLN −
e−mLS
−m
−m
LN
LS
1−e
1−e
#
"
2

2
z
w
e−w −
e−z
= KMIC +
1 − e−w
1 − e−z
"
#
2

2
x
y
−
e−x −
e−y
1 − e−x
1 − e−y

(2.3.29)

Now MIC = 0 implies KMIC = 0 and so then KVIC reduces to
KVIC =

"

w
1−e−w

2



z
e−w −
1−e−z

2

# "
e−z −

x
1−e−x

2



y
e−x −
1−e−y

2

e−y

#

(2.3.30)
where 0 < x < w, y < z and (2.3.27) holds. (Note that this expression is invariant
to interchange of w and y.) Now for fixed x > 0 with 0 < x < w, y < z we see that
(2.3.27) implies z → ∞ if either w → ∞ or y → ∞ and we obtain
lim KVIC = −

w,y→∞



x
1 − e−x

2

e−x < 0

(2.3.31)
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Thus MIC = 0 implies VIC < 0 for sufficiently large w and y. Of course VIC → 0 as
x → ∞ and this limit coincides with the original (non-truncated) Poisson distribution
where VIC = 0 iff MIC = 0. Moreover the convergence of KVIC to 0 is rapid.
Consider the example x = 5, w = 6, and y = 8. Solving (2.3.27) for z yields
z = 8.9825 (compare this with the value z = 9 from the linear approximation (2.3.28)),
and we obtain KVIC = −0.0697. However, we end this example by noting that
VIC is not always negative for MIC = 0. The sign flips to positive for some very
small values near the origin. Letting x = 0.05, w = 0.1, and y = 0.15 (this would
correspond to a high probability of zero subprocesses occurring for the original (nontruncated) Poisson), we solve (2.3.27) numerically to obtain z = 0.19845. This yields
KVIC = 0.000788 > 0.
We now consider a special type of gen-CN model.
Definition 3: hybrid gen-CN models: These are gen-CN models in which we
can partition Ki = ni + Ri where n is distributed across participants in cell * according to some nonnegative discrete distribution P∗ (n) (no variation over trials) and
Ri is a nonnegative discrete random variable. The quantity ni can be interpreted as
a minimum on the number of subprocesses that must be executed by participant i
(may encompass resting-state subprocesses plus possibly particular task-related subprocesses) and Ri represents additional subprocesses that may arise trial to trial due
to a variety of reasons, such as variability of the stimulus input sequence or failure to
tag subprocesses as completed.
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Corollary 3.3: Suppose we have a hybrid gen-CN model where Ki = ni + Ri . Define
i
i
i
i
nMIC = (EHS
[ni ] − EHN
[ni ]) − (ELS
[ni] − ELN
[ni ])
i
i
i
i
RMIC = (EHS
[E(Ri)] − EHN
[E(Ri )]) − (ELS
[E(Ri)] − ELN
[E(Ri)])

(2.3.32)
(2.3.33)

and
i
i
i
i
[Var(Ri )]) − (ELS
[Var(Ri )] − ELN
[Var(Ri )]) (2.3.34)
RVIC = (EHS
[Var(Ri )] − EHN

Then KMIC = nMIC + RMIC and KVIC = RVIC, and applying Theorem 3 yields
MIC = E i [µ(θi)](nMIC + RMIC)

(2.3.35)

VIC = E i [µ(θi )2 ]RVIC + E i [σ 2(θi)](nMIC + RMIC)

(2.3.36)

and

proof: Substituting E(ni + Ri ) = ni + E(Ri ) for E(Ki ) in (2.3.1) yields KMIC =
nMIC+RMIC, whereas noting that Var(Ki ) = Var(ni +Ri ) = Var(Ri ) yields KVIC =
RVIC. Now apply Theorem 3. 4
The simplest example of a hybrid gen-CN model is a translated Poisson distribution (see Appendix A).
Example 12: translated Poisson: Suppose we have a hybrid gen-CN model where
there exists an integer n ≥ 1 such that Ki = n + Ri and Ri is Poisson over trials
with mean mi where m is distributed across participants in cell * according to some
distribution with mean E∗i [mi ] = λ∗ . Thus Ki follows a translated Poisson distribution
with translation factor n. It follows that nMIC = 0 and since mi = E(Ri ) = Var(Ri )

57
for the Poisson, we obtain
i
i
i
i
RMIC = (EHS
[mi] − EHN
[mi]) − (ELS
[mi] − ELN
[mi])

= (λHS − λHN ) − (λLS − λLN )

(2.3.37)

= RVIC
Thus applying Corollary 3.3 it follows that VIC = 0 iff MIC = 0 here.
Example 13: Suppose we have a hybrid gen-CN model Ki = ni + Ri where n is
distributed across participants according to some distribution P∗ (n) in cell *, and the
random variables Ri have the property that the distribution of R across participants
in cell LN is the same as that of R across participants in cell HN, and the distribution of R across participants in cell LS is the same as that of R across participants
in cell HS. (This assumption describes a model that implies that the number of random additional subprocesses R is driven by diagnostic status alone, a model which
would likely posit that individuals with schizophrenia tend to incur more additional
“incidental” subprocesses (interpreted here as “errors”) above their baseline level ni
i
i
i
than do normal controls.) Thus we obtain ELN
[E(Ri )] = EHN
[E(Ri )], ELS
[E(Ri )] =
i
i
i
i
i
EHS
[E(Ri )], ELN
[Var(Ri )] = EHN
[Var(Ri )], ELS
[Var(Ri )] = EHS
[Var(Ri )], and con-

sequently RMIC = 0 and RVIC = 0. Thus Corollary 3.3 yields
MIC = E i [µ(θi )] nMIC and VIC = E i [σ 2(θi )] nMIC

(2.3.38)

which coincides with the expressions for MIC and VIC in the gen-CN model without
variation (i.e., where we remove Ri from the model and simply consider ki = ni
distributed across participants; see Corollary 3.1). However, despite this equivalence
in the final expressions for MIC and VIC, these two models are not equivalent. The
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hybrid model allows for more variation in Ti over trials (by varying the number of
subprocesses executed on a trial) and also captures a possible qualitative difference
between patients and controls.
Example 14: Here we present a variation on Example 13 but with a very different
interpretation. Assume Ki = ni + Ri where the distribution of Ri does not depend
on i and moreover, the distribution of Ri over trials is the same in both cells LN and
D

LS (denoted in shorthand by RLN ∼ RLS ), as is the distribution of Ri over trials
D

in cells HN and HS (denoted RHN ∼ RHS ). Recall that the same set of stimuli
is presented to all participants in cells LN and LS (low encoding load) whereas a
different set of stimuli is presented to all participants in cells HN and HS (high
encoding load). Thus this model can be used to describe the situation where there
is a certain amount of variability over items in the stimulus input sequence (leading
to variability in the number of subprocesses required for encoding on a trial) with
that degree of variability potentially depending on the encoding load set. As in
Example 13 we obtain RMIC = RVIC = 0, yielding (2.3.38) here as well. However,
just as in Example 13, this hybrid model is not equivalent to the corresponding genCN model without variation, and indeed an experimenter might be very concerned
about a high degree of variability among items in a stimulus set.
Finally we close out this section by presenting a detailed example of a hybrid
model.
Example 15: Suppose we have a hybrid gen-CN model Ki = ni +Ri where ni follows
a translated Poisson distribution (with translation factor m ≥ 1) across participants
D

in cell * with E∗i [ni] = m+λ∗. Suppose Ri ∼ geom(pi ) over trials where p is distributed
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over (0, 1) according to a beta distribution with pdf f(p) = β∗pβ∗ −1 with β ∗ > 2 in
cell * (see Example 6 for details and calculations). It follows that
nMIC = (λHS − λHN ) − (λLS − λLN )

(2.3.39)

whereas


 

βHN
βLS
βLN
βHS
RMIC =
−
−
−
βHS − 1 βHN − 1
βLS − 1 βLN − 1

(2.3.40)

and



βHS
βHN
RVIC =
−
(βHS − 1)(βHS − 2) (βHN − 1)(βHN − 2)


βLN
βLS
−
−
(βLS − 1)(βLS − 2) (βLN − 1)(βLN − 2)

(2.3.41)

Thus from Corollary 3.3 it follows that
MIC = E i [µ(θi )] (nMIC + RMIC)

(2.3.42)

VIC = E i [µ(θi )2 ] RVIC + E i [σ 2(θi )] (nMIC + RMIC)

(2.3.43)

and

and the signs of MIC and VIC will depend on the particular values of λ∗ and β∗.
In the next section we consider the problem of distinguishing between gen-CN
models with and without variation.

2.4

Testing for Variation in Generalized CutlerNeufeld Models

In the previous section we have seen that gen-CN models without variation always
yield the signature VIC = 0 iff MIC = 0 whereas gen-CN models with variation can
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also yield that signature or a variety of other MIC-VIC signatures, depending on the
specific model. Variation in Ki over trials can be explained by the physical mechanism
driving the encoding process (see Examples 7-12) or be due to other sources, such
as attentional errors associated with diagnostic status (Example 13) or to variability
over items in the stimulus encoding set (Example 14). There is probably no real-world
case where there is absolutely no variation in Ki over trials, but it is of interest to
detect cases where this variation is substantial enough to be informative. Detecting
this variation may give us insight into the physical mechanism guiding the encoding
process or, if the source of variation is the stimulus set of the experiment, it may lead
the experimenter to modify and more tightly control the input sequence.
The following theorem provides a simple test for the presence of variation in
some cases.
Theorem 4: Suppose we have a gen-CN model in which MIC = 0 and VIC 6= 0.
Then this is a gen-CN model with variation.
proof: Since MIC = 0 implies VIC = 0 in gen-CN models without variation (see
Corollary 3.1) the observation of MIC = 0 with VIC 6= 0 implies we have a model
with variation. Another way to see this is to note that MIC = 0 ⇒ KMIC = 0 and
thus VIC 6= 0 ⇒ E i [µ(θi)2 ]KVIC 6= 0, which in turn implies E∗i [Var(Ki )] > 0 for
some cell. Thus Var(Ki ) > 0 for at least some participants.
Theorem 4 is so useful because we often have factorial additivity of means
(i.e., MIC = 0) and given the sample variances of reaction times we can do a test
for interaction to determine potential factorial additivity of variances. If we reject
additivity of variances, i.e., conclude VIC 6= 0, then we have strong evidence that
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there is variation over trials.
However, as earlier examples have shown, it is possible to observe MIC =
VIC = 0 even when there is variation over trials (see Examples 7 and 12, and also
Examples 13 and 14 when nMIC = 0). Thus, observation of MIC = VIC = 0 is not
in itself sufficient evidence of no variation. In the following we develop a technique
which can aid in elucidating whether variation exists which may be applied in general,
even when VIC = 0. In order to apply this technique, however, we need to assume
that we have obtained the actual encoding times of each participant. We discuss this
further after stating and proving the following theorem.
Theorem 5: Suppose we have a gen-CN model. If the ratio E(Var(T ))∗/E(T )∗
varies depending on the cell *, then we have a gen-CN model with variation.
proof: From (2.3.5) and (2.3.6) of Theorem 3 we obtain
E(Var(T ))∗ = E i [µ(θi)2 ]E∗i [Var(Ki )] + E∗i [E(Ki )]E i [σ 2(θi )]

(2.4.1)

and
E(T )∗ = E∗i [E(Ki )]E i [µ(θi)]
and thus the ratio
E i [µ(θi)2 ]E∗i [Var(Ki )] + E∗i [E(Ki )]E i [σ 2(θi )]
E(Var(T ))∗
=
E(T )∗
E∗i [E(Ki )]E i[µ(θi )]
E i [Var(Ki )]
= b ∗i
+ c
E∗ [E(Ki )]

(2.4.2)

(2.4.3)

where for convenience here we set
b=

E i [µ(θi )2]
E i [µ(θi)]

and c =

E i [σ 2(θi )]
E i [µ(θi )]

(2.4.4)

Obviously, if there is no variation over trials, then Var(Ki ) = 0 for each participant
and the ratio (2.4.3) is a constant over cells (and specifically equals c). Thus if (2.4.3)
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differs over at least two cells, this implies there must be variation over trials for at
least some participants. 4
Now, in terms of applying Theorem 5 using sample data, we assume that for
each participant i we have their actual encoding times ti1, . . . , tiN based on N trials.
Over these N trials we compute the sample mean t¯i and sample (intertrial) variance s2i
P
¯
for each participant i. We then estimate E(T )∗ by t̄∗ = ( M
i=1 ti)/M and E(Var(T ))∗

P
2
by s¯2∗ = ( M
i=1 si )/M, where M is the number of participants per cell. Then we have

the following:

Corollary 5.1: Suppose we have a gen-CN model. Define the sample ratio r∗ by
r∗ = s¯2∗ /t̄∗ . Then
lim lim r∗ =

M →∞ N →∞

E(Var(T ))∗
E(T )∗

with probability 1

(2.4.5)

provided 0 < E(T )∗ < ∞ and E(Var(T ))∗ < ∞. If r∗ differs in a statistically
significant fashion over at least two cells, then we have strong evidence that this is a
gen-CN model with variation.
proof: see Appendix C. 4
In the following examples we fix the sample sizes at N = 200 and M = 100 for
an individual experiment, regarding these as feasible experimental values, and then
repeat the experiment 500 times. This enables us to calculate the average ratio r¯∗ in
each cell over the 500 repetitions, as well as calculate the sample standard deviation
sd∗ of the 500 ratios for each cell. This will provide an idea, in a single experiment,
of the extent to which differences between ratios in various cells are due to genuine
differences or due to statistical error. We will see that the choice of base distribution
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significantly affects the statistical error, and the conclusion is, not surprisingly, that
N and M should be made as large as possible to reduce this unwanted error.
In all of the following examples, models and parameter values have been chosen so that MIC = VIC = 0 so that Theorem 4 cannot be applied to assess the
presence of variation over trials. All numerical work was carried out using the R
statistical programming language (R(2013)). We examined two base distributions
– the exponential(θ) in which a rate parameter θ was generated randomly from a
Gam(30, 10) distribution for each participant, and a lognormal distribution LN(θ, Σ2 )
in which we fixed Σ = 1 and generated θ randomly from a normal N(0, 1) distribution
for each participant. In the case of the exponential base with the above parameter
values, the statistical error was generally small and Corollary 5.1 worked well; in the
case of the lognormal base with the above parameter values, the statistical variation
was large, and greater values of M and N would be required to draw reliable conclusions from a single experiment. This is likely due to the thicker tail of the lognormal
distribution.
D

Note that in the case of the exponential base with rate θ ∼ Gam(30, 10) and
D

in the case of a lognormal base LN(θ, 1) where θ ∼ N(0, 1), it is possible to explicitly
calculate the theoretical constants b and c in (2.4.4), yielding
bexpo = cexpo = .35714

and blognorm = 7.389, clognorm = 12.696

(2.4.6)

Thus, for any chosen distribution on the number of subprocesses K, it is then possible
to explicitly calculate the theoretical ratios
E i [Var(Ki )]
E(Var(T ))∗
= b ∗i
+ c
E(T )∗
E∗ [E(Ki )]

(2.4.7)
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for our two chosen base distributions. These can then be compared with the obtained
simulated average ratios r¯∗ in each cell. In the following tables, the first row of
numbers consist of the simulated average ratios r¯∗ in each cell, accompanied by the
sample standard deviation over the 500 repetitions in that cell. The second row of
numbers consists of the (true) theoretical ratios (2.4.7) in each cell.
Example 16: Here we used the exponential base, and there is no variation over
trials; k varied only over participants with parameter λ∗ depending on the cell. We
D

actually used a translated Poisson k = 1 + x where x ∼ Pois(λ∗ ) with parameters
λLN = 2, λHN = 5, λLS = 20, and λHS = 23. (These parameter choices yield MIC =
VIC = 0.) The reason for using the translated Poisson was simply to avoid the
possibility of an entire vector of 0s and hence a zero encoding time. The results are
presented in Table 2.1.
Table 2.1: k Poisson without variation over trials (exponential base)
r̄LN sdLN
.357 .0097
.357

r̄HN
.357
.357

sdHN
.0090

r̄LS
.356
.357

sdLS
.0085

r̄HS
.358
.357

sdHS
.0087

Example 17: Here we used the exponential base, and there is no variation over trials;
k followed a geometric distribution over participants with parameter p∗ depending on
the cell. We employed pLN = 1/2, pHN = 1/6, pLS = 1/20, and pHS = 1/24 (these
parameter values result in MIC = VIC = 0). The results are presented in Table 2.2.
Note that the standard deviations are very small in both Examples 16 and 17, and
that accurate results would likely be obtained with a single experiment. The stability
of the sample ratios across cells is suggestive of a model without variation in both
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Table 2.2: k geometric without variation over trials (exponential base)
r̄LN sdLN
.357 .0112
.357

r̄HN
.358
.357

sdHN
.0120

r̄LS
.356
.357

sdLS
.0115

r̄HS
.358
.357

sdHS
.0115

examples. Also note that the sample ratios in both examples yield approximately
the same value .357, which is the common value cexpo in (2.4.7) (the theoretical ratio
here).
Example 18: This is Example 16 (Poisson without variation over trials) repeated
with the lognormal base in place of the exponential base. The results are presented
in Table 2.3.
Table 2.3: k Poisson without variation over trials (lognormal base)
r̄LN
12.3
12.7

sdLN
6.00

r̄HN
12.3
12.7

sdHN
5.61

r̄LS
12.2
12.7

sdLS
6.00

r̄HS
12.1
12.7

sdHS
5.96

Example 19: This is Example 17 (geometric without variation over trials) repeated
with the lognormal base. The results are presented in Table 2.4.
Table 2.4: k geometric without variation over trials (lognormal base)
r̄LN
12.0
12.7

sdLN
9.72

r̄HN
11.5
12.7

sdHN
5.84

r̄LS
11.9
12.7

sdLS
7.09

r̄HS
12.2
12.7

sdHS
9.34

Note that for both Examples 18 and 19 the average cell ratios (computed over
500 repetitions of the experiment) yield an approximate value of 12 (which provide
a slight underestimate of the true value clognorm in (2.4.7)). However, the standard
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deviations are comparatively large, and a single experiment (with the given values of
N = 200 and M = 100) might give the appearance of significant differences between
ratios in cells and produce misleading results.
We now consider some examples where Ki is varying over trials. The first
point to note is that the Poisson distribution is in a special position because it satisfies Var(Ki ) = E(Ki ) and hence the ratios will not vary over cells. In fact any
integer multiple Xi = nKi of a Poisson distribution Ki will share this property, since
Var(Xi ) = Var(nKi ) = n2 Var(Ki ) = n2 E(Ki ) = nE(nKi ) = nE(Xi ). Thus Theorem 5 will not pick up variation over trials in the case of a Poisson or any of its integer
multiples. We illustrate this with the following.
Example 20: Here Ki follows a Pois(λ∗ ) distribution over trials with no variation
over participants, and the exponential base is used. The cell parameters are λLN =
2, λHN = 5, λLS = 20, and λHS = 23, yielding MIC = VIC = 0. The results are
presented in Table 2.5. Note that the standard deviations are very small and the
ratios very stable across cells. The simulated mean cell ratios of approximately .714
exactly match the theoretical ratio bexpo + cexpo of (2.4.7).
Table 2.5: K Poisson with variation over trials (exponential base)
r̄LN sdLN
.714 .0176
.714

r̄HN
.715
.714

sdHN
.0178

r̄LS
.714
.714

sdLS
.0178

r̄HS
.715
.714

sdHS
.0170

Example 21: Translated Poisson distributions do not share the special position of the
Poisson and its integer multiples. Specifically, if Ki is a translated Poisson distribution
varying over trials, then Theorem 5 may pick up this variation provided the standard
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deviations are small. Here we consider the exponential base and Ki = 5 + Xi where
D

Xi ∼ Pois(λ∗ ) over trials with cell parameters λ∗ identical to those of Example 20.
The results are presented in Table 2.6. Note that the cell ratios are small, but
the difference between the largest ratio and the smallest ratio is well outside twice
the standard deviations, indicating that a single experiment will pick up genuine
differences. Note the close match with the theoretical ratios (2.4.7).
Table 2.6: K translated Poisson with variation over trials (exponential base)
r̄LN sdLN
.459 .0111
.459

r̄HN
.536
.536

sdHN
.0125

r̄LS
.642
.643

sdLS
.0154

r̄HS
.652
.651

sdHS
.0170

Example 22: Here we consider the case where Ki follows a geometric(p∗) distribution
over trials with the exponential base and no variation over participants. The parameter values are pLN = pLS = .5 and pHN = pHS = .05 (representing the situation where
successful encoding depends only on encoding load) which yields MIC = VIC = 0.
The results are presented in Table 2.7. Note the sharp deviations between the cell
ratios, well outside the scope of the standard deviations, and the close match with
the theoretical ratios.
Table 2.7: K geometric with variation over trials (exponential base)
r̄LN
.715
.714

sdLN
.018

r̄HN
7.15
7.14

sdHN
.194

r̄LS
.715
.714

sdLS
.020

r̄HS
7.15
7.14

sdHS
.198

Example 23: Here we consider the case where Ki follows a binomial distribution over
trials (no variation over participants) with the exponential base. We assume there
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are a maximum of n = 100 subprocesses which could be activated, with schizophrenia
patients activating a subprocess with probability pLS = pHS = .8 and normal controls
activating a subprocess with probability pLN = pHN = .2, yielding MIC = VIC = 0.
The results are presented in Table 2.8.
Table 2.8: K binomial with variation over trials (exponential base)
r̄LN sdLN
.644 .0154
.643

r̄HN
.643
.643

sdHN
.0148

r̄LS
.428
.429

sdLS
.0100

r̄HS
.429
.429

sdHS
.0100

Note that the difference between the largest and smallest cell ratios is well outside
the range of the standard deviations, indicating that a single experiment would pick
up genuine differences. Also note the close match with the theoretical ratios.
Example 24: Here we consider a hybrid model (see Definition 3) where Ki varies
over both trials and participants. We express Ki = ni + Ri where n varies over
participants according to a Poisson distribution with parameters λLN = 2, λHN =
5, λLS = 20, λHS = 23, and Ri follows a geometric distribution over trials with pLN =
pLS = .7 and pHN = pHS = .2. The exponential base is assumed. The results are
presented in Table 2.9.
Table 2.9: K hybrid Poisson-geometric with variation over trials (exponential base)
r̄LN
.421
.421

sdLN
.012

r̄HN
1.07
1.07

sdHN
.032

r̄LS
.367
.367

sdLS
.009

r̄HS
.612
.612

sdHS
.016

Again we have a close match with the theoretical ratios and see that standard
deviations are sufficiently small that a single experiment would pick up genuine dif-
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ferences between the cell ratios. However, as noted in Examples 18 and 19, this need
not be true if we alter the base distribution. Changing the base distribution can lead
to differences that are purely the result of statistical error. We illustrate this further
with the following example.
Example 25: Here we repeat Example 20 (Ki Poisson over trials) with the lognormal
base. The results are presented in Table 2.10. We see that, whereas the cell mean
Table 2.10: K Poisson with variation over trials (lognormal base)
r̄LN
18.6
20.1

sdLN
7.49

r̄HN
19.0
20.1

sdHN
7.03

r̄LS sdLS
19.4 10.88
20.1

r̄HS sdHS
20.4 11.78
20.1

ratios (over 500 repetitions) are stable at about a value of 19 (representing a slight
underestimate of the theoretical value blognorm + clognorm = 20.1 in (2.4.7)), the sample
standard deviations are large so that a single experiment might return highly variable
ratios over cells, leading the experimenter to conclude there is variation over trials.
Ironically such an occurrence would lead to the correct conclusion (since there is
variation over trials) even though theoretically this technique should actually fail at
detecting the case of random Poisson trials.
We now repeat Examples 21-24 using the lognormal base in place of the exponential base. We see that the mean cell ratios correctly pick up the variation over
trials (which can be verified by comparing with the standard errors of these means,
√
given by sdmean∗ = sd∗ / 500) but that the individual cell standard deviations sd∗ are
so large in some cases as to possibly blur these differences on a single experiment. We
also note that the simulated cell ratios consistently slightly underestimate the true
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theoretical ratios in the case of the lognormal base.
Example 26: Here we repeat Example 21 (Ki translated Poisson over trials) using
the lognormal base. The results are presented in Table 2.11. Note that the mean
cell ratios reveal some differences (as they should) but their actual values on a single
experiment would probably be blurred by the large standard deviations. Nonetheless
the conclusion based on a single experiment would likely be that variation over trials
exists.
Table 2.11: K translated Poisson with variation over trials (lognormal base)
r̄LN
14.1
14.8

sdLN
5.33

r̄HN sdHN
15.9 9.95
16.4

r̄LS sdLS
18.3 14.37
18.6

r̄HS sdHS
17.9 8.76
18.8

Example 27: Here we repeat Example 22 (Ki geometric over trials) with a lognormal
base, and the results are presented in Table 2.12.
Table 2.12: K geometric with variation over trials (lognormal base)
r̄LN sdLN
19.7 11.82
20.1

r̄HN
148.7
153.1

sdHN
68.62

r̄LS
19.7
20.1

sdLS
11.41

r̄HS
150.1
153.1

sdHS
76.47

The cell mean ratios differ sharply here, correctly indicating variation over
trials, and these marked differences would almost certainly be observed by a single
experiment, although a blurring of the actual values due to the standard deviations
might occur.
Example 28: Here we repeat Example 23 (Ki binomial over trials) with the lognormal base. The results are presented in Table 2.13. The cell mean ratios correctly
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Table 2.13: K binomial with variation over trials (lognormal base)
r̄LN
17.8
18.6

sdLN
8.87

r̄HN
18.1
18.6

sdHN
8.78

r̄LS
13.6
14.2

sdLS
5.95

r̄HS
13.5
14.2

sdHS
5.62

pick up the differences and hence the variation over trials but the standard deviations
may blur the actual values in the outcome of a single experiment.
Example 29: Here we repeat Example 24 (Ki hybrid Poisson-geometric) with the
lognormal base, and the results are presented in Table 2.14.
Table 2.14: K hybrid Poisson-geometric with variation over trials (lognormal base)
r̄LN
13.5
14.0

sdLN
9.11

r̄HN
27.1
27.5

sdHN
15.44

r̄LS
11.9
12.9

sdLS
4.37

r̄HS
17.1
18.0

sdHS
6.33

Again we see marked mean cell differences but large standard deviations.
Note: We have seen that the choice of base distribution can introduce considerable
variability into the individual cell ratios, so that a single experiment may produce
incorrect or inconclusive results. The most significant effect of large standard deviations is to create the appearance of differences between cell ratios even when there is
none (leading the experimenter to erroneously conclude there is variation over trials
when such is not the case). The experimenter is less likely to erroneously conclude
that there is no variation over trials when such variation is in fact present, although
large standard deviations can blur the differences between cells and lead to incorrect
estimates of cell ratios. The most effective method of reducing error is to increase
the number of trials N per participant as well as the number of participants M per
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cell to the greatest degree possible, since obviously repeating the experiment hundreds of times is not possible. However, considerable increases in N and M may be
necessary to reduce the standard deviations to suitable levels. By way of illustrating
that this method works in principle, we increased N and M to the values N = 1000
and M = 500 in Examples 18 and 19. Note the reduced (yet still large) standard
deviations presented below:
Example 30: This is Example 18 (Poisson without variation over trials) repeated
for N = 1000 and M = 500. The results are presented in Table 2.15. Contrast this
with Table 2.3.
Table 2.15: k Poisson without variation over trials (lognormal base)
r̄LN
12.6
12.7

sdLN
3.50

r̄HN
12.7
12.7

sdHN
4.50

r̄LS
12.6
12.7

sdLS
3.44

r̄HS
12.4
12.7

sdHS
2.56

Example 31: This is Example 19 (geometric without variation over trials) repeated
for N = 1000 and M = 500. The results are presented in Table 2.16. Contrast this
with Table 2.4.
Table 2.16: k geometric without variation over trials (lognormal base)
r̄LN
12.3
12.7

sdLN
4.02

r̄HN
12.7
12.7

sdHN
5.61

r̄LS
12.3
12.7

sdLS
3.98

r̄HS
12.4
12.7

sdHS
4.31

Note that, in addition to the reduced standard deviations, Examples 30 and 31 exhibit improved convergence of the simulated mean ratios to the theoretical ratios;
specifically, the downward bias of the simulated values seen in Examples 18 and 19 is
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noticeably decreased. Further increases in N and M would result in further improved
convergence and further reduction in the standard deviations.

2.5

Results for Models with Varying Θ

In Secs 2.3 and 2.4 we focused attention on generalized Cutler-Neufeld (gen-CN) models which are specific members of the class of general serial mixture models (Sec 2.2)
having the special property that the only quantity whose distribution differs depending on the cell * is the number of subprocesses K. In various factorial experiments
involving schizophrenia patients and controls, gen-CN models have seemed sufficient
to capture the changes across cells in mean encoding times E(T )∗ and average intertrial variances E(Var(T ))∗. However, many other models might be selected from
the class of general serial mixture models (not just for modelling encoding times in
schizophrenia, but potentially other cognitive processes as well). In particular, we
might question the favoured position being delegated to K in gen-CN models, and
wonder whether changes in the distribution of the vector Θ over cells might better
describe observed data. This changes the focus from the number of subprocesses K
to the encoding speed (governed by Θ) of individual subprocesses. However, the definition of Θ depends explicitly on the choice of base distribution; thus to work with Θ
we must first select a particular base distribution (which was not the case for gen-CN
models). Having to choose a base distribution is not a barrier to obtaining results;
however, it does mean that results need to be derived on a case-by-case basis.
We now proceed to determine MIC-VIC signatures for a variety of serial mixture models with different choices of base and Θ. Throughout these derivations we
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make the assumption that Ki = ki does not vary over trials, and that the distribution
of k across participants is the same in every cell. Instead it will be Θ that is allowed
to vary across trials, participants, and cells. This amounts to a reversal of the roles
of K and Θ from that of gen-CN models.

2.5.1

Gamma Base with Varying Rate Parameter V

Here we choose a gamma base (see Appendix B) with accompanying vector Θ =
(A, V ) where A denotes the shape parameter and V denotes the rate parameter. It
will be too complex to cope with both A and V varying over trials and cells, so in
this subsection we assume it is only V which is allowed to vary in that manner. This
leads to the following:
Theorem 6: Let `ij follow a gamma base distribution with Θi = (ai, Vi ) where the
rate parameter Vi is allowed to vary over trials and participants within a cell as well
as to vary across cells. The shape parameter ai can vary over participants within a
cell but not over trials, and moreover must follow the same distribution in each cell.
We also assume that the number of subprocesses ki can vary over participants in a
cell but not over trials, and must follow the same distribution in each cell. Further
assume that the random processes ai , Vi , and ki act independently of each other over
participants and trials. Define
i
i
i
i
IVMIC = (EHS
[E(1/Vi )] − EHN
[E(1/Vi )]) − (ELS
[E(1/Vi )] − ELN
[E(1/Vi )]) (2.5.1)

and
i
i
i
i
IVVIC = (EHS
[Var(1/Vi )] − EHN
[Var(1/Vi )]) − (ELS
[Var(1/Vi )] − ELN
[Var(1/Vi )])

(2.5.2)
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and
i
i
i
i
IVSQMIC = (EHS
[E(1/Vi2 )] − EHN
[E(1/Vi2 )]) − (ELS
[E(1/Vi2 )] − ELN
[E(1/Vi2)])

(2.5.3)
Then
MIC = E i [ki ]E i [ai]IVMIC

(2.5.4)

VIC = E i [ki2]E i [a2i ]IVVIC + E i [ki ]E i [ai]IVSQMIC

(2.5.5)

and

note: The prefactor “IV” in the notation above stands for “Inverse of V”.
proof: For the gamma base distribution µ(Θi ) = ai /Vi and σ 2(Θi ) = ai/Vi2 . Plugging
into (2.2.10) and using the independence of the processes we obtain
E(T )∗ = E∗i [E(Ki )]E∗i [E(ai/Vi )]
= E i [ki ]E∗i [aiE(1/Vi )]

(2.5.6)

= E i [ki ]E i[ai]E∗i [E(1/Vi )]
so
MIC = (E(T )HS − E(T )HN ) − (E(T )LS − E(T )LN )
i

(2.5.7)

i

= E [ki ]E [ai]IVMIC
Similarly, plugging into (2.2.11), we obtain
E(Var(T ))∗ = E i [ki2]E∗i [Var(ai /Vi )] + E i [ki ]E∗i [E(ai/Vi2 )]
= E i [ki2]E∗i [a2i Var(1/Vi )] + E i [ki ]E∗i [aiE(1/Vi2 )]

(2.5.8)

= E i [ki2]E i [a2i ]E∗i [Var(1/Vi )] + E i [ki ]E i [ai]E∗i [E(1/Vi2 )]
Then
VIC = (E(Var(T ))HS − E(Var(T ))HN ) − (E(Var(T ))LS − E(Var(T ))LN )
=E

i

[ki2 ]E i[a2i ]IVVIC

i

i

+ E [ki ]E [ai]IVSQMIC as claimed. 4

(2.5.9)
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In the corollary below we consider the subcase where Vi = vi does not vary over trials.
Corollary 6.1: Suppose the premise of Theorem 6 holds. Further suppose vi varies
only over participants and cells with no variation over trials. Then Var(1/Vi ) =
Var(1/vi ) = 0 for each participant, yielding IVVIC = 0. Thus
MIC = E i [ki ]E i [ai]IVMIC

(2.5.10)

and
VIC = E i [ki ]E i [ai]IVSQMIC

4

(2.5.11)

The following two examples illustrate the application of Corollary 6.1.
Example 32: Assume the premises of Theorem 6 and Corollary 6.1 both hold.
Consider the case where v follows a Gam(u, r∗) distribution across participants in cell
*, i.e., the shape parameter u > 2 stays the same for each cell but the rate parameter
r∗ varies. Then we know that
E∗i [1/vi ] =

r∗
u−1

and E∗i [1/vi2 ] =

r∗2
(u − 1)(u − 2)

Let r, h, g, f be defined by rLN = r, rHN = r + h, rLS = r + g, and rHS = r + f.
Note that (2.5.6) plus the usual factorial data assumptions implies h > 0, g > 0, and
f > 0. Then
i
i
i
i
IVMIC = (EHS
[1/vi ] − EHN
[1/vi ]) − (ELS
[1/vi )] − ELN
[1/vi ])



 

rHS
rHN
rLS
rLN
=
−
−
−
u−1 u−1
u−1 u−1
=

1
[f − (h + g)]
u−1

(2.5.12)
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and
i
i
i
i
IVSQMIC = (EHS
[1/vi2 ] − EHN
[1/vi2 ]) − (ELS
[1/vi2] − ELN
[1/vi2 ])

 

2
2
2
2
rHN
rLS
rLN
rHS
=
−
−
−
(u − 1)(u − 2) (u − 1)(u − 2)
(u − 1)(u − 2) (u − 1)(u − 2)


=

1
[(r + f)2 − (r + h)2 − {(r + g)2 − r2 }]
(u − 1)(u − 2)

=

1
[2r[f − (h + g)] + f 2 − (h2 + g 2 )]
(u − 1)(u − 2)

(2.5.13)

Since IVMIC = 0 iff f = h + g, substituting this constraint into IVSQMIC yields
IVSQMIC =

2hg
> 0
(u − 1)(u − 2)

(2.5.14)

so MIC = 0 implies VIC > 0 always in this model.
note: Consider the case of the Erlang model, which has the exponential base (a
special case of the gamma where ai = 1 for all participants) and the two parameters
k and v. The Neufeld model extends the Erlang to the case where k and v are both
allowed to vary over participants in each cell. One can then make a choice – attempt
to explain changes in E(T )∗ and E(Var(T ))∗ by changes in k over cells, or attempt to
explain changes in E(T )∗ and E(Var(T ))∗ by changes in v over cells. The first choice
(which was the choice made by Neufeld) leads to the signature VIC = 0 iff MIC = 0
(see Corollary 3.1) whereas the second choice, when assigning v a Gam(u, r∗ ) distribution (recall Neufeld used a fixed gamma distribution to describe v in each cell)
leads to VIC > 0 whenever MIC = 0 (Example 32). This shows that, if we assume
the premise of a basic Neufeld model, factorial data which supports additivity in both
means and variances suggests that neurophysiological changes due to schizophrenia
and encoding load are explained by increases in the number of subprocesses k required
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for encoding, whereas factorial data which supports additivity in means but superadditivity of variances suggests that neurophysiological changes due to schizophrenia
and encoding load are explained by decreases in the rate v at which subprocesses are
executed.
The above note describes the possible choice between two models and the
resulting interpretation of neurophysiological processes, but it is also important to
realize that Example 32 specifically assumed a Gam(u, r∗ ) distribution on v. The
conclusions of that example can be altered by changing the behaviour of v, as we do
in the next example. There we retain a gamma distribution on v but introduce a
relationship between the rate parameter r∗ and the shape parameter u∗ .
D

Example 33: Consider a modification of Example 32 where v ∼ Gam(u∗, r∗ ) and
there exists some β > 0 such that r∗ = β(u∗ − 2). The shape parameter u∗ can
vary over (2, ∞) which results in r∗ varying over (0, ∞). The connection between the
parameters introduces a linear relationship between E∗i [1/vi2 ] and E∗i [1/vi ]; specifically
E∗i [1/vi2] = βE∗i [1/vi ]. To see this, note that
E∗i [1/vi ] =

β(u∗ − 2)
r∗
=
u−1
u∗ − 1

(2.5.15)

and
E∗i [1/vi2]

r∗2
β 2(u∗ − 2)2
=
=
=β
(u∗ − 1)(u∗ − 2)
(u∗ − 1)(u∗ − 2)



β(u∗ − 2)
u∗ − 1



= βE∗i [1/vi ]
(2.5.16)
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Applying this yields
i
i
i
i
IVSQMIC = (EHS
[1/vi2 ] − EHN
[1/vi2 ]) − (ELS
[1/vi2] − ELN
[1/vi2 ])
i
i
i
i
= (βEHS
[1/vi ] − βEHN
[1/vi ]) − (βELS
[1/vi ] − βELN
[1/vi ])

(2.5.17)

= β IVMIC
Thus IVSQMIC = 0 iff IVMIC = 0, yielding VIC = 0 iff MIC = 0.
Note: There are some restrictions to the applicability of Example 33. Note from
(2.5.15) that E∗i [1/vi ] is an increasing function of u∗ but is bounded above by an
asymptote at β, i.e., 0 < E∗i [1/vi ] < β. Applying (2.5.6), this in turn implies the
restriction 0 < E(T )∗ < E i [ki ]E i [ai] β which must be considered when applying the
model to data. Moreover, the asymptote at β for E∗i [1/vi ] sometimes precludes the
possibility of a solution to MIC = 0. In order to see this, for convenience in this
example let c∗ = E∗i [1/vi ]. Now suppose we have 0 < cLN < cLS < cHN < cHS < β
where cLS − cLN > β/2. This forces cLS > β/2 and thus cHS − cHN < β − β/2 =
β/2. This results in IVMIC < 0 whenever this pattern arises. However, there are
other circumstances which produce solutions to IVMIC = 0. For example, suppose
0 < cLN < cLS < cHN < β/2. Then cLS − cLN = b < β/2 and it follows that
cHN + b < β/2 + β/2 = β which implies that cHN + b is an admissible value for cHS .
Setting cHS = cHN + b yields IVMIC = 0. Similarly, if 0 < cLN < cHN < cLS < β/2
then once again cLS −cLN = b < β/2 and setting cHS = cHN + b yields a solution to
IVMIC = 0.
In the next two examples, Vi varies over trials rather than participants.
Example 34: Assume the premise of Theorem 6 holds. Suppose the rate parameter
Vi follows an inverse Gaussian distribution over trials (no variation over participants)
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in each cell, with the assumption that the shape parameter λ is fixed in each cell
D

whereas the mean µ∗ shifts from cell to cell, i.e., Vi ∼ IG(µ∗ , λ) in cell *. For
convenience let φ∗ = 1/µ∗ and ψ = 1/λ. It follows that
E(1/Vi ) = φ∗ + ψ,

Var(1/Vi ) = ψφ∗ + 2ψ 2,

E(1/Vi2 ) = φ2∗ + 3ψφ∗ + 3ψ 2 (2.5.18)

Then, setting m = φLN and defining h, g, f by φHN = m + h, φLS = m + g, and
φHS = m + f, yields
i
i
i
i
IVMIC = (EHS
[E(1/Vi )] − EHN
[E(1/Vi )]) − (ELS
[E(1/Vi )] − ELN
[E(1/Vi )])

= (φHS − φHN ) − (φLS − φLN )
= f − (h + g)

(2.5.19)

and also
i
i
i
i
IVVIC = (EHS
[Var(1/Vi )] − EHN
[Var(1/Vi )]) − (ELS
[Var(1/Vi )] − ELN
[Var(1/Vi )])

= ψ[(φHS − φHN ) − (φLS − φLN )]
= ψ[f − (h + g)]

(2.5.20)

Therefore IVVIC = 0 iff IVMIC = 0. However
i
i
i
i
IVSQMIC = (EHS
[E(1/Vi2 )] − EHN
[E(1/Vi2 )]) − (ELS
[E(1/Vi2 )] − ELN
[E(1/Vi2 )])

= [(φ2HS + 3ψφHS )−(φ2HN + 3ψφHN )]−[(φ2LS + 3ψφLS )−(φ2LN + 3ψφLN )]
= 2m[f − (h + g)] + f 2 − (h2 + g 2 ) + 3ψ[f − (h + g)]

(2.5.21)

so substituting in f = h + g always yields
IVSQMIC = 2hg > 0

(2.5.22)
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so MIC = 0 always implies VIC > 0.
Note: We can impose different relationships between µ∗ and λ∗ to produce other
results; for example, if the mean and shape parameter are identical in each cell but
change from cell to cell, then it can easily be seen that IVMIC = 0 implies both
IVVIC > 0 and IVSQMIC > 0 as illustrated below:
Example 35: Assume the premise of Theorem 6 holds. Suppose the rate parameter
Vi follows an inverse Gaussian distribution over trials (no variation over participants)
in each cell, with the assumption that the mean and shape parameters coincide in
D

each cell and shift from cell to cell, i.e., Vi ∼ IG(λ∗ , λ∗ ) in cell *. For convenience let
φ∗ = 1/λ∗ . It follows that
E(1/Vi ) = 2φ∗ ,

Var(1/Vi ) = 3φ2∗ ,

E(1/Vi2 ) = 7φ2∗

(2.5.23)

Then
i
i
i
i
IVMIC = (EHS
[E(1/Vi )] − EHN
[E(1/Vi )]) − (ELS
[E(1/Vi )] − ELN
[E(1/Vi )])

= 2[(φHS − φHN ) − (φLS − φLN )]
= 2[f − (h + g)]

(2.5.24)

where we define m, h, g, f as in Example 34. Then also
i
i
i
i
IVVIC = (EHS
[Var(1/Vi )] − EHN
[Var(1/Vi )]) − (ELS
[Var(1/Vi )] − ELN
[Var(1/Vi )])

= 3[(φ2HS − φ2HN ) − (φ2LS − φ2LN )]
= 3 [2m[f − (h + g)] + f 2 − (h2 + g 2 )]

(2.5.25)
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and similarly
i
i
i
i
IVSQMIC = (EHS
[E(1/Vi2 )] − EHN
[E(1/Vi2 )]) − (ELS
[E(1/Vi2 )] − ELN
[E(1/Vi2)])

= 7 [2m[f − (h + g)] + f 2 − (h2 + g 2 )]

(2.5.26)

so substituting in f = h + g always yields
IVVIC = 6hg > 0 and IVSQMIC = 14hg > 0

(2.5.27)

so MIC = 0 always implies VIC > 0.

2.5.2

Gamma Base with Varying Shape Parameter A

Here we assume `ij follows a gamma base distribution with vector Θi = (Ai , vi), i.e.,
D

`ij ∼ Gam(Ai, vi ), where Ai may vary across participants, trials, and cells, whereas
vi can only vary across participants with the same distribution in each cell. Thus we
are simply reversing the rules for Ai and vi from the previous subsection. This yields
the following:
D

Theorem 7: Here we assume `ij ∼ Gam(Ai , vi) where the shape parameter Ai is
allowed to vary over trials and participants within a cell as well as vary across cells.
The rate parameter vi can vary over participants within a cell but not over trials,
and moreover must follow the same distribution in each cell. We also assume that
the number of subprocesses ki can vary over participants in a cell but not over trials,
and must follow the same distribution in each cell. Further assume that the random
processes Ai, vi , and ki act independently of each other over participants and trials.
Define
i
i
i
i
AMIC = (EHS
[E(Ai)] − EHN
[E(Ai)]) − (ELS
[E(Ai)] − ELN
[E(Ai )])

(2.5.28)
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and
i
i
i
i
AVIC = (EHS
[Var(Ai )] − EHN
[Var(Ai)]) − (ELS
[Var(Ai)] − ELN
[Var(Ai)]) (2.5.29)

Then
MIC = E i [ki ]E i [1/vi ]AMIC

(2.5.30)


VIC = E i [1/vi2] E i [ki2]AVIC + E i [ki ]AMIC

(2.5.31)

and

Therefore if MIC = 0 the sign of VIC depends on the sign of AVIC.
proof: For the gamma base distribution µ(Θi ) = Ai /vi and σ 2(Θi ) = Ai/vi2 . Plugging
into (2.2.10) and using the independence of the processes we obtain
E(T )∗ = E∗i [E(Ki )]E∗i [E(Ai/vi )]
= E i [ki ]E∗i [(1/vi )E(Ai)]

(2.5.32)

= E i [ki ]E i[1/vi ]E∗i [E(Ai)]
so
MIC = (E(T )HS − E(T )HN ) − (E(T )LS − E(T )LN )
i

(2.5.33)

i

= E [ki ]E [1/vi ]AMIC
Similarly, plugging into (2.2.11), we obtain
E(Var(T ))∗ = E i [ki2]E∗i [Var(Ai /vi )] + E i [ki ]E∗i [E(Ai/vi2 )]
= E i [ki2]E∗i [(1/vi2)Var(Ai )] + E i [ki ]E∗i [(1/vi2)E(Ai )]
(2.5.34)
= E i [ki2]E i [1/vi2 ]E∗i [Var(Ai )] + E i [ki ]E i[1/vi2 ]E∗i [E(Ai)]

= E i [1/vi2 ] E i [ki2]E∗i [Var(Ai)] + E i [ki ]E∗i [E(Ai )]
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Then
VIC = (E(Var(T ))HS − E(Var(T ))HN ) − (E(Var(T ))LS − E(Var(T ))LN )
 i
i
= E i [1/vi2]E i [ki2] (EHS
[Var(Ai)] − EHN
[Var(Ai )])
i
i
− (ELS
[Var(Ai )] − ELN
[Var(Ai )])

 i
i
i
i
+ E i [1/vi2 ]E i[ki ] (EHS
[E(Ai )] − EHN
[E(Ai)]) − (ELS
[E(Ai)] − ELN
[E(Ai)])

= E i [1/vi2] E i [ki2 ]AVIC + E i [ki ]AMIC

as claimed. 4

(2.5.35)

Corollary 7.1: Suppose the premise of Theorem 7 holds. Further suppose Ai varies
only over participants with no variation over trials. Then Var(Ai ) = 0 for each
participant, yielding AVIC = 0. Thus VIC reduces to VIC = E i [1/vi2 ]E i[ki ]AMIC
and so VIC = 0 iff MIC = 0. 4
Corollary 7.1 shows that the signature VIC = 0 iff MIC = 0 is obtained in the
case of a gamma base distribution where ai , vi, and ki vary only over participants,
and the shifting in E(T )∗ across cells is explained by shifting the distribution of
ai . Thus this model is a competitor for a gen-CN model without variation (using a
gamma base, e.g., the Cutler-Neufeld model) where the shifting in E(T )∗ across cells
is explained by shifting the distribution of ki (see Corollary 3.1). Here the two models
mimic each other.
We now consider a series of examples with a gamma base where Ai varies
only over trials. We employ different positive distributions for Ai since, as a shape
parameter, Ai must satisfy Ai > 0. We have chosen to model Ai with continuous
distributions (as would most likely be done in practice) but there is no reason discrete
distributions could not be employed. The quantities m, h, g, and f that are defined
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in some of these examples (whose values depend on the example) are always positive
due to (2.5.32) and the shifting values of E(T )∗ in our factorial models.
Example 36: Ai follows a gamma distribution over trials with shifting shape
parameter and fixed rate parameter: Assume the premise of Theorem 7 holds.
Suppose that, in cell *, Ai follows a gamma distribution over trials (no variation
D

over participants) with shape parameter a∗ and fixed rate parameter b, i.e., Ai ∼
Gam(a∗ , b). Then
E(Ai ) =

a∗
b

and

Var(Ai) =

a∗
b2

(2.5.36)

Thus
i
i
i
i
AMIC = (EHS
[E(Ai)] − EHN
[E(Ai)]) − (ELS
[E(Ai)] − ELN
[E(Ai )])

(2.5.37)

= (1/b)[(aHS − aHN ) − (aLS − aLN )]
and
i
i
i
i
AVIC = (EHS
[Var(Ai )] − EHN
[Var(Ai)]) − (ELS
[Var(Ai)] − ELN
[Var(Ai)])

= (1/b2 )[(aHS − aHN ) − (aLS − aLN )]

(2.5.38)

= (1/b)AMIC
Thus AVIC = 0 iff AMIC = 0 and so VIC = 0 iff MIC = 0.
Note that Example 36, where Ai is varying over trials, produces the same
MIC-VIC signature as the case where ai varies only over participants (Corollary 7.1)
but these models are not equivalent as the former produces more variability in the
trials Ti .
Example 37: Ai follows a gamma distribution over trials with fixed shape
parameter and shifting rate parameter: Assume the premise of Theorem 7 holds.
In cell *, let Ai follow a gamma distribution over trials (no variation over participants)

86
D

with fixed shape parameter a and shifting rate parameter b∗, i.e., Ai ∼ Gam(a, b∗) in
cell *. Then
E(Ai ) =
and setting m =

1
bLN

,

1
bHN

a
b∗

= m+h,

1
bLS

and

Var(Ai) =

= m+g, and

a
b2∗

1
bHS

(2.5.39)

= m+f yields

i
i
i
i
AMIC = (EHS
[E(Ai)] − EHN
[E(Ai)]) − (ELS
[E(Ai)] − ELN
[E(Ai )])

= a[(1/bHS − 1/bHN ) − (1/bLS − 1/bLN )]

(2.5.40)

= a[f − (h + g)]
and
i
i
i
i
AVIC = (EHS
[Var(Ai )] − EHN
[Var(Ai)]) − (ELS
[Var(Ai)] − ELN
[Var(Ai)])

= a[(1/b2HS − 1/b2HN ) − (1/b2LS − 1/b2LN )]

(2.5.41)

= a[((m + f)2 − (m + h)2 ) − ((m + g)2 − m2 )]
= a[2m[f − (h + g)] + f 2 − (h2 + g 2 )]
Now AMIC = 0 iff f = h + g and substituting this constraint into AVIC yields
AVIC = 2ahg > 0

(2.5.42)

Thus MIC = 0 always implies VIC > 0 here.
Example 38: Ai follows an inverse Gaussian distribution over trials with
shifting mean and fixed shape parameter: Assume the premise of Theorem 7
holds. Here we assume that, in cell *, Ai follows an inverse Gaussian distribution
over trials (no variation over participants) with mean a∗ and fixed shape parameter
D

b, i.e., Ai ∼ IG(a∗, b) in cell *. Then
E(Ai ) = a∗

and

Var(Ai) =

a3∗
b

(2.5.43)
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so
i
i
i
i
AMIC = (EHS
[E(Ai)] − EHN
[E(Ai)]) − (ELS
[E(Ai)] − ELN
[E(Ai )])

= (aHS − aHN ) − (aLS − aLN )

(2.5.44)

= f − (h + g)
where we set m = aLN and aHN = m + h, aLS = m + g, and aHS = m + f. Then
i
i
i
i
AVIC = (EHS
[Var(Ai )] − EHN
[Var(Ai)]) − (ELS
[Var(Ai)] − ELN
[Var(Ai)])

1
= [(a3HS − a3HN ) − (a3LS − a3LN )]
b
1
= [((m + f)3 − (m + h)3 ) − ((m + g)3 − m3)]
b

(2.5.45)

1
= [3m2[f − (h + g)] + 3m[f 2 − (h2 + g 2 )] + f 3 − (h3 + g 3 )]
b
Since AMIC = 0 iff f = h + g, substituting this constraint into AVIC yields
1
AVIC = [3m[(h + g)2 − (h2 + g 2)] + (h + g)3 − (h3 + g 3 )]
b
1
= [3m(2hg) + 3(h2 g + hg 2 )]
b

(2.5.46)

1
= (3hg)[2m + h + g] > 0
b
Thus MIC = 0 always implies VIC > 0.
Note: We do not consider the case of the inverse Gaussian where we hold the mean
fixed and only shift the shape parameter, since in this case E(Ai ) = a is the same in
all four cells, rendering E(T )HS = E(T )HN = E(T )LS = E(T )LN which is not of any
practical interest.
Example 39: Ai follows a lognormal distribution over trials with shifting
associated normal mean and fixed associated normal variance: Assume the
premise of Theorem 7 holds. In cell *, let Ai follow a lognormal distribution over trials
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(no variation over participants) with an associated normal mean a∗ and associated
D

normal variance b2 , i.e., Ai ∼ LN(a∗, b2) in cell *. Then
b2

b2

E(Ai ) = ea∗+ 2 = ea∗ e 2

and

2

2

2

2

Var(Ai ) = e2a∗+b (eb −1) = e2a∗ eb (eb −1) (2.5.47)

Setting m = eaLN and defining h, g, f by eaHN = m+h, eaLS = m+g, and eaHS = m+f,
we obtain
i
i
i
i
AMIC = (EHS
[E(Ai)] − EHN
[E(Ai)]) − (ELS
[E(Ai)] − ELN
[E(Ai )])
b2

= e 2 [(eaHS − eaHN ) − (eaLS − eaLN )]

(2.5.48)

b2

= e 2 [f − (h + g)]

and
i
i
i
i
AVIC = (EHS
[Var(Ai )] − EHN
[Var(Ai)]) − (ELS
[Var(Ai)] − ELN
[Var(Ai)])
2

2

b2

b2

2

2

= eb (eb − 1)[(e2aHS − e2aHN ) − (e2aLS − e2aLN )]

(2.5.49)

= e (e − 1)[((m + f)2 − (m + h)2 ) − ((m + g)2 − m2)]
= eb (eb − 1)[2m[f − (h + g)] + f 2 − (h2 + g 2 )]

Since MIC = 0 iff f = h + g, substituting this constraint into AVIC yields
2

2

AVIC = 2eb (eb − 1)hg > 0

(2.5.50)

so MIC = 0 always implies VIC > 0.
Example 40: Ai follows a lognormal distribution over trials with fixed
associated normal mean and shifting associated normal variance: Assume
the premise of Theorem 7 holds. In cell *, let Ai follow a lognormal distribution
over trials (no variation over participants) with an associated normal mean a and
D

associated normal variance b2∗, i.e., Ai ∼ LN(a, b2∗) in cell *. Then
b2
∗

b2
∗

E(Ai ) = ea+ 2 = ea e 2

2

2

2

2

and Var(Ai ) = e2a+b∗ (eb∗ − 1) = e2a eb∗ (eb∗ − 1) (2.5.51)
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Setting m = e

b2
LN
2

and e

b2
HN
2

= m + h, e

b2
LS
2

= m + g, and e

b2
HS
2

= m + f, we obtain

i
i
i
i
AMIC = (EHS
[E(Ai)] − EHN
[E(Ai)]) − (ELS
[E(Ai)] − ELN
[E(Ai )])

= ea [(e

b2
HS
2

−e

b2
HN
2

= ea [f − (h + g)]
2

2

) − (e

b2
LS
2

−e

b2
LN
2

)]

(2.5.52)

and
2

2

2

2

2

2

AVIC = e2a[(ebHS (ebHS − 1)−ebHN (ebHN − 1))−(ebLS (ebLS − 1)−ebLN (ebLN − 1))]
= e2a[(m + f)2 [(m + f)2 − 1] − (m + h)2 [(m + h)2 − 1]]
− e2a[(m + g)2 [(m + g)2 − 1] − m2[m2 − 1]]

= e2a ((m + f)4 − (m + h)4 ) − ((m + g)4 − m4)
− (m + f)2 + (m + h)2 + (m + g)2 − m2
= e2a[4m3 [f − (h + g)] + 6m2 [f 2 − (h2 + g 2 )] + 4m[f 3 − (h3 + g 3 )]
+ e2a[f 4 − (h4 + g 4 )] − 2m[f − (h + g)] − [f 2 − (h2 + g 2 )]]
= e2a[(4m3 − 2m)[f − (h + g)] + (6m2 − 1)[f 2 − (h2 + g 2 )]]
+ e2a[4m[f 3 − (h3 + g 3 )] + f 4 − (h4 + g 4)]

(2.5.53)

Since MIC = 0 iff f = h + g, substituting this constraint into AVIC yields
AVIC = e2a[(6m2 − 1)[(h + g)2 − (h2 + g 2 )] + 4m[(h + g)3 − (h3 + g 3 )]
+ e2a[(h + g)4 − (h4 + g 4 )]

(2.5.54)

= e2a[(6m2 − 1)[2hg] + 12m[h2g + hg 2 ] + 4[h3 g + hg 3 ] + 6h2 g 2 ]
= e2a(2hg)[(6m2 − 1) + 6m(h + g) + 2(h2 + g 2 ) + 3hg] > 0
so MIC = 0 always implies VIC > 0. (Note that m > 1 always in this example.)
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Example 41: Ai follows a Weibull distribution over trials with shifting
scale parameter and fixed shape parameter: Assume that the premise of Theorem 7 holds. Suppose that, in cell *, Ai follows a Weibull distribution over trials
(no variation over participants) with shape parameter a and scale parameter b∗, i.e.,
D

Ai ∼ Wei(a, b∗) in cell *. Then

E(Ai ) = b∗ Γ(1 + 1/a) and Var(Ai ) = b2∗ Γ(1 + 2/a) − (Γ(1 + 1/a))2

(2.5.55)

Set m = bLN and define h, g, f by bHN = m + h, bLS = m + g, and bHS = m + f. Then
i
i
i
i
AMIC = (EHS
[E(Ai)] − EHN
[E(Ai)]) − (ELS
[E(Ai)] − ELN
[E(Ai )])

= Γ(1 + 1/a)[(bHS − bHN ) − (bLS − bLN )]

(2.5.56)

= Γ(1 + 1/a)[f − (h + g)]
Now
i
i
i
i
AVIC = (EHS
[Var(Ai)] − EHN
[Var(Ai)]) − (ELS
[Var(Ai )] − ELN
[Var(Ai)])


= Γ(1 + 2/a) − (Γ(1 + 1/a))2 [((m + f)2 − (m + h)2 ) − ((m + g)2 − m2)]

= Γ(1 + 2/a) − (Γ(1 + 1/a))2 [2m[f − (h + g)] + f 2 − (h2 + g 2 )]

(2.5.57)

Now AMIC = 0 iff f = h + g and substituting this constraint into AVIC yields

AVIC = 2 Γ(1 + 2/a) − (Γ(1 + 1/a))2 hg > 0

(2.5.58)

Thus MIC = 0 always implies VIC > 0.
Note: So far we have seen, in the case of a gamma base with a varying shape
parameter, and with the the notable and important exceptions of Corollary 7.1 and
Example 36 where the signature VIC = 0 iff MIC = 0 is obtained, in all other
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examples MIC = 0 implied VIC > 0. The latter tends to occur because of the
definition of AVIC and the fact that variances tend to skew concave upward because
of the squaring operation. However, in the case where Ai follows a Weibull distribution
with fixed scale parameter but shifting shape parameter, it can be shown that whereas
many cases with MIC = 0 do result in VIC > 0, this is not universally true; there
exist specific solutions where MIC = 0 yields VIC < 0. One is illustrated below.
Example 42: Ai follows a Weibull distribution over trials with fixed scale
parameter and specific varied shape parameter values: Assume the premise of
Theorem 7 holds. Suppose that, in cell *, Ai follows a Weibull distribution over trials
(no variation over participants) with scale parameter b and specific shape parameters
D

a∗, i.e., Ai ∼ Wei(a∗, b) in cell *. Then

E(Ai ) = b Γ(1 + 1/a∗ ) and Var(Ai ) = b2 Γ(1 + 2/a∗ ) − (Γ(1 + 1/a∗ ))2

(2.5.59)

For convenience we define x∗ = 1/a∗ and set xLN = 0.46, xHN = 0.56, and xLS =
0.66. Then define mLN = Γ(1.46) = 0.8856, mHN = Γ(1.56) = 0.8896, and mLS =
Γ(1.66) = 0.9017. Now the result MIC = 0 is equivalent to the constraint
mHS = mHN + mLS − mLN = 0.8896 + 0.9017 − 0.8856 = 0.9057

(2.5.60)

Solving numerically yields Γ(1.684) = 0.9057 so xHS = 0.684 corresponds to MIC = 0
here. We can then compute
i
i
i
i
AVIC = (EHS
[Var(Ai )] − EHN
[Var(Ai)]) − (ELS
[Var(Ai)] − ELN
[Var(Ai)])

= b2[(0.3965 − 0.2654) − (0.3678 − 0.1845)]
= −b2(0.0522) < 0
Thus the possibility VIC < 0 when MIC = 0 does arise here.

(2.5.61)
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2.5.3

Inverse Gaussian Base with Varying Mean M

Here we choose an inverse Gaussian base (see Appendix B) with accompanying vector
Θ = (M, Λ) where M denotes the mean of the distribution and Λ denotes the shape
parameter. We will restrict consideration to the case where only M is allowed to vary
over cells. This leads to the following
Theorem 8: Here we assume `ij follows an inverse Gaussian base distribution with
Θi = (Mi , λi ) where the mean Mi is allowed to vary over trials and participants
within a cell as well as vary across cells. The shape parameter λi can vary over
participants within a cell but not over trials, and moreover must follow the same
distribution in each cell. We also assume that the number of subprocesses ki can vary
over participants in a cell but not over trials, and must follow the same distribution in
each cell. Further assume that the random processes Mi , λi , and ki act independently
of each other over participants and trials. Define
i
i
i
i
MMIC = (EHS
[E(Mi )] − EHN
[E(Mi )]) − (ELS
[E(Mi )] − ELN
[E(Mi )])

(2.5.62)

and
i
i
i
i
MVIC = (EHS
[Var(Mi )]−EHN
[Var(Mi )])−(ELS
[Var(Mi )]−ELN
[Var(Mi )]) (2.5.63)

and
i
i
i
i
MCUMIC = (EHS
[E(Mi3)] − EHN
[E(Mi3 )]) − (ELS
[E(Mi3 )] − ELN
[E(Mi3 )]) (2.5.64)

Then
MIC = E i [ki ]MMIC

(2.5.65)
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and
VIC = E i [ki2 ]MVIC + E i [ki ]E i[1/λi ]MCUMIC

(2.5.66)

proof: For the inverse Gaussian distribution µ(Θi ) = Mi and σ 2 (Θi ) = Mi3 /λi . Using
(2.2.10) we obtain
E(T )∗ = E i [ki ]E∗i [E(Mi )]

(2.5.67)

and using (2.2.11) we obtain
E(Var(T ))∗ = E i [ki2]E∗i [Var(Mi )] + E∗i [ki ]E i[1/λi ]E∗i [E(Mi3)]

(2.5.68)

from which the results follow. 4
The following two examples are illustrations of Theorem 8.
Example 43: Assume the premise of Theorem 8 holds. Suppose Mi does not vary
over trials but does vary over participants in cell * according to a Gam(a∗ , b) distribution. Then Var(Mi ) = 0 so MVIC = 0 and we have Mi = mi with
E∗i [mi ] =

a∗
b

and E∗i [m3i ] =

(a∗ +2)(a∗ +1)a∗
b3

(2.5.69)

Setting m = aLN and defining h, g, f by aHN = m + h, aLS = m + g, and aHS = m + f
(note h > 0, g > 0, f > 0 as usual using (2.5.67)), we obtain
1
MMIC = [f − (h + g)]
b

(2.5.70)
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and
MCUMIC =

1
{[(m+f +2)(m+f +1)(m+ f) − (m+h+2)(m+h+1)(m+h)]
b3
− [(m+g+2)(m+g+1)(m+g) − (m + 2)(m + 1)m]}

=

1 3
f − (h3 + g 3 ) + (3m + 3)[f 2 − (h2 + g 2 )]
b3
+ (3m2 + 6m + 2)[f − (h + g)]

(2.5.71)

Substituting in f = h + g yields
MCUMIC =

3
hg(h + g + 2m + 2) > 0
b3

(2.5.72)

so MIC = 0 implies VIC > 0.
Example 44: Assume the premise of Theorem 8 holds. Suppose Mi varies over
D

trials according to an exponential distribution with rate ci , i.e., Mi ∼ expo(ci ). For
convenience let ai = 1/ci and suppose a varies over participants in cell * according to
D

a gamma distribution where a ∼ Gam(α, b∗ ). Then
E(Mi ) = ai ,

Var(Mi ) = a2i ,

E(Mi3 ) = 6a3i

and setting d∗ = 1/b∗ yields
E∗i [E(Mi )] = E∗i [ai] = αd∗ ,

E∗i [Var(Mi )] = E∗i [a2i ] = α(α + 1)d2∗

and
E∗i [E(Mi3)] = E∗i [6a3i ] = 6α(α + 1)(α + 2)d3∗
Set m = dLN and define h, g, f by dHN = m + h , dLS = m + g, and dHS = m + f.
Note that h > 0, g > 0, f > 0 as usual by (2.5.67). Then
MMIC = α[(dHS − dHN ) − (dLS − dLN )] = α[f − (h + g)]

(2.5.73)
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and
MVIC = α(α + 1)[(d2HS − d2HN ) − (d2LS − d2LN )]
2

2

(2.5.74)
2

= α(α + 1)[2m[f − (h + g)] + f − (h + g )]
whereas
MCUMIC = 6α(α + 1)(α + 2)[(d3HS − d3HN ) − (d3LS − d3LN )]

= 6α(α + 1)(α + 2) f 3 − (h3 + g 3 ) + 3m[f 2 − (h2 + g 2 )]

(2.5.75)

+ 3m2 [f − (h + g)]
Substituting in f = h + g yields both
MVIC = 2α(α + 1)hg > 0

(2.5.76)

MCUMIC = 18α(α + 1)(α + 2)(hg)(h + g + 2m) > 0

(2.5.77)

and

Thus MIC = 0 always implies VIC > 0 here.
Note that expressions for MIC and VIC can always be developed for other base
distributions and varying choices of Θ simply by employing the general expressions
for cell means and variances given by (2.2.10) and (2.2.11). Here in Sec 2.5 we have
attempted to produce relatively simple expressions for MIC and VIC by holding the
distribution of k and that of at least one component of the vector Θ constant over
trials and cells. For example, in Theorem 8, only Mi was allowed to vary over trials
and cells. However, if one is willing to accept more complicated expressions for MIC
and VIC, then one can allow other quantities to vary over trials and/or cells as well,
and simply plug into (2.2.10) and (2.2.11).
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2.6

Discussion and Future Directions

Encoding is the mental process by which a cognitive task is transformed into an
internal representation which facilitates carrying out the task at hand. In this chapter
we observed that, for patients with schizophrenia, encoding latencies are prolonged
as compared to those of normal controls whereas other mental operations, such as
making comparisons with memory sets, and executing a response time, are spared
by the disease process. Moreover, the prolonged encoding times in schizophrenia are
even seen in comparison to other psychiatric controls (such as patients with major
depressive disorder) with the greatest increase found among schizophrenia patients
with paranoid symptoms (delusions and hallucinations). Thus prolonged encoding
times appear to be an earmark of the schizophrenia disease process.
In this chapter we also reviewed the outcomes of 2 × 2 factorial experiments
in which encoding load (low vs. high) and health diagnostic status (normal vs.
schizophrenia) were manipulated. These experiments were always seen to feature
factorial additivity of means (MIC = 0) whereas we might observe factorial additivity of variances (VIC = 0) or factorial nonadditivity of variances (VIC 6= 0) depending
on the experiment. The persistent observation of MIC = 0 suggests that the total
encoding time can be broken down into a sum of encoding times of individual subprocesses (a serial model). Previously developed models (the Erlang model, Neufeld
model, and Cutler-Neufeld model) were in fact examples of such serial models which
featured the signature VIC = 0 if and only if (iff) MIC = 0, and were suitable to
describe the outcomes of certain factorial experiments. The goal of this chapter was
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to develop a much broader class of serial models which could address a variety of factorial experimental paradigms with differing MIC-VIC signatures. The general serial
mixture models of Sec 2.2 are the class that emerged from this pursuit. This class
allows the individual subprocess encoding times to be distributed according to any
continuous positive infinite-tailed distribution (called the base distribution) whereas
the Erlang and Neufeld models both utilized an exponential base. This new flexibility in base distribution is not only potentially useful for modelling encoding times
but for application to modelling other cognitive processes which may follow different
distributions. The serial mixture models of Sec 2.2 also feature the innovation of the
Neufeld model whereby parameter values are allowed to vary according to participant
(thus incorporating heretofore “exogenous model noise” into the model itself, leading to Bayesian mixture models) but extend beyond this to further allow parameter
values to vary from trial to trial. The value of the latter is particularly seen when
considering the number of subprocesses Ki executed by the ith participant on any
given trial. It is easy to posit physical (and neurophysiological) mechanisms which
would lead to Ki varying from trial to trial. One such mechanism is the stimulus set
of the experiment itself, where there may be variability in the encoding requirements
of individual items in the set. Sec 2.3 presents examples of other mechanisms which
can lead to variability in Ki over trials. Sec 2.5 focuses on cases where the parameter
Θ of the base distribution itself varies over trials, representing the situation in which
the encoding speed of a subprocess increases or decreases depending on the trial.
One main sequela of the development of the general serial mixture models of
Sec 2.2 was the derivation of general closed-form expressions for the mean encoding
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time E(T )∗ and average intertrial variance E(Var(T ))∗ in each cell. These expressions
allow us to derive the form of MIC and VIC for any general serial mixture model.
Of course under many circumstances these expressions can be quite complicated, so
in Secs 2.3 and 2.5 we focus on special cases where particularly elegant and simple
expressions for MIC and VIC can be obtained. In Sec 2.3 we consider the special
case of what we call generalized Cutler-Neufeld (gen-CN) models. These models
are general serial mixture models where the base distribution is arbitrary and the
only variable which can vary over trials and cells is the number of subprocesses Ki .
These models, which are an extension of the Cutler-Neufeld model of Sec 2.1.2, not
only provide simple concise expressions for MIC and VIC but allow for a variety
of MIC-VIC signatures which are explored through a series of examples. Moreover,
the models themselves are supported by experimental evidence that has suggested
that the changes in E(T )∗ across cells can be explained by shifts in the distribution
of Ki across cells. Thus these models may have wide applicability. Note that one
particularly significant result in this section is that if Ki does not vary over trials
(what we call gen-CN models without variation) then we always obtain the signature
VIC = 0 iff MIC = 0. Thus observation of VIC 6= 0 implies there is some variation
in subprocess number over trials. However, various examples also illustrate the fact
that VIC = MIC = 0 can be obtained in some situations where variation is present.
Sec 2.4 addresses the problem of determining, using factorial data, whether variation
is present in a gen-CN model. As noted earlier, Sec 2.5 considers special cases of the
general serial mixture model where the parameter Θ of the base distribution is allowed
to vary across participants, trials, and cells. (In a sense, this is the reverse of the set-
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up in Sec 2.3.) The results here are dependent on the choice of base distribution. It
is worth noting that the signature VIC = 0 iff MIC = 0 can be obtained here as well
in some special cases, e.g., Corollary 7.1 and Example 36.
Note that although throughout this chapter we have been focusing on the sign
of VIC when MIC = 0, we have actually derived explicit expressions for VIC in each
example. Most of these expressions involve constants unknown to the experimenter, so
it would be difficult to match any of these signatures against one set of experimental
data, i.e., against a single estimated value for VIC. However, this situation may
change if we are able to manipulate the encoding load and health status and obtain
a second value of VIC. For example, consider the case of a gamma base where we are
trying to decide between the shape parameter A following a gamma distribution with
shifting rate parameter (Example 37) or A following an inverse Gaussian distribution
with shifting mean (Example 38). Now for both these examples, when MIC = 0, we
have
E(T )∗ = c E∗i [E(Ai )] and VIC = d AVIC

(2.6.1)

where c > 0 and d > 0 are constants unknown to the experimenter. Define the
quantities h0 > 0 and g 0 > 0 by E(T )HN = E(T )LN + h0 and E(T )LS = E(T )LN + g 0.
Note that h0 and g 0 can easily be estimated from the estimates of E(T )LN , E(T )HN ,
and E(T )LS based on factorial data. In Example 37, the quantities E(T )LN , E(T )HN ,
and E(T )LS , can be represented respectively by acm, ac(m + h), and ac(m + g), so
h0 = ach and g 0 = acg in this example. (Note in this example that m = 1/bLN .) It
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then follows from (2.5.42) and (2.6.1) that there exists d0 > 0 such that
VIC = d0 h0 g 0

for Example 37

Similarly, in Example 38, the quantities E(T )LN , E(T )HN , and E(T )LS , can be represented respectively by cm, c(m + h), and c(m + g), so h0 = ch and g 0 = cg in this
example. (Here m = aLN = E(T )LN /c.) Plugging into (2.5.46) and (2.6.1) yields
existence of a constant d00 > 0 such that
VIC = d00 (h0 g 0)[2E(T )LN + h0 + g 0 ]

for Example 38

Note in particular that, in Example 38, VIC is a function of the mean encoding
latency in the first cell as well as the differences h0 and g 0 between cells, whereas
in Example 37, VIC is only a function of the differences between cells. In theory,
repetitions of the experiment that yield different choices for h0 and g 0 would allow
us to distinguish between the above two expressions for VIC and thus between the
two models. Numerical studies in this area would be a fruitful avenue to explore for
future work.
Another area for future work would be the development of the distribution of
the ratio statistic r∗ = s¯2∗/t¯∗ proposed in Sec 2.4 as a method for testing for variation in
generalized Cutler-Neufeld models. As noted in that section, the standard deviation
of r∗ is highly dependent on the underlying base distribution, so it would be useful to
have distributional results for different choices of base. A related problem, possibly
more easily accomplished in the short term, would be numerical work determining
the required sample sizes necessary to obtain desired standard deviations for different
base distributions. Experimenters could then choose sample sizes according to the
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base distribution believed to be applicable to their problem or, more likely, according
to a “worst case scenario” choice for base distribution.
It would also be desirable to develop explicit expressions for MIC and VIC
for at least some general serial mixture models where more than one quantity is
varying over trials and/or cells. Of course term-by-term expressions for MIC and
VIC can always be obtained by plugging into (2.2.10) and(2.2.11) (see Examples 4
and 5 where both K and V are varying over trials) and then applying (2.1.3) and
(2.1.5). However, such expressions (at least for VIC) are bound to be complicated
and unwieldy. It would be of interest to determine if there is a subset of models with
at least two quantities varying over trials and/or cells for which somewhat concise
and elegant expressions can be obtained for MIC and VIC.
Finally, a core assumption made in the definition of the general serial mixture
model (Definition 1) was that the process that governed the number of subprocesses K
was independent of the process that governed the random vector Θ. This permitted
factoring in several expressions and led to the simplicity of many of the obtained
results, in particular (2.2.10) and (2.2.11). However, one can easily envisage situations
where Ki and Θi are linked for participant i. Such cases might need to be solved on
a case-by-case basis, but exploration of this area would be of interest.
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Applications of stochastic modelling to the assessment of group and individual
differences in cognitive functioning. Psychological Assessment, 14, 279-298.
Neufeld, R. W. J., Vollick, D., Carter, J. R., Boksman, K., Levy, L. R., George, L.,
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Chapter 3
Nonlinear Indices in Schizophrenia
and Bipolar Disorder
3.1

Introduction to Chapter 3

The idea that the human brain operates as a series of interacting nonlinear processes
initially generated considerable enthusiasm about potential applications to the study
of schizophrenia and bipolar disorder (Ehlers, 1995; Globus & Arpaia, 1994; Heiby,
1995; Melançon, Joanette, & Bélair, 2000; Schmid, 1991). It seems natural to consider
schizophrenia and bipolar disorder together as they represent the two major psychoses
and share some commonalities in both symptoms and genetics (Demjaha, MacCabe,
& Murray, 2012; Murray et al., 2004). Schizophrenia research moved more quickly
to meet this interest in nonlinear dynamics, and more recent articles (Breakspear,
2006; Paulus & Braff, 2003) have argued vigorously for continuing exploration of
this area. Nonlinear research in bipolar disorder is now emerging as well. A wealth
of nonlinear techniques exist, and we refer the reader to Heath, Kelly, and Longstaff
(2000), Guastello (2009), Guastello and Gregson (2011), and Heath (2014) for general
overviews of these techniques, especially as they are applied to psychological and
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biological data.
In this chapter1 we focus on applications of nonlinear indices to univariate
time series Xt arising from electroencephalogram (EEG) studies, electrocardiogram
(ECG) studies, and mood studies. A nonlinear index is a numerical value that either
quantifies some aspect of nonlinearity about a system (the indices we have called the
phase space indices) or is inspired by nonlinear concepts such as fractal dimension
and entropy (the indices we have called the time domain indices). Evaluating phase
space indices requires embedding procedures to reconstruct the underlying system
dynamics whereas evaluating time domain indices does not. A summary of the indices
we consider is given in Table 3.1. This list is by no means exhaustive, but for space
constraints it was necessary to limit the number of indices. Nonlinear indices stand
apart from linear quantities such as the mean, variance, and power spectrum of a
time series.
Table 3.1: Summary of Nonlinear Indices

1

symbol
λ1
KSE
D2

Phase Space Indices
name
largest Lyapunov exponent
Kolmogorov-Sinai entropy
correlation dimension

description
predictability index
information index
spatial clustering index

symbol
ApEn
SampEn
MSE
LZC
Hc
KFD
HFD
RBFD
Methods I and II

Time Domain Indices
name
approximate entropy
sample entropy
multiscale entropy
Lempel-Ziv complexity
compression entropy
Katz fractal dimension
Higuchi fractal dimension
Real box fractal dimension
symbolic dynamics

description
randomness index
randomness index
multiple scales SampEn indices
pattern index
compressibility index
graph roughness index
graph roughness index
graph roughness index
symbol complexity indices

A slightly modified version of this chapter has been published as Cutler and Neufeld (2019)
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Nonlinear indices are frequently referred to as complexity indices in the literature (Fernández, Gómez, Hornero, & López-Ibor, 2013; Takahashi, 2013). However,
the notion of “complexity” is an ill-defined one (Kantz & Schreiber, 1997, p. 91)
although the recent article by Yang and Tsai (2013) has described complexity as
occupying a position intermediate between order and randomness. The different nonlinear indices actually measure somewhat different quantities (possibly one reason
for the many contradictory findings in the literature) and entropy indices typically
reach their maximum for totally random series, not complex ones (however, see Heath
(2015) for an index which reaches its maximum at the edge of chaos).
The purpose of this chapter is threefold. The first is to provide an accessible
self-contained description of the nonlinear indices and techniques under consideration. The second is to discuss the ways in which nonlinear indices and techniques
have been applied to EEG data, ECG data, and mood data in schizophrenia and
bipolar disorder. The third involves a lengthy quantitative investigation (Section 3.4)
into a hypothesis put forward by Lee, Choo, Im, and Chae (2008) and Fernández et
al. (2013) which can be paraphrased as “higher complexity in EEG tends to be the
default condition in symptomatic unmedicated schizophrenia (especially first-episode
patients) with this tendency being dampened or even inverted by medication (antipsychotics), increasing age, and decreasing symptomatology”. For brevity, we will
call this the L-F proposal. We find only weak quantitative evidence to support individual aspects of this proposal, but suggest that the underlying symptomatology of
the patients may provide the key to untangling apparent contradictions.
For the purpose of identifying the research studies for this systematic review
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and quantitative analysis, we searched PsychInfo, PubMed, Scopus, and Google
Scholar for all combinations of the words nonlinear, correlation dimension, Lyapunov, chaos, fractal, entropy, and symbolic dynamics coupled with each of the terms
schizophrenia, bipolar disorder, mania, manic depression, and bipolar depression.

3.2
3.2.1

Phase Space Indices
Dynamical Systems, Attractors, and Time Series

The definitions of phase space indices are predicated on the assumption that the
observed time series Xt is a univariate measurement on an underlying multivariate
dynamical system ϕt evolving in N dimensions. The N-dimensional space is typically
called state space or phase space. If y0 is the starting position of the system in phase
space (called the initial condition) then ϕt (y0) denotes the position of the system in
phase space after t units of time have passed. The curve {ϕt (y0) | t ≥ 0} is called the
trajectory of the system with initial condition y0.
A dynamical system is called linear if ϕt (c1 y1 + c2 y2) = c1ϕt (y1) + c2ϕt (y2);
otherwise it is called nonlinear. The long-run behaviours of linear systems are relatively simple. Depending on the initial condition, the trajectory may become unbounded over time, or settle onto an attracting fixed point, limit cycle (e.g., an ellipse),
or torus (Hirsch & Smale, 1974). Accordingly, the behaviour of the measured time series Xt is simple as well. However, in the nonlinear case, the long-run behaviour of ϕt
can be very complex if N ≥ 3. In such a situation, it is possible that, for a collection
of initial conditions, the trajectories exhibit chaotic behaviour (see Sec 3.2.3 below)
and settle onto a complicated fractal attractor (a set so structurally intricate that
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it has a noninteger dimension; see Mandelbrot (1977, 1982)). When the underlying
dynamics are chaotic, the measured time series Xt will be so irregular as to appear
random (also called stochastic) even though a latent determinism is generating the
series.
Phase space indices can be used to identify and quantify aspects of nonlinearity
and chaos. However, before we define these indices, it is necessary to cope with the
fact that in practice we usually do not know the actual dynamical system. All we
have available to us is the univariate time series Xt . The next section considers
reconstruction of the underlying dynamics from knowledge of Xt alone.

3.2.2

Reconstruction of Dynamics from the Time Series

It may seem evident that having only a univariate measurement on a multivariate
system will yield only partial information about the underlying dynamics of the multivariate system. However, if the measurement function is sensitive to changes in all
the variables (as is typically the case) following one measurement over time will reveal
information about the entire system. This is done by the method of time-delay embeddings, first introduced by Packard, Crutchfield, Farmer, and Shaw (1980), which
we describe below. At this point we will simplify our presentation by noting that the
continuous-time realization Xt is, in practice, sampled only at discrete time steps,
say with step size ∆t. Thus the sampled data takes the form X∆t , X2∆t , . . . , Xn∆t .
For convenience we will represent this as X1 , X2 , . . . , Xn . Let L ≥ 1 and M ≥ 1 be
(M )

integers and define the vector Xj
(M )

Xj

by

= (Xj , Xj+L , Xj+2L , . . . , Xj+(M −1)L )

(3.2.1)

114
(M )

Thus Xj

is a vector in M-space which consists of M points of the original time

series separated by L units in time. L is called the lag or delay, and should be
chosen so that consecutive elements of the vector are neither too correlated nor too
(M )

uncorrelated. The sequence of vectors Xj

, j = 1, 2, . . . , n − (M − 1)L, sketches

out a curve in M-space. Celebrated reconstruction theorems (Takens, 1981; Sauer,
Yorke, and Casdagli, 1991) state that, under “most” typical conditions, if M is large
enough, the curve sketched out by the vectors (3.2.1) will mimic (with perhaps some
minor distortions) the trajectory of the underlying dynamical system as it moves
around its attractor. In the case that this mimicking occurs, we refer to (3.2.1) as a
time-delay embedding of the system and M as the embedding dimension. Since the
required embedding dimension M is unknown apriori, an approach to determining
it has been given by Kennel, Brown, and Abarbanel (1992), called the method of
false nearest neighbours (FNN). Cao (1997) modified the FNN method to be less
subjective and more efficient, an algorithm we will denote CFNN. The methods FNN
and CFNN seem to be the most popular ways of determining M in papers after the
year 2000. Prior to that the Grassberger-Procaccia (GP) algorithm (Sec 3.2.5 below)
was generally used. It is important to note that different choices of lag and embedding
method can produce different answers, and these differences can affect estimates of
the phase space indices.

3.2.3

Lyapunov Exponents (λ1 ) and Chaos

For a dynamical system ϕt evolving in N-space, a spectrum of numbers can be obtained that indicate the long-run rate of divergence (or convergence) of two initially
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close trajectories along N principal axes of motion. These are called the Lyapunov
exponents of the system and are typically ordered largest to smallest
λ1 ≥ λ2 ≥ . . . ≥ λN

(3.2.2)

Positive exponents indicate directions of expansion whereas negative exponents indicate directions of contraction. The existence of at least one positive exponent (i.e.,
λ1 > 0) implies that any two nearby trajectories diverge exponentially fast. In this
case, if ∆y0 denotes a very small perturbation so that the starting points of two
nearby trajectories are given by y0 and y0 + ∆y0, respectively, then the distance
between the two trajectories at time t is:
||ϕt (y0 + ∆y0) − ϕt (y0)|| ≈ eλ1 t||∆y0||

(3.2.3)

This rapid exponential expansion of an originally small perturbation is known as sensitivity to initial conditions. A dynamical system is called chaotic if it stays bounded
over time, has no stable periodic cycles (in practice this means that if you select an
initial condition at random then the trajectory will never repeat itself numerically)
and the system displays sensitivity to initial conditions (i.e., has at least one positive
Lyapunov exponent). Chaotic systems are of such great interest because they are
deterministic and may involve a small number of variables (the Lorenz system has
only three) and yet, because of the sensitivity to initial conditions, behave almost
as unpredictably as a random process. Much of the search for chaos from data has
centred on a search for a positive Lyapunov exponent. We call the phase space index
λ1 a predictability index since greater positive values of λ1 imply faster separation
of trajectories and greater unpredictability of the system. It is possible to estimate
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λ1 using only the time-delay reconstructions of the previous section; a variety of algorithms exist (Kantz & Schreiber, 1997; Kreindler & Lumsden, 2007; Rosenstein,
Collins, & De Luca, 1993; Wolf, Swift, Swinney, & Vastano, 1985).

3.2.4

Kolmogorov-Sinai Entropy (KSE)

The Kolmogorov-Sinai entropy index (KSE) is closely tied to the notion of Lyapunov
exponents and can be defined as
KSE =

X

λi

(3.2.4)

λi >0

The sum of the positive Lyapunov exponents governs the rate at which new information comes into the system. Chaotic systems create information as they evolve
because trajectories that are initially so close that we cannot tell them apart will
become separate and distinct under the stretching actions of the system. Thus KSE
is called an information index.

3.2.5

Correlation Dimension and the GP Algorithm

The indices λ1 and KSE measure active dynamical properties of the underlying system. Another value of interest is a static quantity, which is the number of distinct
dimensions that characterize the system attractor A. A higher number of dimensions
is generally viewed as reflecting greater system complexity. In the chaotic case A typically has a fractional dimension, and thus verification of a fractional dimension for
A has been used as an identifier of chaos. One difficulty here is that the trajectories
of the system typically visit different regions of A with unequal probabilities, so it
may require enormous sample sizes to get an accurate picture of A. Thus experimen-
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talists turned their attention to dimension quantities associated with the probability
distribution over the attractor. The most popular of these has been the correlation
dimension.
Correlation Dimension (D2 )
Let P denote the probability distribution describing the relative frequency with which
the trajectories visit different regions of A. Suppose X and Y are two vectors drawn
randomly and independently from the phase space according to P . For each r > 0
the spatial correlation integral is defined to be the probability that those two vectors
are no more than distance r apart, i.e.,
C(r) = Probability(||X − Y|| ≤ r)

(3.2.5)

As r → 0 this quantity is believed to scale as rD2 , i.e.,
C(r) ∼ rD2

(3.2.6)

where the exponent D2 is called the correlation dimension. It turns out that D2 is a
lower bound on the dimension of A (Cutler, 1991) and is often viewed as a measure
of complexity, although really it is a measure of the spatial clustering of points over
A. Given a sample of time-delay embedded vectors X1 , . . . , Xn , Grassberger and
Procaccia (1983a) introduced the sample correlation integral
Cn (r) =

XX
2
I[||Xj −Xi ||≤r]
n(n − 1) i j>i

(3.2.7)

where I[||Xj−Xi ||≤r] = 1 if ||Xj − Xi || ≤ r and is otherwise 0. Thus Cn (r) is simply
the proportion of pairs of vectors in the sample that are no more than r units apart.
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Cn (r) is the natural estimator of the correlation integral C(r) defined in (3.2.5). In
order to estimate D2 , Grassberger and Procaccia (1983a) proposed that log Cn (r)
should be plotted versus log r and a suitable scaling region (a region of linear slope)
determined. The estimate of D2 is then the slope of this scaling region. Various
difficulties with and improvements of this procedure have been discussed (Denker &
Keller, 1986; Eckmann & Ruelle, 1992; Theiler, 1986, 1990). Accurate estimates of
D2 require long time series of stationary noise-free data.
The Grassberger-Procaccia (GP) Algorithm
As noted in Sec 3.2.2, the required embedding dimension M can be determined by
methods such as FNN or CFNN. Historically, the Grassberger-Procaccia (GP) algorithm (Grassberger & Procaccia, 1983a, 1983b) has been used, as will be seen in
some of the earlier papers we review. For each embedding dimension M = 1, 2, . . .
the embedded M-vectors are constructed and an estimate D̂2 is obtained by plotting
log Cn (r) versus log r. The value of M at which the estimates D̂2 stop changing (assuming this occurs) is taken as the embedding dimension. Moreover, the final value
of D̂2 is taken to be the estimate of D2 . When this occurs, the correlation dimension
estimates are said to converge. If the estimates fail to converge, this suggests that the
underlying system is very high-dimensional or maybe even stochastic. A problem with
this algorithm is that coloured noise with a 1/f α power-law spectrum can produce
(false) convergence of the D2 estimates (Osborne & Provenzale, 1989). Coloured noise
actually has infinite correlation dimension but the rate at which the trajectory “fills
out” this infinite-dimensional space can be so slow that the GP algorithm appears to
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converge to a finite value (Cutler, 1994; Theiler, 1991).

3.2.6

Surrogate Data Tests for Nonlinearity

The phase space indices λ1 , KSE, and D2 directly capture some qualities of a noisefree dynamical system. However, they can also be used in another way. If the
original univariate time series Xt is stochastic (i.e., noisy) it will appear irregular
and unpredictable (like a chaotic process) whether it is a linear or nonlinear process.
The phase space indices (as well as other discriminating statistics) can be used to
detect the presence of nonlinearity in Xt . The null hypothesis H0 that is assumed is
that Xt is a linear Gaussian stochastic process. A statistical test is carried out by
constructing B independent surrogate series. The surrogate series are obtained by a
method which retains the linear properties of Xt but destroys any nonlinear structure.
The linear properties of Xt are contained in its autocorrelation function (equivalently,
its Fourier transform or power spectrum). Thus each surrogate series is created to
have the same mean, variance, and autocorrelation function as Xt by computing the
fast Fourier transform of the original series, randomizing the phases, then inverting
the transform to obtain the surrogate series (Chan & Tong, 2001; Kantz & Schreiber,
1997; Kugiumtzis, 2000; Theiler, Eubank, Longtin, Galdrikian, & Farmer, 1992).
The randomization of the phases destroys any nonlinear structure in the surrogate
series. A discriminating statistic is then used to see if there is a difference between the
original series and the collection of surrogate series. Very often D2 is used. If we set
the size of the test to be α = .05 we would construct 40 independent surrogate series,
(1)

(2)

(40)

calculate D̂2 for the original series, and D̂2 , D̂2 , . . . D̂2

for the surrogate series.
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We would only reject H0 and conclude there was some nonlinear structure in Xt if
D̂2 was either smaller or larger than all 40 surrogate D2 estimates, since Prob(D2 ≤
(1)

(2)

(40)

(1)

(2)

(40)

min(D̂2 , D̂2 , . . . D̂2 ) = Prob(D2 ≥ max(D̂2 , D̂2 , . . . D̂2 ) < 1/40 = .025 which
yields a two-sided hypothesis test at α = .05.

3.3

Time Domain Indices

These are indices based directly on Xt and do not require phase space reconstruction.

3.3.1

Approximate Entropy (ApEn) and Sample Entropy (SampEn)

Pincus (1991, 1995) developed an index which could rank time series in order of their
degree of randomness. Pincus (and others) use the term “order of complexity” but it
should be understood that Pincus’ index, called approximate entropy ApEn, assigns
its highest values to completely random series. It has received wide use in the analysis
of EEG signals and heart rate series as well as other psychological, physiological, and
biological processes; see Pincus (2006) for a review of applications.
We now describe the ApEn index. Let X1 , . . . , Xn be the time series, let m ≥ 1,
(m)

and create the m-vectors Xi

= (Xi , Xi+1 , . . . , Xi+(m−1) ) for i = 1, . . . , n − (m − 1).
(m)

Let the “tolerance limit” r > 0 be fixed. Xj
(m)

||Xj

(m)

is considered a “match” to Xi

if

(m)

− Xi || ≤ r. Using the simplifying notation of Richman, Lake, and Moorman

(2004), the index ApEn(m, r, n) can be defined as
 
n−m
Ai
1 X
ApEn(m, r, n) = −
log
n − m i=1
Bi
(m)

(3.3.1)

where Bi denotes the number of matches with Xi , and Ai denotes the number
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(m+1)

of matches with Xi

. Note that the ratio Ai /Bi is an estimate of the conditional
(m+1)

probability that a vector of length m+1 matches Xi

given that the vector of length

(m)

m matches Xi . When these conditional probabilities are close to 1, ApEn(m, r, n) is
close to zero. Pincus (1991, 1995) found that he could effectively distinguish between
the degree of randomness for many series using as few as n = 75 − 1000 observations,
with m = 1 or 2, and r selected to be 0.1·SD or 0.2·SD, where SD is the standard
deviation of X1 , . . . , Xn .
The counts in Ai and Bi in (3.3.1) include “self-matches” which has been
criticized by Richman and Moorman (2000) and Richman et al. (2004). The selfmatches cause a downward bias in the ApEn index. Richman and colleagues also claim
that ApEn is dependent on series length and has problems with relative consistency.
In order to remedy these problems, they modified the definition of ApEn to create an
index they called sample entropy SampEn. This index is defined as
 
A
SampEn(m, r, n) = − log
B

(3.3.2)

where B is the number of matches among vectors of length m and A is the number of
matches among vectors of length m + 1. Self-matches are not included in the counts
for A and B. Note that the ratio A/B can be viewed as an estimate of the conditional
probability of a match of length m + 1 given a match of length m.

3.3.2

Multiscale Entropy (MSE)

Multiscale entropy (MSE) is actually a family of indices derived from SampEn for
different scaling factors τ . Let X1 , . . . , Xn be the original time series, and for each
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τ = 1, 2, . . . , n define a new time series X τ whose elements are given by
Xjτ

1
=
τ

jτ
X

i=(j−1)τ +1

Xi

for 1 ≤ j ≤ [n/τ ]

(3.3.3)

The MSE values are generated by calculating SampEn for each of the series X τ
(Costa, Goldberger, & Peng, 2005). Note that τ = 1 reproduces the original time
series and yields the usual SampEn value. SampEn(τ ) provides information about
short-range temporal irregularity when τ is small and information about long-range
temporal irregularity when τ is large.

3.3.3

Lempel-Ziv Complexity (LZC) and Compression Entropy (Hc)

Here the time series Xt is coarse-grained into a sequence of 0’s and 1’s by setting
s(t) = 1 if Xt > m and s(t) = 0 if Xt ≤ m where m is the median of the time
series. Lempel and Ziv (1976) developed a measure of pattern complexity that begins
by scanning the sequence s(1), . . . , s(n) left to right and updating the counter c(k)
each time a new pattern is observed. For example, if the sequence was 0101101
then c(7) = 3 since the new patterns are 0, 1, 011. Usually c(n) is then normalized
to account for the length of the original sequence, producing a value known as the
Lempel-Ziv complexity (LZC); see Li et al. (2008) for detailed discussion.
Ziv and Lempel (1977) developed an algorithm for compressing data strings.
The compression entropy Hc is defined to be Hc =

length of compressed string
.
length of string

et al. (2004) for discussion and application to heart rate series.

See Baumert
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3.3.4

Fractal Dimension of the Graph (KFD, HFD, and RBFD)

Here measures of the fractal dimension (FD) of the graph G = {(t, Xt ) | t ≥ 0} are
considered. The FD of a graph falls between 1 and 2, where FD is higher when the
graph is rougher. (A smooth line would have FD = 1.) There are three popular
algorithms which are employed to estimate FD, one due to Katz (1988), a second
due to Higuchi (see Bahrami, Seyedsadjadi, Babadi, & Noroozian (2005) for the
algorithm), and a “real” box-counting algorithm which has a long history (see Cutler
(1993, p. 74) for discussion). The Katz fractal dimension (KFD) is given simply by
KFD =

log10(n)
log10(n) + log10 (d/L)

(3.3.4)

where n is the number of data points, d is the planar extent of the observed graph, and
L is the length of the linearly-interpolated observed graph. In the Higuchi method,
successive linear approximations with step size r = 1, 2, . . . , rmax are constructed with
a computed vertical length L(r). If L(r) scales as r−HFD , i.e.,
L(r) ∼ r−HFD

(3.3.5)

then the exponent HFD is taken as the Higuchi fractal dimension. In the real boxcounting method, for each small  > 0, a “real” box count is computed
N =

X

(max Xt − min Xt )(1/)

(3.3.6)

where the differences between the max and min of the graph are computed and then
summed across nonoverlapping strips of width . If
N ∼ −RBFD

(3.3.7)
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then the exponent RBFD is taken as the real box-counting fractal dimension. These
algorithms need not always yield the same answer (and in particular the estimated
KFD can sometimes exceed 2), although HFD and RBFD should be closely related.

3.3.5

Symbolic Dynamics

Another way of assessing the regularity of a time series is through the method of
symbolic dynamics. Symbolic dynamics have increasingly been used in the analysis of
heart rate variability (HRV) (Voss et al., 1996; Voss, Baier, Schulz, & Bär, 2006) so
we describe it in this context. A heart rate series is generated by an electrocardiogram
(ECG) recording, and the times between successive beats are computed, called the
RR-intervals. Specifically, RRi = Ti − Ti−1 is the time between the (i − 1)th and
ith beat. (Usually only normal-to-normal beats are considered.) There are two basic
methods of generating a symbol sequence a0 , a1, . . . from the RR series.
Method I: Choose a threshold parameter c (e.g., c = 10 ms) and set ai = 0 if
RRi − RRi−1 ≤ c and ai = 1 if RRi − RRi−1 > c. The sequence of 0’s and 1’s is
often analyzed for its regularity in two basic ways. One is to calculate plvar (which
is based on the number of occurrences of six consecutive 0’s) and phvar (which is
based on the number of occurrences of six consecutive 1’s). A large value of plvar
indicates low variability in the RR series and is often indicative of cardiac disease,
whereas a large value of phvar indicates high variability and is typical of healthy
persons. Another way the sequence is analyzed is to concatenate successive symbols
into 3-letter “words” ai ai+1 ai+2 and calculate the Shannon entropy (see (3.3.9) below)
of the frequency distribution of the words, usually corrected for sample size. A higher
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value for the entropy indicates greater randomness in the sequence.
Method II: This is more sophisticated. Here we choose a 4-letter alphabet {0, 1, 2, 3},
let µ = the mean of the RR-series, and let c be a parameter (often c = 0.1). Then set

0 µ < RRi ≤ (1 + c)µ




 1 (1 + c)µ < RRi < ∞
ai =
(3.3.8)

2
(1
−
c)µ
<
RR
≤
µ

i



3 0 < RRi ≤ (1 − c)µ

Concatenating three successive symbols generates a 3-letter word ai ai+1 ai+2 which
can take on one of 43 = 64 values. The frequency distribution of the 3-letter words
(over the 64 possible bins) can be evaluated by Shannon entropy (see (3.3.9) below).
Other statistics that are sometimes considered are Word Count (WC) which is the
percentage of different words encountered out of the possible 64, as well as the number
of “forbidden” words (words that occur with probability p < .001). Voss et al. (1996)
and Voss et al. (2006) note that a high percentage of words consisting only of 0’s and
2’s indicates abnormal regularity and tends to categorize serious cardiac patients.
Shannon entropy: Consider K bins with probabilities p1 , p2 , . . . , pK where
1. The Shannon entropy H is defined to be
H = −

K
X

pi log pi

PK

i=1

pi =

(3.3.9)

i=1

where 0 · log 0 = 0. Note that H reaches a maximum of log K if the probabilities
are uniformly distributed over the K bins (maximum randomness) and reaches a
minimum of 0 if pi = 1 for some i (minimum randomness).
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3.4

Applications to EEG

Pritchard, Duke, and Krieble (1995), Theiler and Rapp (1996), and Palus (1996)
studied several EEG data sets obtained from healthy adults and concluded, based on
surrogate data techniques, that there was evidence of nonlinearity in the EEG but
not low-dimensional chaos. The EEG likely combines some nonlinear properties with
nonstationary stochastic elements. As such, the actual specific values of nonlinear
index estimates (contaminated by choice of algorithm and stochastic noise) probably
do not reflect meaningful characteristics in themselves. However, comparisons of
these values between groups (e.g., patients vs. healthy controls) may provide useful
information. Ideally we would hope to be able to distinguish between groups, at least
under certain conditions.
EEG recordings are carried out with varying numbers and placements of electrodes. The placement of an electrode can significantly alter the value of the index
being estimated (often this is the purpose of the study, e.g., the difference between
patients and controls might be statistically significant at frontal electrodes but nonsignificant at parietal electrodes). Very early papers have featured analysis at just a
few electrodes (often one or two) whereas now most (although not all) papers use a
multiplicity of electrodes encompassing the entire scalp. Generally articles calculate
indices for patients and controls from an EEG segment at each electrode and present
those electrodes at which a statistically significant difference (p < .05) is obtained.
In terms of deriving overall conclusions for a given paper, this situation is simplified
by the fact that in the papers we have studied, differences at individual electrodes
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are either statistically nonsignificant (ns) or significant in the same direction, so that
one may make a global statement such as “this index was higher in the patients”.
This statement does not mean it was true at every electrode, but that it was true
at those which were found to be statistically significant. It should be noted that
seldom is a mixed ANOVA (with patients and controls as between-groups and electrodes and/or conditions as within-subjects) or corrections for multiple comparisons
between electrodes (e.g., Bonferroni corrections) carried out (some exceptions include
Akar, Kara, Latifoğlu,& Bilgiç, 2015a, and Carlino et al., 2012). Whereas this can be
considered a weakness in some studies (if 20 electrodes are compared and uncorrected
statistically significant differences (p < .05) are found at one or two, is it surprising
or meaningful?) it can also be argued that different regions of the brain deserve to
be evaluated separately and an observed difference at even one electrode may signify important information about that brain location. Finally we note that, whereas
the above electrode-by-electrode analysis is most common, a few authors appear to
have compared averages over all electrodes (e.g., Chen et al., 2013, Sabeti, Katebi, &
Boostani, 2009), and yet others have included comparisons by electrode groups (e.g.,
comparisons among frontal, temporal, and occipital lobes such as those presented by
Thilakavathi, Shenbaga, Bhanu, & Malaippan, 2017).

3.4.1

EEG in Schizophrenia

There have been a multitude of nonlinear index EEG studies comparing schizophrenia
patients to healthy controls, often producing contradictory results. Fernández et al.
(2013) give an excellent discussion of the situations in which these various contra-
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dictions arise and provide an argument, derived from the disconnection hypothesis
of Friston (1996) and Friston and Frith (1995), for the notion that nonlinear indices
should be higher in schizophrenia patients than controls. Building on an insight of Lee
et al. (2008), they sought to explain the observation that this was frequently not the
case as the result of the interplay of symptoms, medication (antipsychotics), and age.
Specifically, recall the L-F proposal that higher complexity tends to be the default condition in symptomatic unmedicated schizophrenia (especially first-episode patients)
with this tendency being dampened or even inverted by medication (antipsychotics),
increasing age, and decreasing symptoms. Fernández et al. (2011) provide empirical
support for the proposed effect of aging by noting that, in a magnetoencephalography study, LZC decreased with age in schizophrenia patients, a phenomenon they
attributed to a possible “progressive defect”.
The present authors began this work with three notions in mind. The first
was that more studies have been done since the Fernández et al. (2013) article and
perhaps sufficient data now existed for a quantitative analysis of the L-F proposal.
The second was that perhaps enough data existed that it could be determined if the
actual condition under which the EEG data was collected (e.g., resting eyes-closed
vs. counting or visual stimulation) also played a consistent role in the outcome. We
believed that condition could play a role since various other authors have noticed a
change in outcome (increase or decrease) when moving from one condition to another
(e.g., Kirsch, Besthorn, Klein, Rindfleisch, & Olbrich, 2000). Finally we hoped that
enough data existed that perhaps differences in behaviour between nonlinear indices
could be discerned. Unfortunately, neither a clear difference between nonlinear in-
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dices nor a clear consistency within conditions emerged from the data. However,
the decision to include all conditions permitted us to inflate our data set (allowing
a quantitative analysis of aspects of the L-F proposal) and to make the observation
that, in many cases, the outcome was a statistically nonsignificant (ns) difference
between schizophrenia patients and controls. This is true even in papers that report
a significant difference; for example, the authors may have collected data under three
conditions of which only one was statistically significant. This raises the possibility
of a serious “file drawer” problem, involving papers that were shelved because they
did not obtained statistically significant differences.
In the presentation that follows we have accepted the statistical conclusions
of the authors of each paper at face value provided that they have indicated that a
statistical test has been carried out and that the statistical data they offer does not
contradict their conclusions. In the latter respect, we note that Sabeti et al. (2009)
conclude that ApEn, LZC, and HFD are lower in schizophrenia patients than controls, but the error bars (standard deviations) they present on their graph lead to
a statistically nonsignificant conclusion for their sample size of 20. (Thus we have
entered “ns” for their paper in Table 3.6). Similarly, Katebi and Sabeti (2012) report that D2 , HFD, and KFD are lower in schizophrenia patients than controls, but
electrode-by-electrode independent-sample t-tests of the means and standard deviations presented in their table produce ns results. It should be noted that in the case
of HFD, the use of a paired t-test (with electrodes acting as “blocks” and ignoring the
individual standard deviations) does produce a globally significant result, but other
authors do not use this approach and there is some conceptual question as to whether
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it is appropriate. Thus we have entered “ns” in Tables 3.2 and 3.6. At times we have
also used data provided by other authors to augment their results; for example, Carlino et al. (2012) provide means and standard deviations at each electrode for each
of their four conditions, enabling us to carry out independent-sample t-tests at each
electrode for each condition. We note that their entry at the Fp2 electrode for controls
in the resting eyes-open condition appears to be a typographical error, and we have
ignored it, assigning that electrode a “ns” value in keeping with other electrodes in
that condition.
Quantitative Analysis of Correlation Dimension in Schizophrenia
Sufficient data has been collected on D2 that a quantitative analysis can be carried
out on it alone. (It is desirable to separate the nonlinear indices if possible in order to
reduce confounds.) The outcomes are listed in Table 3.2 by year of publication, where
“higher” implies that D2 was higher in the schizophrenia patients than controls. We
divide patients into four groups and retain the following notation throughout: MED =
medicated, NMF = never-medicated first episode, UM = unmedicated (which includes
the possibility of prior medication), and UMx = unmedicated for at least x months.
Medication, in the context of schizophrenia patients, always refers to antipsychotics.
The paper of Lee et al. (2001b) is often cited as an example of UM patients
yielding a lower correlation dimension than controls but they utilized a spatial embedding (rather than time delay embeddings) to calculate a global dimension DS whose
interpretation and relation to D2 is controversial (Pezard, Lachaux, Thomasson, &
Martinerie, 1996; Pritchard, 1999; Pritchard, Krieble, & Duke, 1996). Hence we have
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not included it in Table 3.2 or our analysis. We have also omitted a commonly cited
paper by Elbert, Lutzenberger, Rockstroh, Berg, and Cohen (1992) since they actually computed pointwise dimension D1 , a related but distinct quantity that provides
an upper bound on D2 .
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Table 3.2: Outcome of D2 in EEG of schizophrenia patients vs. controls by condition
authors
Koukkou et al. (1993)

N
15

mean age
27.6

patient status
NMF

condition
initial resting
rest eyes closed
before audio #1
after audio #1
before audio #2
after audio #2

result
ns
ns
higher
higher
higher
ns

Koukkou et al. (1993)

12

27.3

remitted UM3

initial resting
rest eyes closed
before audio #1
after audio #1
before audio #2
after audio #2

ns
ns
ns
ns
ns
ns

Röschke et al. (1994)

11

28

acute UM3

sleep stage II
sleep stage III
sleep stage IV
REM sleep

lower
ns
ns
lower

Lutzenberger et al. (1995)

18

34.4

chronic MED

count backwd
observe pendulum
imagine pendulum

ns
higher
ns

Hoffman et al. (1996)

12

33.9

UM1 or NMF

passive visual

lower

Jeong et al. (1998)

13

27.3

MED

rest eyes closed

lower

Saito et al. (1998)

9

20.7

NMF

rest eyes closed

higher

Kirsch et al. (2000)

87

26.9

remitted MED

rest eyes open
task CPT1
task CPT2

ns
higher
higher

Lee et al. (2001a)

18

30.6∗

UM

rest eyes closed

higher

Jin et al. (2003)

10

35.8∗

chronic MED

rest eyes closed
sound & light

lower
lower

Katebi et al. (2012)

10

?

?

rest eyes open

ns

Carlino et al. (2012)

17

34.7

stable MED

rest eyes closed
rest eyes open
count forward
count backward

higher
ns
ns
higher

Zhao et al. (2012)

31

25.9

MED

rest eyes closed

higher

(table continued next page)
MED = medicated (antipsychotics)
UM = unmedicated; UMx = unmedicated for at least x months
NMF = never medicated first-episode
sample sizes for controls similar or identical to those of patients so omitted from table

∗

controls are not age-matched with patients, otherwise age-matched
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Table 3.2 (continued):
authors
Chen et al. (2013)

N
45

mean age
31

patient status
NMF

condition
rest eyes closed
rest eyes open
count backward
memory test
number cancel

result
ns
ns
lower
ns
lower

Akar et al. (2015a)

22

34.6

neg symps MED

rest eyes closed
white noise
music
after music

ns
ns
higher
ns

From Table 3.2 we see that out of the 43 reported conditions (each condition
within each study is counted as a separate condition, even if that condition is also
examined in another study), D2 is higher in patients in 12 conditions and lower in
patients in 8 conditions. This is a 3:2 ratio. Moreover, we calculated the effect sizes
(Hedge’s g) for the statistically significant results for those papers for which such data
was available, and most effect sizes were large (g > 0.8) and all were at least mediumlarge (g > 0.6), regardless of whether D2 was higher or lower. This suggests that
statistically significant results (whether higher or lower) are reporting a meaningful
effect, and further suggests that something distinctly different is occurring in studies
that yield higher rather than lower results (and conversely).
From Table 3.2 we also see that the greatest number (23) of outcomes are in
fact ns. An ns outcome actually has an important role to play here. For example, if
there is a propensity toward higher D2 in UM patients and medication reduces this
propensity (a tenet of the L-F proposal) then we may see a shift from higher D2
toward ns differences in MED patients.
We also note from Table 3.2 that there appears to be a strong “study effect”,
i.e., within any given study, we do not see “higher” appear in one condition and
“lower” appear in another. Rather, the outcomes of any one study are all of the same
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type (higher or lower) with perhaps some ns outcomes mixed in for some conditions.
This suggests that the “study effect” (possibly due to the fact that repeated measures
are carried out on the same group of patients) is more important than the conditions
under which the study is carried out. This in itself lends support for something like
an L-F proposal which suggests that patient characteristics are the dominating factor
in outcome. However, laboratory procedures (which may differ from laboratory to
laboratory) may also contribute to this pattern of outcomes.
In order to quantitatively test aspects of the L-F proposal, we will utilize
contingency tables (chi-square tests of independence). For example, Table 3.3 tests
whether medication status is independent of outcome. UNMED combines all those
conditions in which the patients are NMF, UM, or UMx (in other words, it comprises
all conditions in which patients were unmedicated at the time of the study). The
observed number of conditions, with the expected number (under the hypothesis of
independence) alongside in brackets, is given in each cell. The observed chi-square
statistic and its p-value is given at the base of the table. As we can see, there is no
evidence of an association between medication status and outcome.
Table 3.3: Contingency Table Medication Status vs. Outcome for D2
higher lower

ns

UNMED

5[6.86]

5[4.57]

14[12.57]

MED

7[5.14]

3[3.43]

8[9.43]

χ2obs,2 = 1.651, p = .438

Two caveats must be made here. First, it is typical to require expected cell
frequencies of at least 5 to validate the chi-square approximation. However, this
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requirement can be relaxed, as discussed in Lawal and Upton (1984). It is sufficient
if the minimum expected frequency exceeds 5s/rc where s is the number of cells
having expected frequency < 5 and r and c are, respectively, the number of rows and
columns in the table. Here we require min > 1.67 which is clearly satisfied. The
second caveat we must make is to acknowledge again that, within studies, outcomes
are repeated measures on the same group of patients, possibly contributing to what
we have already noted is a “study effect”. However, it is important to realize that it is
the conditions (not the patients) which are actually being slotted into the contingency
tables. To use an analogy, if we regard a condition as being a geographical region being
evaluated for independence of its agricultural yield and rainfall, there is no difficulty in
seeing widely-separated geographical regions (conditions from different laboratories)
as unrelated entities, while we might expect physically close but distinct geographical
regions (different conditions evaluated in the same laboratory) to potentially have
similarities in rainfall and yield. This does not prevent us from classifying these
regions into a table, and we expect that strong trends within the data would be
picked up by the chi-square statistic.
We carried out a similar analysis to look for an age effect. It was decided
to partition the data into those in which the mean age of the sample was under 30
and those in which the mean age was over 30. This division was not arbitrary. It
permitted the division into two groups of roughly equal size, and resulted in a 2-year
age gap between the oldest in the younger group and the youngest in the older group.
Moreover, since the first-time onset of schizophrenia is usually prior to age 30, we
expected to catch most of such patients in the first group. The results are displayed

136
in Table 3.4. No association between age and D2 outcome is observed.
Table 3.4: Contingency Table Age vs. Outcome for D2
higher lower

ns

under 30

7[6.29]

3[4.19]

12[11.52]

over 30

5[5.71]

5[3.81]

10[10.48]

χ2obs,2 = 0.920, p = .631

It can be argued that the L-F proposal really suggests an interplay between age,
medication, and symptomatology, so we present a contingency table which examines
UNMED and Under Age 30 vs. MED and Over Age 30. The expected cell frequencies
of this reduced data set are too low to carry out a chi-square analysis but we present
the table for visual inspection. Unfortunately too little is known about the actual
symptomatology of patients in most studies to include this in any meaningful way.
Table 3.5: Contingency Table Medication Status × Age vs. Outcome for D2
higher lower

ns

UNMED and under 30

4[4.53]

2[2.27]

11[10.20]

MED and over 30

4[3.47]

2[1.73]

7[7.80]

In the next subsection we augment our data set by including outcomes from
other nonlinear indices.
Quantitative Analysis of All Indices in Schizophrenia
It could be argued that the data set in Table 3.2 is too small for the chi-square
statistic to pick up moderate associations. In Table 3.6 we compile data from all
other nonlinear indices. Our procedure will be to repeat the analysis of the preceding
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subsection, using all the nonlinear indices together (including D2 from Table 3.2,
although, for the sake of parsimony, we have not re-entered those values in Table 3.6).
This makes the basic (and questionable) assumption that all nonlinear indices behave
the same way with respect to medication, age, and symptomatology.
For the reader’s convenience, in Table 3.6 we have grouped papers together by
index, so that the reader may see how outcomes differ even within the same index.
Some authors have studied more than one index in the same paper so their paper
appears multiple times on the table, once for each index. For example, Thilakvathi
et al. (2017) have studied LZC, ApEn, and HFD, so their paper appears thrice.
Once again we notice a very strong “study effect” that in fact extends to all indices
measured within the same study. By that we mean not only do we observe the same
result (or ns) for a given index measured over different conditions, if authors measure
one index as lower in patients then they will also measure other indices as lower in
patients. There are only two exceptions to this rule. Akar et al. (2015a) found D2
to be higher in patients in the music condition (see Table 3.2) while finding λ1 to be
lower in patients in all conditions (see Table 3.6). Thilakvathi et al. (2017) found both
LZC and ApEn to be ns in the resting eyes-closed condition but HFD to be higher
in patients in that condition. Totalling over both Tables 3.2 and 3.6, we observe 29
conditions in which the index is higher in patients than controls and 19 in which it is
lower, maintaining the same 3:2 ratio observed for D2 alone.
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Table 3.6: Outcome of index in EEG of schizophrenia patients vs. controls by condition
authors
Röschke et al. (1995)

index
λ1

N
13

mean age
28

patient status
acute UM3

condition
sleep stage I
sleep stage II
sleep stage III
sleep stage IV
REM sleep

result
ns
ns
ns
ns
higher

Kim, & Jeong et al. (2000)

λ1

25

25.1

MED

rest eyes closed

lower

Keshavan et al. (2004)

λ1

10

20.5

NMF

rest eyes closed
sleep stage I-II
sleep stage III-IV
REM sleep

ns
ns
ns
lower

Akar et al. (2015a)

λ1

22

34.6

MED

rest eyes closed
white noise
music
after music

lower
lower
lower
lower

Fritzsche et al. (2006)

KSE

22

32.2

stable MED

rest eyes closed
count backward

higher
higher

Zhao et al. (2012)

KSE

31

25.9

MED

rest eyes closed

higher

Li et al. (2008)

LZC

62

34.8

NMF

rest eyes closed
count backward

higher
higher

Sabeti et al. (2009)

LZC

20

33.4

MED

rest eyes open

ns

Zhao et al. (2012)

LZC

31

25.9

MED

rest eyes closed

higher

Akar et al. (2016)

LZC

22

41.1

chronic MED

rest eyes closed

lower

Cerquera et al. (2017)

LZC
LZC

9
10

42.2
40.3

deficit MED
nondeficit MED

rest eyes open
rest eyes open

ns
ns

Thilakvathi et al. (2017)

LZC1

55

40.3

MED

rest eyes closed
visual stimulus 1
visual stimulus 2

ns
higher
higher

Sabeti et al. (2009)

ApEn

20

33.4

MED

resting eyes open

ns

Taghavi et al. (2011)

ApEn

10

36.5

remitted MED

rest eyes open

lower

Akar et al. (2016)

ApEn

22

41.1

chronic MED

rest eyes closed

lower

Thilakvathi et al. (2017)

ApEn

55

40.3

MED

rest eyes closed
visual stimulus 1
visual stimulus 2

ns
higher
higher

(table continued next page)
1

Thilakvathi et al. (2017) call this Kolmogorov complexity but in fact they have defined LZC
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Table 3.6 (continued):
authors
Takahashi et al. (2010)

index
MSE

N
22
15

mean age
25.6
25.7

patient status
NMF
post MED

condition
resting
resting

result
higher
ns

Raghavendra et al. (2009)

HFD

18

?

NMF

rest eyes closed

lower

Sabeti et al. (2009)

HFD

20

33.3

MED

rest eyes open

ns

Katebi et al. (2012)

HFD

10

?

?

rest eyes open

ns

Thilakvathi et al. (2017)

HFD

55

40.3

MED

rest eyes closed
visual stimulus 1
visual stimulus 2

higher
higher
higher

Katebi et al. (2012)

KFD

10

?

?

rest eyes open

ns

Akar et al. (2015b)

KFD

22

41.1

chronic MED

rest eyes closed, noisy
rest eyes closed, denoised

ns
lower

Yu et al. (2016)

RBFD

17

28

NMF

Tower of Hanoi
TMT-A
TMT-B

ns
higher
higher

The contingency tables (computed for those articles for which mean age and/or medication status are known as required) are:
Table 3.7: Contingency Table Medication Status vs. Outcome for All Indices
higher

lower

ns

UNMED

11[13.33]

7[8.74]

22[17.93]

MED

18[15.67]

12[10.26]

17[21.07]

χ2obs,2 = 3.105, p = .212
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Table 3.8: Contingency Table Age vs. Outcome for All Indices
higher

lower

ns

under 30

13[13.15]

5[8.16]

21[17.69]

over 30

16[15.85]

13[9.84]

18[21.31]

χ2obs,2 = 3.375, p = .185

Tables 3.7 and 3.8 show no evidence for an association between medication
status and outcome, or between age and outcome, although in the latter case we see
that younger patients are about 2.5 times more likely to have a higher than a lower
outcome, whereas older patients are almost equally likely to have either outcome.
Adding in the other indices has not only increased the sample size but increased the
available age status in the pool (e.g., we now have some samples in which the average
age exceeds 40). This time we have enough data to compare UNMED and Under 30
vs. MED and Over 30.
Table 3.9: Contingency Table Medication Status × Age vs. Outcome for All Indices
UNMED and under 30
MED and over 30

higher

lower

ns

8[9.26]

3[5.74]

19[15]

13[11.74]

10[7.26]

15[19]

χ2obs,2 = 4.557, p = .102

In Table 3.9 we see a weak trend suggesting that age and medication factors
may combine to create some sort of effect on outcome. Younger unmedicated patients
appear about 2.5 times more likely to have a higher index than a lower one relative
to controls; older medicated patients are about equally likely to have higher or lower
indices. Perhaps what is most striking from Table 3.9 is the observation that the
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UNMED and Under 30 group are almost twice as likely to have an ns outcome rather
than any other outcome; this may be partly accounted for by the inclusion in Table 3.9
of the young unmedicated remitted patients of Koukkou, Lehmann, Wackermann,
Dvorak, and Henggeler (1993) who were ns under six conditions (Table 3.2). Table 3.9
suggests that medication may produce a slight shift from higher to lower or ns results
in older patients.
Missing in the above analysis is the role of symptomatology as most papers
do not supply details of this. However, the next subsection deals with some results
and hypotheses concerning the role of symptoms.
The Role of Symptomatology in Index Outcome in Schizophrenia
Even the extreme ends of the L-F proposal do not always hold true, as can be seen
in Keshavan, Cashmere, Miewald, and Yeragami (2004) who found lower λ1 in very
young NMF patients (Table 3.6), and in Thilakvathi et al. (2017) who found higher
LZC, ApEn, and HFD in MED patients whose average age exceeded 40 (Table 3.6).
This, combined with the mixture of results from Tables 3.2 and 3.6, the strong “study
effect”, and weak, at best, evidence of association provided by the chi-square analyses,
suggests that other factors beyond age and medication status must be in play. The
L-F proposal does suggest that symptomatology plays a role, favouring higher indices
for NMF patients (who are highly symptomatic with positive symptoms almost by
definition) and lower indices for chronic patients, who are dominated by negative and
cognitive symptoms. In this section, we propose that recent work by Cerquera, Gjini,
Bowyer, and Boutros (2017) sheds some light on this subject, explaining why young
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UNMED patients may score lower and older MED patients may score higher. Specifically, Cerquera et al. (2017) studied two separate groups of schizophrenia patients.
One group was defined to have deficit schizophrenia (DS), a syndrome characterized
by severe primary and persistent negative symptoms, poor psychosocial premorbid
functioning, and worse prognosis than their nondeficit (NDS) counterparts (Kirkpatrick & Galderisi, 2008). To qualify as DS, a patient must meet criteria on the
Scale for the Deficit Syndrome (Kirkpatrick, Buchanan, McKenny, Alphs, & Carpenter, 1989). There is some question in the literature as to whether DS may even be a
separate disease entity from NDS. Cerquera et al. ’s patients were medicated, were not
young, and sample sizes were small (mean age of DS = 42.2, N = 9; mean age of NDS
= 40.3, N = 10). They found the LZC of DS patients to be statistically significantly
lower than that of NDS patients with a large effect size (Cohen’s d = 1.539). The
controls fell in between the two groups, with the DS being lower than the controls
with a trend (p < .1) toward statistical significance and a large effect size (d = 1.002).
The LZC of NDS patients was higher than that of controls with a medium effect size
(d = 0.428) although not statistically different. It is easily argued that with such
small sample sizes there was insufficient power to separate all three groups, and we
propose that replication with sufficient power might show the NDS patients to have
higher LZC than controls, and the controls to have higher LZC than the DS patients.
The authors also found that LZC was positively correlated with general psychopathology scores on the PANSS (Kay, Fiszbein, & Opler, 1987), explained partially by the
emotional component subscale, which comprises anxiety, guilt feelings, depression,
and active social avoidance. Kirkpatrick and Galderisi (2008) point out that DS pa-
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tients are “less distressed” than their NDS counterparts, and it is reasonable to posit
that DS patients might therefore score lower on the emotional component, thereby
suppressing their LZC scores.
We therefore propose that the outcome in index studies may be governed in
part by the predominance of the type of patient (DS vs. NDS) in that particular study.
It may be that NDS patients, governed more by positive symptoms and emotional
reactivity, tend to score as high or even higher than controls. Medication may temper
some of this response; Takahashi et al. (2010) apparently performed the first study to
compare never medicated patients before initiation of medication and after 2-8 weeks
of medication. They used MSE as a discriminator, and found that for high scaling
frequencies τ (10 ≤ τ ≤ 40 depending on electrode location) MSE was significantly
higher in pre-treatment patients than controls in the fronto-central-temporal regions.
These differences became nonsignificant in the fronto-central regions post-treatment,
but the differences in the temporal regions did not vanish.
Koukkou et al. (1993) were the first to consider that symptomatology could
play a role in outcome. They included a group of fully remitted UM3 patients
in their study along with a group of NMF patients and a group of controls. In
Koukkou, Lehmann, Federspiel, and Merlo (1995) they more fully describe the patients in Koukkou et al. (1993), stating that the NMF patients had such severe positive symptoms that they required hospitalization, and the UM3 patients had achieved
“complete clinical and social remission” from which we can conclude the remitted patients were remitted NDS. The D2 values for the remitted patients fell between those
of the NMF patients and the controls, but were not significantly different from either
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of them, although the NMF patients were significantly higher than the controls.
Raghavendra, Dutt, Halahalli, and John (2009) also noted that the type of
symptomatology was relevant. They calculated HFD in NMF patients under the
resting eyes closed condition, and whereas they found HFD to be significantly lower
generally in patients than controls (suggesting to us that perhaps they had several DS
patients) they found that among those patients with prominent positive symptoms
and an absence of negative symptoms, HFD appeared higher than that of controls in
the temporal regions. .

3.4.2

EEG in Bipolar Disorder

Very little work has been done in applying nonlinear indices to EEG in bipolar patients. There seem to have been three papers investigating bipolar disorder or mania.
Thomasson, Pezard, Boyer, Renault, and Martinerie (2002) followed one rapid-cycling
bipolar II patient with a pronounced predictable 48-hour cycle, alternating between
one day of hypomania and one day of depression. They collected mood data twice
daily, and performed a 31-channel EEG (using a motor task response) on each of
six consecutive days. They used the multiple channels to construct a 31-dimensional
spatial embedding and computed KSE for each day. Their main result was that high
values of KSE were correlated with depressed days and low values of KSE were correlated with hypomanic days. Bahrami, Seyedsadjadi, Babadi, and Noroozian (2005)
noted that computer simulations have suggested that increased HFD of the graph of
the EEG is due to “asynchronous co-activation of multiple neuronal populations in
the cortex” (p. 190). Using 19-electrode EEG recordings, they were able to establish
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that HFD of the EEG in acute manic inpatients was significantly greater than that
of controls. (Patients were on a variety of medications). They concluded that brain
complexity is greater during mania, in the sense that the brain is dominated by an
increasing number of independently and asynchronously firing neural assemblies. In
contrast, Bhattacharya (2000) reported that persons with mania exhibited similar
EEG profiles to those of controls.
We were unable to locate any articles examined EEG in bipolar depression.
Articles are now starting to appear on EEG in major unipolar depression. With the
important caveat that behaviour in unipolar depression may not be the same as in
bipolar depression, we note that an (inexhaustive) search of unipolar depression has
revealed a general consensus that nonlinear indices seem to be higher in depression
than in controls. Ahmadlou, Adeli, and Adeli (2012) founder higher HFD (but not
KFD) in unmedicated depressive patients than controls. Akar, Kara, Agambayev,
& Bilgiç (2015a,b) found both higher HFD and higher KFD in medicated depressive
patients, not only in resting conditions but in audio conditions (being subjected to
music and noise). Bachmann, Lass, Suhhova, and Hinrikus (2013) also found higher
HFD in depressive patients. Li et al. (2008) found not only that LZC was higher in
NMF psychotic depression patients compared to controls but that it was even higher
in depression than in schizophrenia. Akar et al. (2015a) as well as Bachmann, Kalev,
Suhhova, Lass, and Hinrikus (2015) also observed higher LZC in depression patients
compared to controls. Thomasson and Pezard (1999) did not use controls but followed
a single recurrent depression patient over the course of treatment and found KSE to
be highly correlated with self-report measures of depression symptoms. Specifically,
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KSE was high at the start of treatment and decreased as health improved.
In a recent article, Jaworska et al. (2018) were able to use pre-treatment MSE
to predict response to antidepressant medication.

3.5

Applications to Heart Rate Variability (HRV)

Persons with schizophrenia or bipolar disorder are at increased risk of cardiovascular
disease and death (Brown, Inskip, & Barraclough, 2000; Enger et al., 2004, Kessing,
Vradi, & Andersen, 2015). Among other factors such as lifestyle habits, this has been
linked to changes in the Autonomic Nervous System (ANS) controlling the rhythms
of the heart. Psychotropic medication is also known to adversely affect the ANS, and
part of the focus of current research is teasing apart the effects of disease from the
effects of medication. Voss et al. (2006) makes the important point that the field
has historically suffered from serious confounding effects, such as having patients on
differing types of medication, having patients with differing degrees of illness, and
featuring a lack of properly matched controls. However, recent studies have made
inroads toward addressing these issues.
A common noninvasive tool is to study the heart rate variability (HRV) of the
RR series (Sec 3.3.5). Reduced HRV is a known risk factor for cardiac illness and
death (Klieger, 1995). It is postulated that greater HRV offers a protective effect,
allowing the heart rhythm to adapt to environmental perturbations and return to
normal functioning (Levy, 1990). Standard linear indices for studying HRV include
SDNN (the standard deviation of the normal-to-normal RR-intervals), RMSSD (the
square root of the mean sum of squared differences between successive normal-to-
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normal RR intervals), and pNN50 (the proportion of successive normal-to-normal
RR intervals that differ by more than 50 ms). A lower value of SDNN, RMSSD, or
pNN50 is indicative of a reduction in some aspect of HRV. It is also typical to analyze
the RR series in the frequency domain, reporting on the power in the low and high
regions of the spectrum, in order to examine the balance between the sympathetic and
parasympathetic (vagal) forces on the heart. HRV is also investigated using nonlinear
indices, the most popular being the time domain indices as they are better suited to
the shorter and noisy RR series arising from ECG data. Typical choices include
symbolic dynamics, Hc, ApEn, SampEn, MSE, and KFD. Lower values for these
quantities are indicative of a reduction in the complexity (more precisely, an increase
in the regularity) of the RR series. Voss et al. (1996) point out that a synthesis of
both linear and nonlinear indices can aid in discriminating between persons at risk
for sudden cardiac events.
As will be seen below, HRV analysis leads to much more consistent results than
those obtained in the EEG analyses of the preceding section. In general, patients with
schizophrenia exhibit reduced HRV and reduced RR complexity compared to healthy
controls. Much less work has been done on bipolar disorder, but results there also
point toward reduced HRV and reduced complexity.

3.5.1

HRV in Schizophrenia

The tendency in schizophrenia toward parasympathetic withdrawal and sympathetic
predominance in heart rate modulation as well as the reduction in HRV, as measured
by linear and spectral indices, has been documented by Montaquila, Trachik, and

148
Bedwell (2015) and Clamor, Lincoln, Thayer, and Koenig (2016). Thus we focus on
articles that have employed nonlinear indices. A number of studies have provided
evidence that RR series from unmedicated (UM) schizophrenia patients result in
significantly lower nonlinear scores than those from healthy matched controls. Compression entropy Hc has been repeatedly evaluated and found to be lower in such
patients (Bär et al., 2007; Bär, Boettger, et al., 2008; Bär, Koschke, et al., 2008;
Schulz, Bär, & Voss, 2015). ApEn and KFD were found to be significantly reduced in
Bär et al. (2007) and Bär, Koschke, et al. (2008). SampEn was found to be lower in
Chang et al. (2009) and Schulz, Bär, and Voss (2015), and only failed to reach statistical significance after Bonferroni correction in Chang et al. (2010). Various versions
of symbolic dynamics (methods I or II) have also revealed reduced complexity in UM
patients (Bär et al., 2007; Bär, Boettger, et al., 2008; Mujica-Parodi, Yeragani, &
Malaspina, 2005; Schulz, Bär, & Voss, 2008; Schulz, Bär, & Voss, 2015). Thus the
evidence that RR complexity is reduced due to schizophrenia itself is compelling.
Antipsychotics can also have an impact on HRV and carry an increased risk of
cardiac death, even for persons without schizophrenia (Silke, Campbell, & King, 2002;
Strauss et al., 2004). Thus research has also focussed on the effects of antipsychotics
on HRV in schizophrenia. The results have suggested that in general antipsychotics
tend to further reduce HRV and complexity. Schulz, Bär, and Voss (2008) examined
46 acute hospitalized patients split into two groups, medicated (MED) and unmedicated (UM). They calculated the Shannon entropy as well as the forbidden words of
the symbolic dynamics Method II words. The Shannon entropy was lower and the
number of forbidden words higher in the MED group, indicating lower complexity.
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They also calculated plvar and phvar from symbolic dynamics Method I. The former
was higher and the latter lower in the MED group, again indicating lower complexity
in the MED group. Schulz, Bär, and Voss (2009) extended this study to include Hc,
also finding it lower in the MED group. One shortcoming of their analysis, as noted
by the authors, is that patients were on a variety of antipsychotics, so differences due
to antipsychotic choice could not be ascertained. Mujica-Parodi et al. (2005), comparing UM patients with patients treated with either clozapine or olanzapine, found
that the percentage word count from symbolic dynamics Method II exhibited a trend
toward lower values among MED patients. Bär, Koschke, et al. (2008) calculated
ApEn, KFD, and Hc in patients before and after seven days of treatment with olanzapine, and found Hc to be significantly lower after treatment. Chang et al. (2010),
however, who studied patients before and after six weeks of risperidone treatment,
did not find a significant change in SampEn or the Shannon entropy of words constructed from symbolic dynamics Method I. The article by Kim, Yi, Lee, and Kim
(2013) is a particularly important paper because it illustrates the point that the effect
of antipsychotics on HRV may be more subtle than simply one of suppression. Kim,
Yi, et al. obtained baseline Positive and Negative Syndrome Scales (PANSS) scores
as well as baseline ApEn and SampEn scores on 42 treatment-resistant patients.
These quantities were re-evaluated after four weeks and again after eight weeks of
monotherapy with clozapine. As a group, the patients exhibited significantly lower
ApEn and SampEn at four weeks than at baseline, with slightly higher (but still suppressed with respect to baseline) values at eight weeks. However, based on changes in
PANSS scores from baseline to eight weeks, Kim, Yi, et al. retrospectively classified
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patients as responders (37.5%) or non-responders (62.5%). They observed that both
ApEn and SampEn decreased from baseline through week four through week eight
for the non-responders. However, for the responders, ApEn and SampEn decreased
through week four, but then increased to slightly above baseline values at week eight.
The difference in ApEn and SampEn values between responders and non-responders
at week eight was statistically significant. In our view this suggests that patients
having a good response to an antipsychotic may be less compromised by deleterious
effects of the medication, possibly because their ANS responds to the improvement
in symptoms. The paper also illustrates the importance of the time frame over which
treatment response is evaluated; the rise in ApEn and SampEn values in responders
was not seen until week eight.
The aforementioned article by Kim, Yi, et al. (2013) suggests that there may
be a relationship between HRV and degree of psychopathology symptoms, and this
has in fact been investigated by a few authors. Kim et al. (2004) compared 50
clozapine-treated patients with 50 controls, using RMSSD, pNN50, ApEn, SampEn
and the Shannon entropy of words constructed from symbolic dynamics Method I. All
these indices were significantly lower in the patient group, but what was new was an
observed significant negative correlation between SampEn and both the total scores
and positive symptoms subscales of the PANSS, even after controlling for clozapine
dose. Chang et al. (2010), who compared PANSS scores before and after six weeks
of risperidone treatment in a small sample (N = 16), found a significant negative
correlation between changes in SDNN and changes in the PANSS positive symptoms
subscale as well as a significant negative correlation between changes in RMSSD and
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changes in both the PANSS total score and positive symptom subscales. SampEn
was not correlated with these changes. Kim, Ann, and Lee (2011) compared SDNN,
RMSSD, and ApEn with PANSS scores of 21 patients on risperidone monotherapy.
Although ApEn was reduced in the patients compared to the controls, ApEn did not
correlate with the PANSS scores. However, similar to what was obtained by Chang et
al., Kim et al. found (after controlling for risperidone dose) a significant negative correlation between PANSS total scores and both SDNN and RMSSD. In addition, they
found a significant negative correlation between the PANSS cognitive/disorganization
factor and both SDNN and RMSSD. Chung et al. (2013) ran a much larger study
(94 medicated patients, 51 healthy controls) and evaluated SDNN, RMSSD, pNN50,
ApEn, and MSE, where an overall score for this last quantity was calculated by summing the SampEn values over all scaling factors 1 ≤ τ ≤ 20. SDNN, RMSSD, and
pNN50 were all negatively correlated with the PANSS positive subscale. MSE was
negatively correlated with the PANSS general psychopathology scale, and both MSE
and ApEn were negatively correlated with the equivalent haloperidol dose of the patients. A unique aspect of this study was that metabolic profiles of the participants
were also examined, and both ApEn and MSE showed some correlation with aspects
of metabolic syndrome, e.g., they both were negatively correlated with amount of
high-density lipoprotein. Thus the HRV indices, especially the linear indices, seem to
be sensitive to degree of psychopathology, particularly the positive symptoms.
Two recent papers have investigated the possible role of HRV indices in evaluating side effects of antipsychotic medication. Kim, Ann, Lee, Kim, and Han (2013)
studied ApEn in the context of Antipsychotic Induced Subjective Restlessness (AISR)
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which can be an unpleasant side effect of antipsychotics and interfere with treatment
compliance. They found that the severity of AISR was significantly negatively correlated with ApEn. Chang et al. (2015) studied a number of linear and nonlinear
HRV indices in the context of subjective self-reports on side effects of antipsychotics.
While they found correlations between side effects and various indices, they pointed
out that SampEn seemed to be more sensitive than the linear indices and exhibited a
significant negative correlation with extrapyramidal and anticholinergic side effects.
In summary, nonlinear (and linear) indices of HRV have been shown to differ
between schizophrenia patients and healthy controls, and to further differentiate between medicated and unmedicated patients in a number of areas. The ultimate goal
would be to do be able to use these indices clinically to predict (and prevent) adverse
cardiac events and adverse responses to certain antipsychotics.

3.5.2

HRV in Bipolar Disorder

There have been comparatively few studies done on bipolar disorder involving nonlinear indices, so we first report on articles involving only linear indices in order
to present evidence that HRV, as measured by linear indices, is reduced in bipolar
patients regardless of clinical mood state. Cohen et al. (2003) analyzed euthymic
medicated bipolar patients and found SDNN to be lower in patients than controls.
The patients were on a variety of medications, but an ANOVA did not reveal any
difference in SDNN between medication groups, so the authors proposed that the
reduced HRV was due to the disease and not the medications. Voggt et al. (2015)
also found reduced SDNN in medicated euthymic bipolar patients and argued that
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medication was not likely the sole cause of the reduction. Lee, Kim, Hong, and Joo
(2012) analyzed medicated bipolar patients who were in a subsyndromal depressive
state and found both SDNN and pNN50 (althought not RMSSD) significantly reduced
compared to controls. The proposal that the disease itself (apart from medication)
carries a risk for reduced HRV has now been supported by recent work of Chang et al.
(2014) and Chang, Chang, Kuo, and Huang (2015). Chang et al. (2014) compared 61
patients during an acute manic episode with 183 matched controls. Participants were
carefully selected to have no physical condition or smoking history that could impact
HRV; moreover, patients could have no comorbid psychiatric diagnosis and had to be
unmedicated for at least one month (UM1). Chang et al. found SDNN significantly
lower in patients than controls. Furthermore, SDNN was inversely correlated with
scores on the Young Mania Rating Scale. Chang et al. (2015) then carried out a
study comparing UM1 depressed bipolar II patients to UM1 depressed unipolar patients and controls (again carefully selecting for physical health, smoking history, and
lack of comorbidities). They found that SDNN was significantly lower in the bipolar
patients than in both the unipolar patients and controls. Since the two patient groups
were matched on severity of symptoms, the authors suggested that their results may
indicate that bipolar II depression and unipolar depression are two distinct diseases.
The most important point to be drawn from these studies, however, is that HRV, at
least as measured by SDNN, appears to be reduced regardless of the clinical state
(manic, depressed, euthymic) of a bipolar patient. A recent meta-analysis (FaurholtJepsen, Kessing, & Munkholm, 2017) concludes that there is evidence for reduced
HRV in bipolar disorder but makes an argument for stricter methodology in studies.
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Most work that has been done in evaluating nonlinear indices in the context
of HRV has focused on SampEn. It was first proposed by Migliorini, Mendez, and
Bianchi (2012) that SDNN and RMSSD might be useful in discriminating between a
bipolar patient and a healthy control (which is consistent with our discussion above)
whereas SampEn (and LZC) might be more sensitive to the actual mood state of the
patient. Migliorini et al. ran a very small study where they computed normal ranges
(5th − 95th percentile) of various indices based on sleep ECG from eight healthy controls. They then determined these same indices for one bipolar patient over four
nights (at least one week apart) who was in a different clinical state during each
night. The different clinical states were different levels of depression (mild or severe)
and different levels of anxiety (low or high). On the fourth night only she was euthymic with low anxiety. SDNN and RMSSD for the patient fell below the normal
5th percentile on all four nights. SampEn, on the other hand, while much below the
normal 5th percentile on the first three nights, increased into the normal range on
the fourth night. Interestingly, LZC was slightly elevated above the normal 95th percentile for the first three nights, dropping into the normal range on the fourth night.
The idea that SampEn might be exploited to predict onset of euthymia (and hence
response to treatment) has been studied further by Nardelli, Valenza, Gentili, Lanata,
and Scilingo (2014) and Lanata, Valenza, Nardelli, Gentili, and Scilingo (2015). The
second paper is essentially an extension of the first with a larger sample size. Ten
hospitalized patients (either experiencing acute depression or an acute mixed depressive/hypomanic episode) were followed from the initiation of treatment or a change
of treatment until remission. In each case SampEn increased almost linearly with
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time, with mixed states exhibiting the lowest SampEn and euthymia exhibiting the
highest. The authors opined that measuring early changes in SampEn might be an
objective way of determining whether a particular treatment protocol was going to
be effective for a given patient. It should be noted that data was obtained using
very long ECG recordings obtained by having patients wear a comfortable textile
T-shirt (with embedded electrodes) as they went about their day. The authors see a
future in such personal monitoring systems in providing patients and physicians with
feedback on multiple indices of HRV and perhaps predicting mood relapses as well as
treatment response. Levy (2014) divided medicated remitted bipolar I patients into
two groups, those with high illness severity (HIS) and those with low illness severity
(LIS). Patients were considered to be HIS if they had ever had a psychotic episode,
otherwise they were classified as LIS. Levy calculated SDNN and SampEn. He found
that SDNN could distinguish between HIS patients, LIS patients, and controls, with
the first group exhibiting the lowest SDNN and the last group exhibiting the highest
SDNN. SampEn, on the other hand, could only distinguish between the HIS group
and the controls, assigning lower value to the first. This again suggests that within
a fixed mood state (in this case euthymia) SampEn is less sensitive to differences in
diagnostic status. Valenza, Nardelli, Bertschy, Lanata, and Scilingo (2014) further
studied the discriminatory power of SampEn by considering MSE at different scales
τ . They utilized a small sample of six depression recordings, five hypomanic recordings, and five euthymic recordings. MSE was not discriminatory when the standard
parameters m = 2, r = 0.15·SDNN were used in calculating SampEn on each series.
However, by changing r to be optimal for each series (in the sense that it maximized

156
approximate entropy for that series) MSE became discriminatory at most values of
1 ≤ τ ≤ 20. In particular it could distinguish the hypomanic sample from the euthymic sample at τ = 1, 2 and τ = 4 − 20. Moreover, the hypomanic sample could
be distinguished from the depressive sample at τ = 1, 9, 10. (The hypomanic MSE
scores were the lowest and the euthymic MSE scores the highest.) Since τ = 1 is
just SampEn, this is further evidence of the discriminatory power of SampEn among
mood states even when samples are small (at least when r is optimal).
A few papers have examined other nonlinear indices. Todder, Bersudsky, and
Cohen (2005) re-analyzed the euthymic data of Cohen et al. (2003) using λ1 as well
as symbolic dynamics (Method II) where they computed the Shannon entropy of the
word distribution. They found no difference between patients and controls on either
index. Thus the lowered HRV that was picked up by SDNN was not buttressed by a
reduction in complexity as reflected by these indices. The reasons are unknown and
could range from a lack of sensitivity within a fixed mood state (similar to SampEn)
to the (unknown) length of the RR series, to which nonlinear indices (especially λ1 )
are sensitive. Henry, Minassian, Paulus, Geyer, and Perry (2010) compared bipolar inpatients who were in an actively manic state with schizophrenia inpatients and
healthy controls. The majority of all patients were on medication. Henry et al. used
symbolic dynamics (Method I) and SampEn along with the linear indices. The manic
patients scored significantly lower than the controls on both nonlinear indices as well
as RMSSD (interestingly, SDNN was reduced but did not reach statistical significance). There was also a trend toward reduced HRV in the schizophrenia patients
(across both linear and nonlinear indices) but these did not reach statistical signifi-
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cance. However, the sample size of the schizophrenia patients was about half that of
the manic patients. Moon, Lee, Kim, and Huang (2013) investigated differences in
HRV in a variety of psychiatric disorders, using more than double the sample sizes of
Henry et al. (2010). ECG recordings were taken 0-7 days after starting medication.
The only nonlinear index used was ApEn which did not reach statistical significance
for any disorder. However, the bipolar patients exhibited significantly reduced SDNN
and RMSSD whereas the schizophrenia patients just exhibited reduced SDNN; moreover, the reductions in bipolar disorder were accentuated compared to schizophrenia.

3.6

Applications to Mood Data in Bipolar Disorder

The application of nonlinear indices to the RR series generated by bipolar patients
was considered in the previous section. Here we consider applications to mood data
generated by self-report measures. Bipolar disorder, as measured by mood data over
time, shows some evidence of cyclical behaviour between manic and depressive states,
but for almost all individuals these cyclicities are too irregular and unpredictable to be
considered truly periodic. This fact was noted almost 100 years ago by Kraepelin (as
discussed and cited by Woyshville, Lackamp, Eisengart, and Gilliland, 1999). As such,
bipolar mood data presents a natural example of a situation ripe for investigation for
the possibility of underlying nonlinear dynamics. In spite of this, there has been
relatively little application of nonlinear indices to the analysis of mood data, possibly
because of the difficulty of collecting sufficiently long time series to produce reliable
estimates. A notable exception is the article by Gottschalk, Bauer, and Whybrow
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(1995) who applied estimates of D2 to distinguish between patients and controls.
Gottschalk et al. followed seven rapid-cycling bipolar patients and 28 healthy controls
over a period of 1-2.5 years. All patients and controls completed daily mood logs (the
controls actually reported mood twice daily, but for the purpose of comparison with
the patients one of the daily reports was later dropped). The mood log utilized was a
100-mm continuous analogue scale ranked from “Very Worst I Felt” to “Very Best I
Felt” with the midpoint designated as “Normal”. Patients placed a mark on the scale
indicating their average mood over the preceding 24 hours. A slightly different but
similar recording procedure was used for controls. Time series lengths ranged from
n = 358 to n = 922 for the patients, which are short compared to the lengths of time
series usually considered in the physical sciences. Plots of the time series revealed clear
distinctions between patients and controls; the latter appeared much more irregular
or “rougher”, whereas the patients’ series seemed to suggest more structure with the
occasional appearance of cyclical features. In the following discussion we omit Patient
7 who was identified by Gottschalk et al. as the “healthiest” of the patients and who
produced data closer to that of the controls. Spectral analysis (which is equivalent to
analysis of the autocorrelation function) suggested that both patients and controls had
power spectra consistent with a 1/f α power spectrum (up to the “noise floor” of the
data) where α̂ = 2.24 for patients and α̂ = 0.57 for controls. The difference between
these two α values was statistically significant. The lack of “peaks” in the spectra
(for both patients and controls) indicates the absence of well-defined periodicities in
the time series, thus validating the observations of Kraepelin. The higher value of α
for the patients is also indicative of a greater degree of short-term correlation in the
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patients’ data, which is suggested from the time series plots. The key result of the
paper, however, was that the Grassberger-Procaccia (GP) algorithm converged for
each of the patients (producing surprisingly low finite values for the estimates of D2 )
whereas the algorithm failed to converge for the controls. The quantitative validity
of the finite D2 estimates cannot be known, as linear correlations in the data may
play a role in the convergence, but the difference in the behaviour of the algorithm
between patients and controls certainly suggests a qualitative difference in dynamics.
In particular, as Gottschalk et al. noted, the time series of the patients is much more
organized than those of the controls. Gottschalk et al. went on to construct three
surrogate series for each patient, and found that the GP algorithm failed to converge
for the surrogate series. This suggests that the patients’ original time series probably
do include nonlinear features, and that the finite D2 values were not simply the result
of strongly-correlated linear noise. However, it was not clear why Gottschalk et al.
did not carry out a full surrogate analysis as described in Sec 2.2.6. This could have
been done by selecting a significance level, generating B or more surrogate series for
each patient, and choosing an embedding dimension M for which the GP algorithm
had converged for that patient. The values of the estimates of D2 for the surrogate
series (using the chosen value of M) could then be compared to the estimate of D2
for the original series. Gottschalk et al. concluded that their results implied evidence
of chaotic dynamics in the bipolar mood data, but in view of the short lengths of the
time series, absence of estimates of Lyapunov exponents, and form of power spectra
(see paragraph below) the best that can be firmly concluded from their analysis is
that bipolar patients exhibit qualitatively more organized dynamics than controls
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with a possibility of nonlinearity.
Krystal and Greenside (1998) provided a short critique of Gottschalk et al.
(1995) where they pointed out that chaotic deterministic dynamics should show power
spectra that decay exponentially fast (not as power laws) in the high frequency range
(Sigeti, 1995a,b). Gottschalk et al. (1998) responded that their spectral data was
also consistent with an exponential decay; statistically neither the exponential model
nor the power-law model fit better (which calls into question the interpretation of
the α estimates mentioned in the original article; see also the comment regarding
Woyshville et al. (1999) below). It may simply be that there is too much noise in the
patients’ data to see a clear exponential decay. However, Gottschalk et al. (1998) do
point out that, for the controls, the power law model fits the data significantly better
than the exponential model.
Woyshville et al. (1999) carried out a shorter study where similar daily mood
data was collected only over a period of 90 days. (In this case patients were identified
as exhibiting affective instability and were not limited to bipolar diagnoses; they had
a variety of Axis I mood disorders). Woyshville et al. did not have enough data to
carry out a GP algorithm analysis, but they did calculate the power spectra of participants as well as the fractal dimension (FD) of the graph of the mood series data,
using a coastline algorithm (Mandelbrot, 1977). They fit power law models to the
spectra, and found the α ratio of patients to controls to be approximately 2, which
is roughly the same ratio as obtained by Gottschalk et al. (1995). Woyshville et al.
made the intriguing suggestion that this ratio was perhaps an invariant characteristic
between patients and controls. However, in view of Gottschalk et al. (1998), these α

161
values must be viewed with caution. Moreover, in a very brief recent report, Kreindler
and Munshi (2015) did not find any significant difference in α between groups consisting of bipolar patients, patients with affective instability, and healthy controls;
nor did Ribeiro and Lourenço (2016). However, Woyshville et al. also found that FD
was significantly lower in patients than controls, which quantitatively supports the
observation that mood series in controls appear rougher than those in patients.
Heiby, Pagano, Blaine, Nelson, and Heath (2003) carried out hourly mood
measurements (using a 7-point Likert scale) 10 times daily on one depressed female
patient and one female control, obtaining a time series of length 1,840 for each. They
found a periodic component in each woman’s power spectrum (stronger in the patient)
which they attributed as possibly being due to the participants’ menstrual cycles.
Using the GP algorithm, Heiby et al. found a D2 estimate of 2.7 for the patient and
a D2 estimate of 4 for a single surrogate series constructed for the patient. (The GP
algorithm did not converge for the control). The D2 estimates for the patient and the
surrogate series are mentioned here only to indicate how potentially indistinguishable
the two may be; a proper analysis using a full set of surrogate series might have
revealed whether the patient’s D2 value was reflecting nonlinear structure or was the
result of strong linear correlations in the time series. The latter is quite possible since
we can expect hourly mood measurements to be highly correlated in a person with
persistent low mood. Katerndahl, Ferrer, Best, and Wang (2007) obtained mood data
from three depressed patients and four controls. Mood data here was also recorded
hourly (while participants were awake) on a 100-mm analogue scale for 30 days. The
authors report D2 , λ1 , KSE, and the results of surrogate data testing (based on 20
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surrogate series) for each participant. These results were produced by a software
package and the authors do not provide details as to how they selected the final
values. Critically, unlike Gottschalk et al. (1995) or Heiby et al., they claim finite
correlation dimensions for the controls (which are not distinguishable from those of the
patients; this is also true of λ1 and KSE). The authors do not offer an explanation for
the lack of distinction. Moreover, they indicate that surrogate data testing indicates
nonlinearity for all participants. However, there is insufficient information to evaluate
their results.
It is important to note that techniques that do not involve embedding methods
have been utilized to evaluate possible nonlinearity in bipolar mood series. Bonsall,
Wallace-Hadrill, Geddes, Goodwin, and Holmes (2012) obtained weekly mood data
from 23 bipolar patients for a period ranging 46-220 weeks; unlike Gottschalk et
al. (1995), however, they used only depression score ratings (the Quick Inventory of
Depressive Symptomatology QIDS-SR). An interesting aspect of their approach is
that, based on the first six months of data, they classified patients as either stable
(n = 11) or unstable (n = 12). Using the Akaike Information Criterion, they fit
various models, and found that distinct nonlinear models best fit the two different
groups. The stable group was best described by a threshold autoregressive model of
order one (TAR(1)) whereas the unstable group was best described by a threshold
autoregressive model of order two (TAR(2)). In both cases the threshold was the
mean score of the individual patient’s mood data. Moore, Little, McSharry, Goodwin,
and Geddes (2014) were critical of the rather large in-sample errors of the TAR
models in Bonsall et al., although the latter indicated that some of this error was
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probably due to runs of missing data. Moore et al. used 100 weekly mood ratings
from eight bipolar patients (employing the same QIDS-SR scale as Bonsall et al.) and
constructed surrogate series for each patient. Comparing the original and surrogate
series using two discriminating statistics, first the ratio of linear vs. nonlinear insample forecast errors, and then a time-reversal asymmetry statistic, Moore et al.
concluded that there was no distinction between the original and surrogate time series.
Thus they found no evidence for nonlinearity in the original mood series. Moreover,
a comparison of various linear and nonlinear out-of-sample forecasts showed little
difference between methods. The authors acknowledged that their conclusion of lack
of nonlinearity in the original series could be due to insensitivity of the discriminating
statistics, short length of the time series, or the sampling frequency. It is worth
noting that Ortiz, Bradler, Garnham, Slaney, and Alder (2015) found that mood
ratings of both healthy controls and euthymic bipolar patients could be modelled
by a linear stochastic process in the form of an autoregressive integrated moving
average (ARIMA(1,1,0)) process. This means that after the original mood series
Xt is differenced to create Zt = Xt − Xt−1 (this is done in order to render the
series stationary) then Zt can be expressed as an AR(1) process Zt = cZt−1 + at.
However, Ortiz et al. point out that a model for medicated euthymic patients may
not fit unmedicated patients or patients experiencing active episodes (recall that the
patients in Gottschalk et al. (1995) were rapid-cycling). The question of linear vs.
nonlinear models remains open.
There have been a few studies using time space indices in bipolar mood data.
Bauer et al. (2011) expanded on a pilot study by Glenn et al. (2006) where they used
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approximate entropy ApEn to see if pre-episode states could be distinguished from
pre-remission states in bipolar patients. They followed 98 patients over a period of
one year, collecting daily mood data (rapid-cycling patients were excluded from the
study). A pre-hypomanic state was defined to be the 60 days before an episode of
hypomania, a pre-depressive state was defined to be the 60 days before an episode of
depression, and a pre-remission state was defined to be the 60 days before a month
(30 days) of euthymia. Thus the time series to be compared were only of length
n = 60. The ApEn parameters used were m = 1 and r = 0.2·SD for each patient.
The key result of the paper is that ApEn(1, r, 60) could distinguish between all
three states, yielding ApEn(pre-hypomanic)> ApEn(pre-depression) > ApEn(preremission), with all differences being statistically significant using t-tests. In contrast,
mean mood could not distinguish between pre-hypomanic and pre-depressive states,
or between pre-hypomanic and pre-remission states. The mood SD was more sensitive
to changes in the time series but still could not distinguish pre-hypomanic states
from pre-depressive states. This points not only to the utility of ApEn as a tool for
distinguishing patterns in data, but to the notion that prodromal changes in bipolar
mood may begin and be detected in longer time periods (e.g., 60 days) before the
onset of an episode. Yeragani, Pohl, Mallavarapu, and Balon (2003) also showed that
ApEn could distinguish between mood in healthy controls (also using n = 60).
Kreindler and Munshi (2015) reported on a study in which they did not find a
significant difference in SampEn on mood ratings between bipolar patients, affectively
unstable patients, and healthy controls. However, Ribeiro and Lourenço (2016) did a
more involved analysis where they examined SampEn for different parameter choices
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m and r over five different 110-mm visual analogue daily mood scales (VAS) (e.g.,
“very worst I ever felt” to “very best I ever felt” was one scale, “very tired/slow”
to “very energetic/excited” was another scale). There were 17 patients with active
affective instability (71% bipolar) and 10 matched controls. Two-way ranked ANOVA
revealed a difference in SampEn between the patient and control groups over the
five VAS, although post hoc Mann-Whitney multiple comparisons did not reveal
a significant difference between the patients and controls on any particular VAS.
There was a second part to the analysis, however, where the authors looked at the
relationship between SampEn and the “load of bad days” which, for each participant,
was defined as the proportion of days in the “very worst – very best” VAS that
fell beneath one standard deviation below the mean score of the VAS. The load
of bad days was seen as a proxy for the amount of daily strain on the affective
system. The authors predicted that, in controls, mood complexity (as measured by
SampEn) would increase as load of bad days increased (indicating a resilient response
to strain) and that this response would be compromised in patients. This hypothesis
was born out; SampEn increased with load of bad days in general, but the relationship
was much stronger in controls, with patients showing on average up to 25% lower
complexity of mood variation than controls for the same load of bad days. The authors
conclude that the healthy response to adversity involves activation of processes of
emotion regulation that lead to increases of complexity in mood variability, and that
this response is impaired in patients with affective disorders. They state that the
main clinical implication of their findings is that “interventions aimed at increasing
flexibility of emotion regulation and complexity of mood variation may be effective

166
treatments for people with affective disorders” (p. 43).

3.7

Discussion and Future Directions

In this chapter we began by reviewing the definitions of the main nonlinear indices
employed in the study of EEG, HRV, and mood data for persons with schizophrenia
or bipolar disorder. This list of indices is not exhaustive, but due to space constraints
we isolated these as the indices receiving most frequent attention. An important point
to be taken from these various definitions is that these indices are generally measuring
different quantities and there is no unique definition of the term “complexity”. In our
view it may be better to avoid that term altogether, but we have sometimes used it
because it is so ubiquitous in the literature.
In the study of EEG in schizophrenia (Section 3.4.1), we performed an exhaustive literature search and investigated the L-F proposal. We saw that if D2 was
used as the index, there was no observable medication or age effect (in contradiction
to the L-F proposal). When all nonlinear indices were combined (requiring the assumption that they all behave the same way with respect to age and medication) we
obtained only weak evidence of age and medication effects. Based on recent work
of Cerquera et al. (2017) we proposed that patient symptomatology (a specific component of the L-F proposal) may be the most important determinant of outcome
relative to healthy controls. It would also be important to determine the extent to
which laboratory techniques are contributing to the apparent “study effect”. Resolving this conundrum may be part of unravelling the observed patterns and ultimately
the neurobiology of schizophrenia.
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Future directions may lie in the area of determining if in fact there are any key
elements of conditions (or tasks) that partly determine the outcome of an index (i.e.,
other than patient symptoms). Results from the present review appear to indicate
elevated D2 in schizophrenia samples for certain tasks. Further scrutiny indicates that
these tasks evidently share requirements for stimulus encoding, meaning the cognitive
translating of presenting stimuli into a format facilitating performance (e.g., sentence
representation for possible later recall, Koukkou et al., 1993; input of continuously
presented items, of the continuous-performance task, Kirsch et al., 2000; and visual
tracking of a pendulum, Lutzenberger et al., 1995; see Cutler and Neufeld (2017) and
Chapter 2 for a discussion of stimulus encoding in schizophrenia.)
Linear and nonlinear indices have consistently pointed toward reduced complexity (increased regularity) of the RR series in schizophrenia with similar conclusions now being reached for bipolar disorder. Studies have shown that antipsychotic
effects on HRV can also be detected via these indices, and it is possible that they
might be employed to predict both adverse and positive responses to treatment. One
of the more intriguing suggestions is that SampEn can be used to differentiate between mood states in bipolar disorder, and that personalized wearable monitoring
systems might utilize HRV indices to predict both mood relapses and response to
treatment. Since such wearable systems are already in the testing stage, this seems
a possibility in the near future.
There have been few studies of mood data using phase space indices likely
because of the difficulty in obtaining sufficiently long time series. Now that attention
is turning more toward time domain indices (which are more applicable to relatively
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short and even noisy time series) we can expect more advances in this area. The
fact that Bauer et al. (2011) found that ApEn could distinguish between pre-manic,
pre-depressive, and pre-remission mood states (while linear measures could not) was
particularly interesting. It suggests that applying nonlinear indices to mood records
might aid in predicting both the onset and nature of relapses. This might become a
particularly powerful tool if it was coupled with prediction methods from HRV data
as discussed in the preceding paragraph.
The focus above has been on EEG and ECG. Future directions will include
applying nonlinear concepts to MEG and fMRI data, the latter offering spatial resolution that may reveal new information.
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of EEGs of patients with major depression during different emotional states.
Computers in Biology and Medicine, 6, 49-60.
Akar, S. A., Kara, S., Agambayev, S., & Bilgiç, V. (2015b). Nonlinear analysis of
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Chapter 4
Concluding Remarks
In this thesis we have focused study on certain observed and potential numerical earmarks of schizophrenia, chiefly in response to cognitive stimuli, but also in response to
the behaviour of the ANS. Numerical quantities have a theoretical advantage over behavioural ones in that in principle they may be more objectively measured. However,
as we observed in Chapter 3, the inconsistency of outcomes in nonlinear indices in the
EEG of schizophrenia patients means there is no simple correspondence between complexity of EEG signals and diagnostic health. Rather, a more involved relationship,
such as the L-F proposal, must be entertained which takes into account factors of
age, antipsychotic medication, patient symptomatology, and laboratory procedures.
To this we may also add the condition, or cognitive stimulus, under which the EEG
is taken. We noted in the discussion at the end of Chapter 3 that D2 was seen to be
higher in certain conditions in which encoding load could be considered high. The L-F
proposal, with all the above components factored in, has never really been properly
investigated in any depth. One might propose a study involving a very large number
of participants over a wide range of ages, different medication dosages (including unmedicated), and different symptomatology (in particular deficit syndrome (DS) vs.
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nondeficit syndrome (NDS)) and develop a multiple regression model using all these
variables. (There would of course be limits on the design as medication dosages, as
well as medication presence or absence, would be controlled by the needs of the patient.) The EEG procedure could then be carried out over a range of cognitive stimuli
(including those with low and high encoding requirements) and a suite of nonlinear
indices could then be evaluated for each participant. In this manner the influence
due to different factors might become clearer. The relationship between nonlinear
indices and HRV in schizophrenia patients, however, is much more direct; schizophrenia patients seem to exhibit reduced complexity in HRV with a concomitant greater
tendency toward adverse cardiac events.
In Chapter 2 we reviewed experimental studies that suggest that prolonged
encoding times in response to cognitive stimuli are a numerical earmark of persons
with schizophrenia, and noted that this prolonged encoding results in a variety of
consequences. The main work of Chapter 2 was then to develop a flexible class of
models (the general serial mixture model introduced in Sec 2.2) that could be applied to describe encoding times (and other cognitive processing latencies) and which
enabled us to explore and illustrate potential physical and neurophysiological mechanisms behind encoding in various experimental paradigms. These models featured
an emphasis on two quantities: the number K of subprocesses being encoded and
the speed Θ at which they were encoded. In Sec 2.3 we focussed on a subclass of
these models where changes in encoding times were explained solely by changes in K
while holding the distribution of Θ constant. These simplified models, which seem
sufficient to explain encoding changes in many cases of schizophrenia, were seen to
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yield a variety of MIC-VIC signatures which can be used for comparisons between
models in terms of fitting them to factorial data. A distinction in these models was
made between the case where K varies only over participants and the case where K
varies over trials rather than, or in addition to, varying over participants. A numerical test for distinguishing these two cases was developed. Further work in developing
the asymptotic behaviour of this numerical test and the sample sizes necessary to
effectively implement it is warranted. In Sec 2.5 we focussed on the reverse case
where Θ was allowed to vary while holding the distribution of K constant. There has
been less experimental evidence linking these models to changes in encoding times in
the case of schizophrenia, but it is possible that these models may be useful in some
experimental paradigms as well as in the case of cognitive processing latencies other
than encoding times. Cases where both K and Θ are allowed to vary simultaneously
are a topic for future study, as are cases where the distributions of K and Θ are not
independent but linked. It is hoped that continuing investigations into the general
serial mixture model will yield a mathematical toolbox of techniques for examining
processing latencies in cognitive neuroscience.
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Appendix A
Discrete Probability Distributions
1. Poisson distribution: K has discrete probability mass function on k =
0, 1, 2, . . . given by
mk e−m
P (K = k) =
k!
D

where m > 0 and E(K) = Var(K) = m. Abbreviation: K ∼ Pois(m)
2. truncated Poisson distribution: K has discrete probability mass function
on k = 1, 2, 3, . . . given by
P (K = k) =
where m > 0, E(K) =

m
1−e−m

mk e−m
(1−e−m ) k!

and Var(K) =

m
1−e−m

−

2
m
1−e−m

e−m

3. translated Poisson distribution: Let n be a fixed positive integer. K has a
translated Poisson distribution with translation factor n if K = X + n where
D
X ∼ Pois(m). Thus E(K) = m + n and Var(K) = m.
4. binomial distribution: K has discrete probability mass function on k =
0, 1, . . . , n given by
 
n k
P (K = k) =
p (1 − p)n−k
k
where 0 < p < 1, E(K) = np, and Var(K) = np(1 − p). Abbreviation:
D
K ∼ binom(n, p)
5. geometric distribution: K has discrete probability mass function on k =
1, 2, 3, . . . given by
P (K = k) = (1 − p)k−1 p

where 0 < p < 1, E(K) = 1p and Var(K) = 1−p
. (Note the geometric is a
p2
special case of the negative binomial (see below) where r = 1.) Abbreviation:
D
K ∼ geom(p).

6. negative binomial distribution: Let r be a fixed positive integer. K has
discrete probability mass function on k = r, r+1, r+2, r+3, . . . given by


k−1
P (K = k) =
(1 − p)k−r pr
r−1
where 0 < p < 1, E(K) =

r
p

and Var(K) =

r(1−p)
.
p2

(The case r = 1 yields the
D

geometric distribution as noted above.) Abbreviation: K ∼ negbinom(r, p).
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Appendix B
Continuous Positive Infinite-Tailed Probability Distributions
1. exponential distribution: Let v > 0 (called the rate parameter; sometimes an
alternate parameterization is used where b = 1/v is called the scale parameter).
D
Abbreviation: ` ∼ expo(v).Then ` has probability density function (pdf)
given by
φ(`) = ve−v` for ` > 0
and mean and variance given by
1
1
and Var(`) = 2 .
E(`) =
v
v
Note the exponential is a special case of the gamma distribution (see below)
where the shape parameter a = 1. Thus an alternative abbreviation for the
D
exponential is ` ∼ Gam(1, v).
2. gamma distribution: Let a > 0 (shape parameter) and v > 0 (rate parameter;
the alternate parameterization b = 1/v is sometimes used where b is called the
D
scale parameter). Abbreviation: ` ∼ Gam(a, v). Then ` has probability
density function (pdf)
φ(`) =

`a−1 v a −v`
e
Γ(a)

for ` > 0

with mean and variance
a
a
and Var(`) = 2
v
v
Some related moments of interest (for a > 2) are:
E(`) =

E(1/`) =

v
v2
v2
, E(1/`2 ) =
, Var(1/`) =
a−1
(a − 1)(a − 2)
(a − 1)2 (a − 2)

Also note that the special case of the gamma where a = k, a positive integer,
D
is called the Erlang distribution and can be expressed as ` ∼ Gam(k, v).
3. inverse Gaussian distribution: Let µ > 0 (the mean) and λ > 0 (the shape
D
parameter). Abbreviation: ` ∼ IG(µ, λ). Then ` has probability density
function (pdf)
r
2
λ − λ(`−µ)
2µ2 `
φ(`) =
e
for ` > 0
2π`3
and the mean and variance are
µ3
E(`) = µ and Var(`) =
λ
Some related moments of interest are:
1 1
1
2
E(1/`) = +
and Var(1/`) =
+ 2
µ λ
µλ λ
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4. Weibull distribution: Let a > 0 be the shape parameter and b > 0 be the
D
scale parameter. Abbreviation: ` ∼ Wei(a, b). Then the pdf is
a
f(`) =
b

 a−1
` a
`
e−( b )
b

for ` > 0

and the mean and variance are
E(`) = bΓ(1 + 1/a) and


Var(`) = b2 Γ(1 + 2/a) − (Γ(1 + 1/a))2

The expo(v) distribution is a special case of the Weibull where a = 1 and
b = 1/v.
5. lognormal distribution: Here −∞ < µ < ∞ and σ 2 > 0 are real numbers
denoting, respectively, the mean and variance of the associated normal distriD
D
bution X ∼ N(µ, σ 2 ). Here ` = eX . Abbreviation: ` ∼ LN(µ, σ 2 ). The pdf
is
(log `−µ)2
1
e− 2σ2
for ` > 0
f(`) = √
` 2πσ 2
and the mean and variance are
σ2

E(`) = eµ+ 2

2

2

and Var(`) = e2µ+σ (eσ − 1)

188
Appendix C
Proof of Corollary 5.1
The conceptual idea behind this corollary is that, conditioning on a specific participant i, the mean of the sequence of observed encoding trials ti1, . . . , tiN should converge as N → ∞ to the theoretical mean E(Ti) = E(Ki )E(µ(Θi )) of that participant
by the strong law of large numbers for i.i.d. sequences. Then, since we can (unconditionally) view the mean E(Ti ) of each participant as an i.i.d. observation from a
distribution with mixture mean E∗i [E(Ti)] = E(T )∗, the mean (

PM

i=1

E(Ti ))/M over

the participants in the cell then converges as M → ∞ to E(T )∗ provided E(T )∗ < ∞.
(A similar conceptual argument can be made for variances.)
The second part of the above argument, concerning the convergence to E(T )∗
of (

PM

i=1

E(Ti ))/M, is correct as it stands. However, the first part of the argument

requires more nuance. A sequence T1, T2, . . . of encoding times from a random participant is an exchangeable sequence (Chow & Teicher, 1988) in that any permutation
of a finite number n ≥ 1 of elements Ti1 , . . . , Tin has the same distribution as every
other permutation of that number of elements, but the sequence is not i.i.d. since
the variables are linked through their (unknown) common distributions of K and Θ.
However, conditional on the distributions of K and Θ, the sequence does become i.i.d.
(Up until now, we have been using the phrase “conditional on participant i” but this
has been a convenient mislabelling; all that is needed to render the sequence i.i.d. is
to condition on the distributions of K and Θ, and many participants may share the
same distributions for these quantities.) An equivalent way to phrase “conditional on
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the distributions of K and Θ” is to state “conditional on the σ-algebra G = σ(K, Θ) of
events generated by K and Θ”. Combining Theorem 2, p. 224, of Chow and Teicher
(1988) with the first theorem of Kuritsyn (1987), we obtain the following convergence
theorem:
Theorem C: If the exchangeable sequence T1, T2, . . . from a random participant with
mixed marginal distribution T satisfies E[|T |] < ∞, then
N
1 X
Tj (ω) = E(T | G)(ω) with probability 1.
lim
N →∞ N
j=1

Consider first the case of the means. Since encoding times are nonnegative, we may
express the mixed marginal mean E[|T |] = E[T ] = E(T )∗ = E∗i [E(Ki )]E∗i [E(µ(Θi)]
where at the last step we revert to our previous notation and employ (2.2.10) in order
to make the link clear. Therefore the premise of Theorem C is verified by checking
that, for the distributions chosen for K and Θ, the mixed marginal mean E(T )∗ =
E∗i [E(Ki )]E∗i [E(µ(Θi )] is finite. (This is so for all examples we have considered in Sec
2.4.) Then across a sequence of encoding times on any participant we obtain
N
1 X
lim
Tj (ω) = E(T | G)(ω) with probability 1
N →∞ N
j=1

where E(T | G)(ω) = E(T | σ(K, Θ))(ω) = E(Ki )(ω)E(µ(Θi ))(ω) = E(Ti )(ω) for all
participants i which share the same distributions for K and Θ. This proves the
part of Corollary 5.1 dealing with the convergence to E(T )∗. For the case of the
P
variance E(Var(T ))∗ we can argue that the mean over participants ( M
i=1 Var(Ti ))/M

converges as M → ∞ to E(Var(T ))∗ provided E(Var(T ))∗ < ∞ so we only need to
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establish that, with probability 1,
N

1
1 X
(Tj (ω) − T̄N (ω))2 =
s2N (ω) =
N − 1 j=1
N −1

N
X
j=1

Tj2 (ω) − N T̄N2 (ω)

!

converges to Var(T | σ(K, Θ))(ω) = Var(Ti )(ω) for all participants i which share the
same distributions for K and Θ. Since Var(T | σ(K, Θ))(ω) = E(T 2 | σ(K, Θ)) −
(E(T | σ(K, Θ)))2, this will follow from Theorem C if we can show, for the given
choices of distributions on K and Θ, we have E[T 2] = E(T 2)∗ < ∞, as then both
terms in the right hand expression for s2N will converge appropriately. Now E[T 2] =
E∗i [Ti2] which will be finite iff E∗i [Var(Ti )] = E(Var(T ))∗ is finite, which can be checked
by applying (2.2.11).
In summary, a sufficient condition for the convergence of r∗ to the theoretical
ratio (2.4.7) is that 0 < E(T )∗ < ∞ and E(Var(T ))∗ < ∞, which proves Corollary 5.1.
(The restriction E(T )∗ > 0 is made so that the theoretical ratio is not undefined.)
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